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1 
Enzymes in Microsystem Technology
In organic synthesis the relatively young field of microsystem technology has become an emerging 
method for reaction screening, optimization and production. 1, 2 Compared to traditional processes, 
miniaturization of chemical reactions provides rapid mass and heat transfer. In addition, the 
controllable flow, usually laminar, of the solutions in microreactors allows fine-tuning of reaction 
conditions and reaction time. Furthermore, microfluidic systems have large surface area to volume 
ratios, which is especially advantageous for catalytic processes in which the catalyst is immobilized 
on the reactor wall. Microreactors even offer the possibility for commercial production of chemicals 
via intelligent engineering of continuous processing and parallelization devices.
  Recently, an increased interest in catalytic reactions performed in microfluidic devices by 
enzymes has emerged. Originally, the use of enzymes in microreactors was restricted to the area of 
diagnostics. Microsystems have unmistakable advantages to offer for this specific application. Manual 
errors can be eliminated when microreactors are integrated with analytical systems. Additionally, this 
integration is expected to result in increased reproducibility. Furthermore, similar analyses can be 
carried out in parallel, which facilitates the routine use of diagnostic systems. Enzymatic 
microreactors have therefore been extensively applied for protein 3-9 and DNA analysis, 10-13 DNA 
amplification, 14-17 and enzyme-linked immuno assays. 18-24
  Lately, biocatalysis in microreactors has started to expand in the direction of synthesis. The 
efficiency of enzymatic conversions is difficult to achieve by traditional organic synthesis, which has 
led to application of enzymes e.g. for the production of chiral compounds. These biocatalysts are 
able to perform reactions with high chemo-, stereo-, and regioselectivity. The use of biocatalysis in 
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the field of organic chemistry reveals more benefits. Since enzymes operate under mild reaction 
conditions, i.e. in aqueous solution, at mild temperature and pH, these reactions avoid organic 
solvent waste, improve process safety and have lower material and energy costs, making biocatalysis 
environmentally friendly. In short, the efficiency and selectivity of enzymes is outstanding  and in 
many cases easier to achieve compared to traditional organic synthesis. This makes the integration of 
biocatalysts with microreactors a promising development for application in organic chemistry.
  Enzymes have been used in microreactors in two ways, namely for screening of enzymes to 
determine the optimal working conditions, which requires only small amounts of enzyme, and for 
actual use in enzyme-catalyzed synthetic production processes. Initial screening experiments were 
performed to investigate whether differences existed between batch scale and miniaturized reaction 
environments. Usually the rates proved to be fairly comparable, 25, 26 but some exceptions were 
observed. For example, Kanno et al. investigated hydrolysis of p-nitrophenyl-β-D-galactopyranoside 
and the reverse transglycosylation reaction of p-nitrophenyl-2-acetamide-2-deoxy-β-D-
glucopyranoside, both catalyzed by β-galactosidase (Scheme 1). 27 They showed that both reactions 
were enhanced in the microreaction channel compared with the batch scale set-up.
  Enzyme screening  in microreactors could also be combined with rapid analysis of converted 
substrate, as was demonstrated by the group of Ismagilov. They created a droplet-based microfluidic 
system, 28, 29 in which aqueous droplets, also called plugs, were separated by an inert fluorinated 
solvent. These aqueous plugs were used to transport substrate and enzyme through the channel, 
which was extended to a three-phase plug-flow system to screen multiple enzymes for one specific 
substrate. 30
  Production of molecules using  enzymatic microreactors is still in a emerging stage, therefore 
model enzymatic conversions are mostly used for development and optimization of these systems. 
The most straightforward method for biocatalysis in microreactors is to use the enzyme in solution. 
Chapter 1 
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Scheme 1. Hydrolysis of p-nitrophenyl-β-D-galactopyranoside by β-galactosidase (a). 
Synthesis of disaccharide via transglycosylation by β-galactosidase (b).
Maruyama et al. showed enzymatic degradation of p-chlorophenol in a two-phase flow. 31 The wall of 
the channel was partially modified to be hydrophobic, which stabilized the aqueous-organic biphasic 
flow. Laccase was located in the aqueous phase, while the substrate was dissolved in isooctane. 
Degradation took place at the liquid–liquid interface, resulting in a high reaction efficiency compared 
to batchwise synthesis. In principle, this can even be extended to three-phase systems with three 
parallel or antiparallel flows. 32 Koch and coworkers also used a two-phase system, but with a pillar 
structure in the channel to stabilize the laminar flow. 33 The aqueous phase contained crude lysate 
with (R)-hydroxynitrile lyase or (S)-hydroxynitrile lyase, which was used for the enantioselective 
production of cyanohydrins from a variety of aldehydes present in the organic phase. Efficiency was 
comparable with results for batch scale synthesis. Since only a small amount of enzymes was 
required, the selected enzymatic reaction in a microreactor proved to be a facile and cost efficient 
screening method. Yoon et al. used laminar flow for the regeneration of the nicotinamide cofactor 
NADH (Scheme 2), which could be applied to a range of enzymes that require such a cofactor. 34 A 
buffer stream and a reagent stream containing flavin adenine dinucleotide (FAD), NAD+ and formate 
dehydrogenase (FDH), flowed side by side between two electrodes covering  the channel walls. 
FADH2 was electrochemically generated from FAD, and FDH regenerated NADH from NAD+ and 
FADH2. As proof of principle the enzyme lactate dehydrogenase (LDH) and the substrate pyruvate 
were also included in the reagent stream, yielding  the in situ conversion of pyruvate into L-lactate in 
the presence of NADH. A yield of 41% was achieved, showing a potentially cost-effective method to 
regenerate cofactors.
  The advantage of large surface area to volume ratios becomes apparent for microreactors 
using immobilized enzymes. Further benefits of immobilization are (1) easy separation of enzyme 
and product, and (2) simple recovery and re-use of the enzyme, which could decrease operational 
costs for future applications. In addition, the stability of immobilized enzymes is often enhanced, 
which increases their lifetime. Immobilization can be achieved by numerous methods (see Chapter 3 
for an extended overview of chemistry for covalent protein immobilization on silicon or glass), and 
can be performed on the walls of the microchannel, 8, 35, 36 on membranes in microchannels, 37 and 
Enzymes in Microsystem Technology
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Scheme 2. Electrochemical regeneration of NADH by formate dehydrogenase, which is 
consumed during the conversion of pyruvate into L-lactate by lactate dehydrogenase.
in channels filled with a silica monolith 38 or silica beads. 39 The group of Dordick used Ni-NTA 
agarose beads to non-covalently immobilize enzymes (Scheme 3a). 8, 40 They produced enzymes with 
a so-called His-tag, which is normally used for purification by affinity chromatography. Such a His-
tag consists of six consecutive histidines that can coordinate to nickel ions bound to agarose beads. 
This coordination is highly efficient and results in high loading of His-tagged proteins. The idea of 
applying a tag  for immobilization was also used by Luo et al. (Scheme 3b). 41 The enzyme S-
adenosylhomocysteine nucleosidase was produced with a pro-tag which consisted of five tyrosine 
residues. The enzyme was conjugated to the aminopolysaccharide chitosan by activation (oxidation) 
of the pro-tag by tyrosinase, followed by spontaneous formation of covalent bonds between the 
oxidized tag and chitosan, after which the conjugate was electrodeposited inside a microfluidic 
channel.
Chapter 1 
12
Scheme 3. Immobilization of a His-tagged protein to Ni-NTA beads (a). Immobilization of 
pro-tagged protein to positively charged chitosan after activation by tyrosinase (b).
Scheme 4. Oxidation of β-D-glucose by glucose oxidase yielding  hydrogen peroxide, 
which is used for the conversion of Amplex Red into resorufin by horseradish peroxidase.
  In subsequent studies, microreactors for enzyme-catalyzed organic synthesis were integrated 
with analytic microfluidic devices. For example, a continuous flow reactor with epoxide hydrolase, 
which catalyzed the kinetic resolution of glycidyl phenyl ether, was integrated with on-chip 
electrophoresis. 42 Furthermore, Limbut et al. combined a urease-containing microchannel with 
conductivity detection. 43 The enzyme urease was immobilized on the reactor walls, and used to 
convert urea into ions. This increased the conductivity of the solution due to the changes in charge 
density. Urea concentrations in human serum samples could thus be determined with this system, 
resulting in data comparable to standard serum analysis, which proved that the use of a microreactor 
is suitable for this application. A final example of the combination of enzymatically-catalyzed 
organic synthesis and analysis in one microfluidic system is a device to determine glucose 
concentrations (Scheme 4). 44 Glucose was converted by GOX into gluconolactone and hydrogen 
hperoxide, which was subsequently used in the detection chamber by HRP to convert Amplex Red 
into fluorescent resorufin. Fluorescence data were obtained using a CCD camera. Glucose 
concentrations ranging from 1 to 10 mM were successfully detected.
  Microreacors have also been integrated with work-up procedures. Honda and coworkers 
developed a continuous flow system consisting of a microreactor with immobilized acylase and a 
microextractor. 45 The acylase hydrolyzed N-acetyl-L-phenylalanine, which remained in the aqueous 
Enzymes in Microsystem Technology
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Scheme 5. Reaction sequence in the pyruvate dehydrogenase complex consisting  of the 
enzymes pyruvate decarboxylase, dihydrolipoyl transacetylase, and lipoamide 
dehydrogenase with cofactors thiamine pyrophosphate (TPP), dihydrolipoamide (Lip), 
nicotinamide adenine dinucleotide (NAD), flavin adenine dinucleotide (FAD), and coenzyme 
A (CoA).
phase after hydrolization, while unhydrolyzed N-acetyl-D-phenylalanine was extracted into an 
organic phase. This way efficient continuous production of optically pure amino acids was achieved.
  In nature, cellular processes like transcription activation and signal transduction are often 
performed by multiple enzymes assembled in complexes. 46 In such a complex the active sites of the 
enzymes are close together so intermediates are quickly processed, which reduces side reactions and 
increases reaction rates. A well-studied example is the pyruvate dehydrogenase complex, which is 
composed of multiple copies of three different enzymes, namely pyruvate decarboxylase, 
dihydrolipoyl transacetylase, and lipoamide dehydrogenase. 47 The complex catalyses the oxidative 
decarboxylation of pyruvate and the acetylation of coenzyme A, which links glycolysis to the citric 
acid cycle (Scheme 5). This multistep, or cascade, reaction even involves five different cofactors. 
Although these cascade reactions take place in complex environments, viz. in the intracellular space 
where many closely-related substrates are available, the enzymes are still able to perform their 
conversions very efficiently.
  Cascade reactions have been used in-vitro, which has especially been beneficial in sugar 
chemistry, because the application of enzymes avoids complex protection/deprotection steps 
resulting in shortened synthetic routes. 48 Ichikawa and coworkers developed two efficient, one-pot, 
multienzymatic methods for the synthesis of sialyl-N-acetyllactosamine, 49 a member of the class of 
sialyl oligosaccharides, which binds to receptors on cell surfaces. The first procedure involved the in 
situ generation of a sialic acid from N-acetylmannosamine catalyzed by sialic acid aldolase, coupled 
with regeneration of the sialic acid functionalized with the cofactor cytidine 5’-monophosphate. The 
second procedure combined the first procedure with the in situ  generation of N-acetyllactosamine, 
linked with regeneration of several precursors. Sheldon and co-workers developed several different 
cascades (Scheme 6). A oxynitrilase-nitrilase system was created for the conversion of benzaldehyde 
Chapter 1 
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Scheme 6. Conversion of benzaldehyde into (S)-mandelic acid (a), conversion of methyl-2-
acetamidoacrylate into L-alanine (b). Rh-catalyst = [Rh1(cod) ((R)-MonoPhos)2]BF [Rh(cod) 
((R)-MonoPhos)]BF4.
into enantiomerically pure (S)-mandelic acid (Figure 6a). 50 Another example is the one-pot chemo-
enzymatic catalysis starting from methyl-2-acetamidoacrylate. The substrate was first asymmetrically 
hydrogenated by a rhodium catalyst and subsequently converted by acylase I, resulting  in L-alanine 
(Figure 6b). 51 The combination of an enzymatic reaction with a chemocatalytic conversion has been 
investigated intensively, and it has been applied e.g. for dynamic kinetic resolution. 52-54
  Microreactors can be especially suitable for the execution of enzymatic cascade reactions 
since there is control over the position of the enzymes, the directed flow, and surface to volume ratio. 
The efficiency of a cascade can be mimicked if the different enzymes involved in the cascade process 
are positioned in the correct order and within the appropriate distance of each other. The continuous 
flow within a microreactor will direct the transport of the reagents from one active site to the next, 
which prevents product inhibition and offers equilibrium control. The advantages of enzymatic 
microreactors, such as less use of solvent and less waste, are even more valid for a multi-step 
reaction in a microreactor, which would mean a more environmentally friendly synthesis. A 
pragmatic approach to apply a multi-step reaction for synthesis is by connecting  two microreactors, 
each containing  another enzyme. 8, 39 This procedure, however, does not exploit the opportunities 
that derive from neighboring enzymes like equilibrium control and circumvention of product 
inhibition, which are especially advantageous for instabile intermediates.
Enzymes in Microsystem Technology
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Scheme 7. Hydrolysis of p-tolyl acetate by C. antarctica lipase B followed by oxidation by 
soybean peroxidase (a). Hydrolysis of sucrose by invertase with subsequent oxidation by 
glucose oxidase yielding  hydrogen peroxide, which is used for the oxidation of p-cresol by 
soybean peroxidase (b).
  A first example of a true cascade in one microreactor was developed by Lee et al. 55 They 
created a bienzymic and trienzymic system, both used for the synthesis of poly(p-cresol) (Scheme 7). 
For the bienzymic chip, Candida antarctica lipase B (CalB) and soybean peroxidase (SBP) were 
coimmobilized (without applying any spacial separation) on the walls of a glass microchannel using a 
reactive coating. CalB was used to hydrolyze p-tolyl acetate yielding acetic acid and p-cresol, while 
SBP oxidized p-cresol with the consumption of H2O2, resulting in a very efficient cascade. The 
trienzymic reactor was assembled from invertase for the hydrolysis of sucrose, and GOx to convert 
the resulting  glucose yielding H2O2 for the last step in the synthesis of poly(p-cresol) by SBP. These 
enzymes were similarly coimmobilized, and exhibited excellent yields of poly(p-cresol) compared to 
the solution-phase reaction.
  A second illustration of a multi-step reaction in a microchannel uses a polymeric monolith. 56 
This work also describes a bienzymic and a trienzymic system. For the positioning of the enzymes in 
the correct order for the sequential catalytic steps inside the microchannel, successive rounds of 
azlactone photopatterning  on the poly(ethylene glycol) coated monolith were executed. Each 
photopatterning  round resulted in a distinct patch of microchannel surface made highly reactive 
towards amino groups present on the surface of the proteins. The first model system involved GOx 
and HRP, the latter converting Amplex Red into resorufin using  hydrogen peroxide from the oxidation 
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16
Scheme 8. Oxidation of β-D-glucose by glucose oxidase yielding hydrogen peroxide, which 
is used for the conversion of Amplex Red into resorufin by horseradish peroxidase (a). 
Hydrolysis of sucrose by invertase followed by the reaction sequence described above (b).
of β-D-glucose to δ-D-glucono-1,5-lactone by GOx (Scheme 8a). The trienzymic system incorporated 
invertase for the hydrolysis of sucrose in fructose and glucose, which was further used for the GOx 
and HRP steps (Scheme 8b). The conversions in both multi-step reactors were analyzed using 
fluorescence, which showed a high dependence of the product yield on the direction of flow.
Aim and Outline of Thesis
Current immobilization methods, used in microreactor technology for the attachment of enzymes to 
the channel wall, modify the complete surface of the entire channel. This complicates the exact 
positioning of different enzymes involved in a cascade process. Furthermore, the enzymes are 
covalently immobilized, which prevents re-use of the reactor and impedes optimization of the 
cascade through repositioning of the enzymes. To achieve these attractive features a reversible 
immobilization system is required. This thesis describes a reversible system using Elastin-like 
polypeptides (ELPs). ELPs represent a special class of structural proteins. They display Lower Critical 
Solution Temperature (LCST) behavior, which is dependent on molecular weight, salt concentration, 
protein composition, and concentration. These polypeptides can be designed and produced as 
heterologous proteins in, for example, recombinant bacteria on the basis of synthetic designer genes. 
Such genes can be constructed using  carefully designed molecular-biological strategies. The finely 
tunable LCST characteristics of ELPs have been applied to position proteins fused to ELPs in a 
controlled fashion, for example in diagnostic devices. 57, 58 This has, for example, been used to 
immobilize ELP-fusion proteins by thermodynamically reversible addressing  of proteins, 57, 59 and for 
the reversible adsorption of organophosphorus hydrolase fused to ELP onto hydrophobic polystyrene 
microtiter plates. 60 
  The main goal of the resarch described in this thesis was the development of a non-covalent 
immobilization system - based on these stimulus-responsive ELPs - to facilitate the positioning of 
proteins in small channels. Control over the thermally triggered positional assembly of proteins is 
especially appealing  in case the mentioned proteins are enzymes operating in different steps of a 
cascade reaction. This thesis presents a strategy for stepwise positional assembly of two ELP fusion 
proteins on one surface using a temperature gradient. To achieve this goal the project is divided into 
several steps which are described in the separate chapters.
  The construction and expression of synthetic genes encoding the intended ELPs is described 
in Chapter 2. The protein engineering strategy, including ELP design, is discussed in detail. 
Characterization of the produced ELPs by matrix-assisted laser desorption/ionization time-of-flight 
mass spectrometry, turbidity measurements, and circular dichroism spectroscopy is reported. In this 
chapter the effect of the salt concentration on the LCST is also investigated.
  For reversible immobilization of enzymes in a microchannel a layer of covalently attached 
ELPs is required. The procedure to accomplish this is described in Chapter 3. In the first half of the 
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chapter, the surface modification of silicon with a well-defined monolayer of chemically reactive 
molecules is reported, combined with the covalent attachment of biotin as a bio-functional model 
compound. Due to quenching of fluorescence by silicon surfaces, glass was studied as an alternative 
substrate compatible with the detection of immobilized fluorescent protein. The functionalization of 
glass with ELPs, as described in the last part, was analyzed by static contact angle measurements and 
X-ray photoelectron spectroscopy.
  Chapter 4 describes how in mixtures of ELPs with different molecular weights or amino acid 
compositions, the individual LCST of the different molecules can still be discerned. The 
characterization of three different ELPs with different molecular weight is reported, and the mixtures 
of these ELPs in varying compositions are investigated using  turbidity measurements. In this way a 
mixture of two ELPs with different amino acid composition is also examined, including  the effect of 
salt concentration on the independent LCST transitions.
  The results of the previous chapters are combined in Chapter 5, which shows the 
immobilization in microchannels of ELPs fused to fluorescent proteins that act as models of globular 
enzymes. Their fluorescence facilitates detection after immobilization in the channel. Construction 
and production of these ELP fusion proteins is described. The LCST of these fusion proteins can be 
controlled by varying the concentration of NaCl. The formation of two fluorescent patches with 
different colors on the bottom of a microreactor using only the temperature-responsive property of 
ELPs is demonstrated. This research is extended towards the immobilization of a Candida Antarctica 
lipase B-ELP fusion protein as the first step towards an enzymatic cascade reaction.
  Chapter 6 shows a more versatile method to obtain ELP-enzyme conjugates compared to 
traditional molecular biology techniques for fusion proteins. The biosynthesis of ‘clickable’ elastins 
and their use as versatile modular building blocks by conjugation of the ELPs via the Cu-catalyzed 
azide-alkyne cycloaddition is presented. This is demonstrated by the conjugation to three different 
moieties, namely fluorescent probes, a polymer, and two proteins, i.e. the enzyme Candida 
Antarctica lipase B and the fluorescent protein DsRed2. The formed protein-ELP hybrids are 
characterized by SDS-PAGE, UV or fluorescence spectroscopy, turbidity measurements and an 
enzyme activity assay. In the future, commercially available enzymes used in known cascade 
reactions might be easily functionalized by this simple technique to obtain enzyme-ELP conjugates 
for application in microreactors.
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Design and Production of Elastin-like 
Polypeptides
Elastin-like polypeptides represent a special class of structural proteins. They display Lower Critical Solution 
Temperature behavior, which is dependent on molecular weight, salt concentration, protein composition, and 
concentration. A series of these polypeptides with varying amino acid composition were designed and 
produced using techniques from protein engineering  and molecular biology. The LCST behavior of the 
purified proteins was characterized by turbidity measurements.
Part of this chapter was published as 
Secreted production of elastin-like polypeptides by Pichia pastoris 
Roelof Schipperus, Rosalie L.M. Teeuwen, Marc W.T. Werten, Gerrit Eggink, Frits A. de Wolf
Applied Microbiology and Biotechnology, 2009, DOI 10.1007/s00253-009-2082-9
Introduction
Biomaterials based on proteins have gained a lot of interest in materials science, predominantly 
because of their biocompatibility. They can possess a wide variety of physical properties, which allow 
hydrogel formation, responsiveness to environmental stimuli, and complexation with drugs and 
nucleic acids and other proteins. 1, 2 Furthermore, protein-based polymers are especially attractive for 
application in surgical materials, implants, scaffolds for tissue engineering, and controlled drug and 
gene delivery systems. 3- 5
  These protein-based materials are usually obtained via protein engineering, 4, 6-8 thus are 
designed on the genetic level. The choice of the twenty natural amino acids results in an enourmous 
diversity of possible combinations. Beside control over amino acid composition, genetic engineering 
determines amino acid sequence and the molecular weight.9 In association with this control on the 
genetic level comes control over the physical properties and the biological characteristics. 10
  Structural proteins represent a special class of biomaterials because of their mechanical 
properties. 1, 11, 12 For example, a high elastic modulus (stiffness) and tensile strength at break in 
combination with high extensibility, are characteristic for dragline silk,13, 14 high stiffness and energy 
storage capacity are typical for collagen, 15 elasticity and extensibility are associated with elastin, 11, 
16 resilience with resilin, 17 high extensibility in combination with only moderate changes of elastic 
forces are the eye-catching feature of the nearly 3000 kDa large titin, 18 and, last but not least, 
elasticity, optical transparency and reversible melting are the well-known properties of gels made out 
of gelatin, which is partly degraded and chemically modified collagen. 19, 20 Many of these features 
are due, in part, to intermolecular covalent bonds and intramolecular or supramolecular interactions, 
which leads to controlled folding and three-dimensional organization.
  Elastin is a structural protein that plays a crucial role in mammalian tissue as it induces 
elasticity to e.g. skin and arteries. 11, 16 It is produced and secreted from the cells as tropoelastin, a 
soluble protein consisting mainly of the alternation of large hydrophobic and smaller hydrophilic 
domains. 16, 21 The hydrophobic regions are rich in the aliphatic amino acids valine, proline, alanine, 
and glycine, and are responsible for the elastic properties of the material. Lysine residues in the 
hydrophilic alanine-rich parts crosslink to form the insoluble mature elastin, after secretion. 22
  Pioneering  work by Urry et al. has shown that the hydrophobic domains of tropoelastin can 
be mimicked by elastin-like polypeptides (ELPs), which are based on amino acid sequences found in 
these hydrophobic regions. The most commonly used ELPs were composed of the amino acid repeat 
sequence Val-Pro-Gly-Xaa-Gly (Val = valine, Pro = proline, Gly = glycine), in which the fourth amino 
acid residue Xaa can be any natural amino acid except proline. 10, 23, 24 Upon heating, ELPs, which 
lack a secondary structure, undergo a phase transition, forming  a hydrophobic β-spiral structure 
resulting in aggregation. 25 This Lower Critical Solution Temperature (LCST) behavior is completely 
reversible. 26 It was demonstrated that the LCST could be varied over an extensive temperature range 
by changing  the hydrophobicity of the fourth residue, the length of the polymer, ionic strength of the 
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medium, the ELP concentration and pH (when acidic or basic residues are inserted at the Xaa 
position). 10, 27-32 
  The unique properties of elastin expand the possibilities for the use of this material in a 
variety of applications. Block copolymers of elastin and silk, and elastin polymers containing  cell 
adhesion domains have been constructed for the formation of hydrogels for tissue engineering. 33-37 
Block copolymers of two different types of elastin have been made to form block copolymer micelles 
and gels with stimulus responsive behavior.  38 Conjugation of ELPs to (bio)molecules resulted in a 
variety of biohybrid materials. Block copolymers of elastin and polyethyleneimine or polyacrylic acid 
have been constructed for the modification of surfaces applied in tissue engineering. 39, 40 ELPs 
modified with drugs 41-45 or fluorescent probes 46, 47 have been used in tumor tissue targeting. 
  The LCST character of ELPs has been applied to position proteins fused to ELPs in a 
controlled fashion for diagnostics. 48, 49 This has for example been used to immobilize ELP-fusion 
proteins by thermodynamically reversible addressing of proteins, 48, 50 and for the reversible 
adsorption of organophosphorus hydrolase fused to ELP onto hydrophobic polystyrene microtiter 
plates, while retaining  its functionality. 51 For our strategy, aiming at the thermally triggered positional 
assembly of two ELP-fusion proteins on one surface, two ELPs with different transition temperatures 
were needed. Protein engineering was used as a method for construction and expression of synthetic 
genes, encoding  the intended ELP’s, which is described in the following section. Finally, the LCST-
based purification and characterization of the ELPs is decribed.
Protein Engineering Strategy
Genetic engineering of repetitive proteins
For the production of the repetitive proteins in a recombinant system, genes coding for these 
repetitive proteins had to be constructed. There are multiple methods to multimerize 7 without using 
the polymerase chain reaction (PCR), as depicted in Scheme 1. The easiest method is 
concatemerization (Scheme 1a), the random ligation of monomeric DNA fragments. For uni-
directional insertion of the DNA-oligomers into the polymer gene, the overhangs of the monomer are 
required to be different and complementary, i.e. non-palindromic. After separation and selection of 
the oligomer with the correct length on agarose gel, the oligomer can be further multimerized and 
ligated into a linearized vector. 13, 52-54 
  An important disadvantage is the lack of control over the final length of the oligomer, 
especially long oligomers are difficult to obtain, since the efficiency of ligation decreases with 
increasing molecular weights. In the second method, iterative multimerization (Scheme 1b), there is 
more control over the gene length and it can also be used to produce block copolymeric proteins. 55 
In each step one monomer is added to the growing  gene, which immediately indicates the amount of 
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Scheme 1. Model (adapted from reference 58) of three multimerization methods: 
concatemerization (a), iterative multimerization (b), recursive directional ligation (c).
Scheme 2. Recursive directional ligation (adapted from reference 31): restriction enzyme 1 
(RE1), restriction enzyme 2 (RE2).3
time involved to produce a gene with a high number of repeats. In more recent versions of this 
recursive directional ligation (Scheme 1c), monomers are combined in tandem, and the resulting 
gene can then be recursively combined up to the desired gene length. 31, 56-58
  Scheme 2 represents in more detail the multimerization method of recursive directional 
ligation. In the first step a synthetic monomeric gene is ligated into a cloning  vector, flanked with 
recognition sites for two different restriction enzymes. These restriction enzymes cleave within the 
recognition site. As for any cloning  strategy it is crucial that the restriction enzymes have only one 
recognition site in the entire vector, including the synthetic monomeric gene. In the next step the 
monomer is digested from the vector using both restriction enzymes RE1 and RE2, and ligated into 
the vector with the momomeric gene, which was linearized with RE1. This results in a dimer, still 
flanked with both recognition sites. Each round of digestion doubles the length of the gene, which 
provides quick multimerization, combined with control over the length of the gene when products of 
previous rounds are used. One of the important requirements for the selection of the restriction 
enzymes is the compatibility of the recognition site with the coding  sequence of the protein. Often 
restriction enzymes of type II are used, 58-60 which have undivided and palindromic recognition sites, 
and the enzymes cleave DNA within the recognition site. 61 These characteristics can raise difficulties 
when trying  to fulfil the mentioned requirement of compatibility between the recognition site and the 
protein coding sequence. 62 A solution is the use of type IIs restriction enzymes, 63-65 which have non-
palindromic recognition sequences and a cleavage site several base pairs away from the recognition 
site. This imposes no limitations on the ligated DNA fragments to be ligated, 7 since any DNA 
sequence can then be inserted without the need for presence of an appropriate restriction site in each 
building  block that is to be inserted in the synthetic gene. Furthermore, the restriction site can be 
designed to be non-palindromic, so the insertion is uni-directional.
Design of adapter
For multimerization and connection of different genes, the synthetic oligonucleotide adapter aIII 
(Scheme 3) was designed. The design combines recursive directional ligation with endonucleases of 
type IIs, 59 which cleave DNA outside their recognition site to one side, resulting in seamless links. 
Design and Production of Elastin-like Polypeptides
25
Scheme 3. Sequence of adapter aIII for multimerization and seamless connection of blocks.
For a highly flexible approach, the adapter was equipped with two cleavage sites on either site of the 
insert. The BsmFI/FokI combination was used for multimerization, while the BsmBI/BanI combination 
was used to seamlessly connect different genes. Adapter aIII was equipped with XhoI/EcoRI 
compatible ends to ligate into the cloning vector pMTL23-δ-BsaI. 66, 67
Design of ELP genes
Several requirements need to be met for the desired application of ELPs in microchannels, where the 
LCST of different ELPs will be used to immobilize enzymes of a cascade reaction. This application 
asks for a sufficient difference in LCST of the ELPs, which can be achieved by control over the amino 
acid composition and the molecular weight. Furthermore, the LCST has to be compatible with the 
optimal range of the enzyme activity.
  A thoroughly investigated ELP is [V5A2G3], 29, 31 in which Xaa of the ELP pentapeptide 
ValProGyXaaGly is replaced by valine, alanine and glycine in a ratio of 5:2:3. This ELP has a 
transition temperature range of 37 – 82 °C depending  on the ELP length. The ELP with 90 
pentapeptides repeats suited our demands, and was the first to be chosen (ELP1). For the sequence of 
the second ELP (ELP2) the alanine in the polypeptide was replaced by the more hydrophobic leucine, 
which should result in a lowered transition temperature. 10, 68
  Both designed ELPs consist of aliphatic amino acids, which means there are no extra 
functional groups available for chemical reactions. For covalent attachment onto a surface through 
amine functionalities, 69-73 the cloning  strategy included a possibility to incorporate two lysines (KK) 
near the N-terminus of the ELPs, in addition to the amino group of the N-terminus.
  To summarize, two different ELPs will be produced, namely ELP1 and ELP2. The composition 
of ELP1 is [V5A2G3-90], and that of ELP2 is [V5L2G3-90]. Of both ELPs, a variant with two additional 
lysines has been prepared, namely KK-ELP1 and KK-ELP2.
Results and Discussion
ELP gene synthesis
The construction procedure for the ELP genes ELP1 [V5A2G3-90] and ELP2 [V5L2G3-90] is depicted in 
Scheme 4. In short, four synthetic oligonucleotides were annealed and ligated into the cloning vector 
to form a monomer consisting of 10 repeats of the pentapeptide. Multimerization until the desired 
chain length was achieved via recursive directional ligation with the type IIs restriction endonucleases 
BsmFI and FokI. A gene library of ELPs with varying lengths is shown in Figure 1.
  The finished ELP genes were transferred to the vectors pMTL23-δ-BsaI-XX and pMTL23-δ-
BsaI-KK using  BsmFI and EcoRI, a type II restriction endonuclease. The latter vector incorporated two 
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additional lysines (KK) near the N-terminus. This resulted in genes for ELP1, KK-ELP1, ELP2, and KK-
ELP2. These four genes were placed in the expression vector pET15b with XhoI and BamHI. This 
vector added a sequence to the ELP genes, which contained a 6xHis-tag and a thrombin cleavage 
site.
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Figure 1. Agarose DNA gel showing a library of ELP with varying lengths, digestion of 
multimerized pMTL23aIII-ELP1 with BsmBI/EcoRI (monomer = [V5A2G3-10]): monomer (a), 
dimer (b), trimer (c), tetramer (d), octamer (e).
Scheme 4. Scheme representing the ELP cloning strategy and multimerization, resulting in the 
genes for ELP1, KK-ELP1, ELP2, KK-ELP2. BsmFI and FokI were used, in combination with 
EcoRI (recognition site: ). The BsmFI site was maintained in the resulting gene for a 
continual ELP sequence.
ELP expression and purification
Four ELP expression pET15b vectors, containing the finished genes, were transformed into the 
Escherichia coli expression strain BLR(DE3). This strain is a recA- derivative of the widely used 
BL21(DE3) strain, which helps stabilize plasmids with repetitive sequences. 74 The proteins were 
usually expressed in 500 mL shake flask cultures with a yield of approximately 10 mg purified protein 
per liter of culture. After breaking the cells, the ELPs were purified by inverse transition cycling (ITC), 
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Figure 2. Silver stained SDS-PAGE gel of ITC (a, two cycles) and native Ni-NTA (b) purified 
ELP1 and ELP2: supernatant 1 (s1), pellet 1 (p1), supernatant 2 (s2), pellet 2 (p2), flow-through 
(FT), elution 1 (e1), and elution 2 (e2).
Figure 3. Coomassie stained SDS-PAGE gel after purification: KK-ELP1 (a), KK-ELP2 (b), ELP1 
(c), ELP2 (d).
30 which exploits the LCST of the proteins. This method alternates between steps of high and low 
temperatures. In the step with the raised temperature salt was added to promote aggregation of the 
ELPs, and after centrifugation the supernantant containing contaminants was discarded. In the next 
step a cold buffer with low salt concentration was added to dissolve the ELP, and after centrifugation 
denatured proteins were removed. To determine whether ITC was also suitable for these ELPs, a 
comparison was made between ITC and native Ni-NTA purification, 75 using the available 6xHis-tag. 
SDS-PAGE (Figure 2) showed that ITC resulted in more pure ELPs, which convinced us to continue 
using ITC as purification method. 
  In Figure 3 all ELP variants are shown after purification by ITC. The weight difference 
between ELP1 and ELP2 is 0.8  kDa, which is clearly visible on gel. A similar difference was observed 
for KK-ELP1 and KK-ELP2.
ELP characterization
The purified proteins were further characterized by MALDI-TOF mass spectrometry. A typical ELP 
spectrum is depicted in Figure 4, and Table 1 shows the determined masses of the ELPs. The measured 
molecular weight of all ELPs was significantly less than the calculated weight. There could be several 
explanations for these differences. First, there could be a deletion of a codon in the ELP gene, 
resulting in a missing  amino acid in the expressed protein, however, no proof was found in DNA 
sequencing results to support this. Secondly, the N-terminal methionine could be removed by 
methionine amino peptidase. 76, 77 Taking into account the removal of this methionine, the difference 
between the calculated and the measured mass would still be around 200 Da for all ELPs, which 
does not fall within the relatively low resolution of 100 Dalton. Thirdly, in addition to N-terminal 
methionine removal the three subsequent amino acids, i.e. glycine and two serine residues, could 
also be cleaved, which would explain the mass difference. However, the tryptic digest performed on 
ELP2 in Chapter 6 did not show the peak expected in the case of removal of the four N-terminal 
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Figure 4. Typical MALDI-TOF spectrum of KK-ELP2.
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Figure 5. Normalized turbidity profile of ELPs (0.1 mg/mL) in PBS measured at 350 nm: ELP1 
(a), KK-ELP1 (b), ELP2 (c), and KK-ELP2 (d). 
Figure 6. Normalized turbidity profile of ELP1 (a) and ELP2 (b) (each 0.1 mg/mL in PBS) 
during heating (↑) and cooling (↓) measured at 350 nm. 
Table 1. Molecular weight and transition temperature of ELPs                                                    
Protein Calculated (Da) Measured (Da)a Tt (°C)b
ELP1 38987 38579 54
ELP2 39802 39397 37
KK-ELP1 39244 38863 54
KK-ELP2 40059 39756 38
a Molecular weight, measured by MALDI-TOF  b Transition temperature, determined at half 
the maximal optical density at 350 nm from turbidity measurements in PBS.                             
amino acids. Further investigation is necessary to find an explanation for the mass difference, e.g. by 
using liquid chromatography-mass spectroscopy, which has a higher resolution than MALDI-TOF 
mass spectroscopy.
  To determine the exact transition temperature, turbidity profiles of aqueous solutions of ELP 1 
and ELP2 (0.1 mg/mL) were measured (Figure 5, Table 1). The transition temperature (54 °C) for ELP1 
and KK-ELP1, determined at half of the maximal optical density at 350 nm, was exactly the same. 
This transition temperature was similar to a previously reported transition temperature. 78 The 
transition temperature for ELP2 and KK-ELP2 differed only 1 °C. The temperature difference between 
ELP1/KK-ELP1 and ELP2/KK-ELP2 is evidence for the large influence of amino acid composition. 79 
The replacement of alanine in ELP1 with the more hydrophobic leucine in ELP2, only 18  amino acids 
of the 450 ELP amino acids, resulted in a decrease in transition temperature of 17 °C.
  Reversibility of the ELP transition was investigated by measuring the turbidity profile of ELP1 
and ELP2 during heating  and cooling (Figure 6). These traces showed that for each separate ELP, the 
transition temperatures obtained during heating and cooling were the same. The less sharp transition 
for cooling  has been observed before by Meyer et al. for ELPs 31, 47, 80 and ELP fusion proteins 30, and 
was attributed to the difference in kinetics between association and dissociation. This reversibility is 
important for the application of ELPs on surfaces featuring release. 
  Extensive experimentation has demonstrated that ELPs are likely to adopt a secondary 
structure with β-turns, predominantly type II β-turns. Urry was able to prove this by using techniques 
including circular dichroism, 25 nuclear magnetic resonance, 26, 27 dynamic light scattering, 81 and X-
ray crystal structure analysis. 82 Similar results were obtained by Tamburro,83-85 although both used 
the data to support two different models that explain ELP elasticity. 86, 87 Debelle suggests that also 
other secondary structures, like β-strands and random coils, are present in ELPs. 21, 22, 88
  Using  circular dichroism (CD) spectroscopy we tried to look at the secondary structure of 
ELP1 and ELP2 in PBS at different temperatures between 5 °C and 75 °C (Figure 7). Due to an 
elevated chloride concentration the optical density was too high to acquire reliable data below 200 
nm. Moreover, the data acquired was very noisy, so no reliable conclusions could be drawn about the 
secondary structure of the ELPs during heating. Since no valid method was available to determine 
concentration at the time of the experiment, a high ELP concentration could be an explanation for the 
noisy spectra. The plots seemed to resemble data acquired for ELPs 24, 89, 90 and ELP fused to proteins 
91 with a shift from random coil to β-turns. For ELP1 the spectra showed a shift from random coil to 
β-turns between 55 °C and 65 °C, which is close to the transition temperature for this protein. Also 
for ELP2 two distinct structures were observed; one below and one above the transition temperature 
of 37 °C. For both ELPs a minimum was visible at 200 nm with a shoulder around 218  nm below the 
transition temperature. Above the transition temperature the minimum at 200 nm turned into a 
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maximum, and the schoulder at 218  nm disappeared for both ELP1 and ELP2. These CD spectra 
supported the turbidity profiles, showing  two distinct regions below and above the transition 
temperature. 
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Figure 8. Normalized CD signal of ELP1 (○) and ELP2 (◼) in PBS at 218 nm measured 
between 5 °C and 75 °C. 
Figure 7. CD spectra of ELP1 (a) and ELP2 (b) in PBS measured at temperatures between 5 °C 
and 75 °C.
  In Figure 8  the plot of the relative CD signal at 218  nm versus the temperature is shown. This 
demonstrates the influence of the temperature on the secondary structure as observed at one specific 
wavelength. 90, 91 For both ELPs the CD signal increased above the transition temperature, resulting  in 
plots that resembled turbidity measurements. Similar plots were obtained for 200 nm, 210 nm and 
222 nm (data not shown).
  To lower the transition temperature of the ELPs to values that were suitable for bio-
applications, turbidity profiles were generated with varying  NaCl concentrations for the fusion 
proteins KK-ELP1 and KK-ELP2 (Figure 9). 92 Going  up to 1 M NaCl the transition temperature of KK-
ELP1 and KK-ELP2 decreased from 54 °C and 38 °C to 36 °C and 24 °C, respectively. The salt 
concentration was increased even further to 2 M, which resulted in a reduced transition temperature 
of 22 °C and 11 °C for KK-ELP1 and KK-ELP2, respectively.
Conclusions
For application of ELPs in the immobilization method of fusion poteins in microchannels, two ELPs 
with different transition temperatures were designed by recursive directional ligation. In addition two 
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Figure 9. Normalized turbidity profile of KK-ELP1 and KK-ELP2 measured at 350 nm (0.1 mg/
mL) in PBS supplemented with NaCl: 0 M (a), 0.5 M (b), 1M (c), 1.5 M(d) and 2 M (e).
ELPs were constructed that contained lysines for chemical reactions. These four ELPs were produced 
in Escherichia coli, and purified using inverse transition cycling. All ELPs showed the expected 
transition temperatures, which greatly depended on the amino acid composition and the 
concentration of solutes in the solvent. The standard expression system for the production of ELPs, 
Escherichia coli shake flask cultures, was used resulting in modest yields of approximately 10 mg 
purified protein per liter of culture. Literature reports optimized yields up to 1.6 g ELP fusion protein 
per liter of culture using  a hyperexpression protocol. 93- 95 Other organisms have also been used 
including tobacco cell cultures, 96 cultures of Aspergillus nidulans, 97 and transgenic tobacco plants. 
98- 101 The yeast Saccharomyces cerevisiae has been applied for the production of tropoelastin. 102 All 
these expression systems require ELP purification from the cell lysate, since expression is inside the 
cells. An interesting  future system expression would be the yeast Pichia pastoris. This microorganism 
is able to secrete the produced proteins into the medium, which greatly facilitates purification.
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Experimental Section
Nomenclature
The ELP constructs are described using the notation ELP[XiYjZk-n], 103 where the capitals between the 
brackets represent the single letter amino acid code replacing  Xaa in the pentapeptide Val-Pro-Gly-
Xaa-Gly. The subscript stands for the number of guest residues in the monomer gene, and the n 
designates the number of pentapeptide repeats. ELP[V5A2G3-90] is abbreviated by ELP1, while ELP2 is 
short for ELP[V5L2G3-90]. Two additional lysines to be used in surface immobilization were 
incorporated into the ELP constructs by modifying the cloning  vector with adapterKK, containing  two 
additional lysines, instead of adapterXX, without these two lysines.
Cloning
Standard molecular biology protocols were used for gene synthesis and oligomerization. Digested 
inserts and linearized vectors were purified by agarose gel electrophoresis (QIAquick Gel Extraction 
Kit, Qiagen, Valencia, CA). All clones were maintained in the E. coli XL1-Blue. Synthetic 
oligonucleotides were purchased from Eurogentec (Seraing, Belgium). 
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ELP gene synthesis
The vector pMTL23-δ-BsaI-aIII was constructed from two synthetic aIII oligonucleotides (Figure 11) 
which were annealed to form double-stranded DNA with XhoI- and EcoRI-compatible ends, and 
ligated into XhoI/EcoRI linearized pMTL23-δ-BsaI (BsaI site removed from Amp gene). 66 A synthetic 
gene encoding 10 repeats of a pentapeptide ELP was constructed from four XiYjZk synthetic 
oligonucleotides (Figure 11). These oligonucleotides were annealed to form double-stranded DNA 
with BsmBI- and EcoRI-compatible ends, subsequently phosphorylated, and ligated into BsmBI/EcoRI 
linearized and dephosphorylated pMTL23-δ-BsaI-aIII, resulting  in pMTL23-δ-BsaI-aIII-ELP-10 (Figure 
10a). The insert was verified by DNA sequencing.
  For a typical oligomerization, pMTL23-δ-BsaI-aIII-ELP-10 was linearized with BsmFI, and 
enzymatically dephosphorylated. The insert was doubly digested from pMTL23-δ-BsaI-aIII-ELP-10 
with BsmFI and FokI, and ligated into the linearized vector. This was repeated until the ELP gene 
contained 90 repeats of the pentapeptide, resulting  in vectors pMTL23-δ-BsaI-aIII-ELP (Figure 10b). 
Colonies were screened by PCR, and the inserts were verified by DNA sequencing.
Adapter gene synthesis
The genes for adapterXX and adapterKK were constructed from synthetic adapter oligonucleotides 
(Figure 11). The oligonucleotides were annealed to form double-stranded DNA with XhoI- and EcoRI-
compatible ends, and ligated into XhoI/EcoRI linearized pMTL23-δ-BsaI, resulting in pMTL23-δ-BsaI-
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Figure 10. Cloning strategy, consisting of multimerization and connection of genes, in 
pMLT23-δ-BsaI. pMTL23-δ-BsaI-aIII-ELP-10 (a), pMTL23-δ-BsaI-aIII-ELP-90 (b), pMTL23-δ-
BsaI-XX or pMTL23-δ-BsaI-KK (c), pMTL23-δ-BsaI-XX-ELP or pMTL23-δ-BsaI-KK-ELP (d).
XX and pMTL23-δ-BsaI-KK (Figure 10c). Colonies were screened by PCR and restriction analysis with 
SmaI, whose recognition site was removed upon correc ligation. The DNA sequence of inserts was 
verified by DNA sequencing. The ELP genes were doubly digested from pMTL23-δ-BsaI-aIII-ELP with 
BsmFI and EcoRI, and ligated into BsmFI/EcoRI linearized and dephosphorylated pMTL23-δ-BsaI-XX 
and pMTL23-δ-BsaI-KK, resulting in pMTL23-δ-BsaI-XX-ELP and pMTL23-δ-BsaI-KK-ELP (Figure 10d). 
Colonies were screened by PCR, and the DNA sequence of inserts was verified by DNA sequencing.
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aIII
Sense    5’-TCGAGAAAAGAGAGGCTGAAGCGGGACGTCTCGGTGCCTAACATCCG-3’
Anti-sense  5’-AATTCGGATGTTAGGCACCGAGACGTCCCGCTTCAGCCTCTCTTTTC-3’
V5A2G3
Sense I   5’-GTGCTGGTGGTGTTCCGGGCGTCGGTGTTCCTGGAGTCGGTGTTCCAGGTGGAGG 
TGTTCCAGGAGCAGGTGTTCCTGGTGTAGGTG-3’
Anti-sense I  5’-GGAACACCTACACCAGGAACACCTGCTCCTGGAACACCTCCACCTGGAACACCGA 
CTCCAGGAACACCGACGCCCGGAACACCACCA-3’
Sense II  5’-TTCCTGGTGTTGGTGTTCCAGGTGTTGGTGTTCCAGGTGGAGGTGTTCCTGGT 
GCTGGAGTTCCTGGTGGTGGTGCCTAACATCCG-3’
Anti-sense II  5’-AATTCGGATGTTAGGCACCACCACCAGGAACTCCAGCACCAGGAACACCTCCA 
CCTGGAACACCAACACCTGGAACACCAACACCA-3’
V5L2G3
Sense I   5’-GTGCTGGTGGTGTTCCGGGCGTCGGTGTTCCTGGAGTCGGTGTTCCAGGTGGAGG 
TGTTCCAGGATTGGGTGTTCCTGGTGTAGGTG-3’
Anti-sense I  5’-GGAACACCTACACCAGGAACACCCAATCCTGGAACACCTCCACCTGGAACACCGA 
CTCCAGGAACACCGACGCCCGGAACACCACCA-3’
Sense II  5’-TTCCTGGTGTTGGTGTTCCAGGTGTTGGTGTTCCAGGTGGAGGTGTTCCTGGTTT 
GGGAGTTCCTGGTGGTGGTGCCTAACATCCG-3’
Anti-sense II  5’-AATTCGGATGTTAGGCACCACCACCAGGAACTCCCAAACCAGGAACACCTCCACC 
TGGAACACCAACACCTGGAACACCAACACCA-3’
AdapterXX
Sense   5’-TCGAGAAAAGAGAGGCTGAAGCGGGACCAGTTCCTGGTGGTGCCTAACATCCG-3’
Anti-sense  5’-AATTCGGATGTTAGGCACCACCAGGAACTGGTCCCGCTTCAGCCTCTCTTTTC-3’
AdapterKK
Sense   5’-TCGAGAAAAGAGAGGCTGAAGCTAAGAAGGGACCAGTTCCTGGTGGTGCCTAACAT 
CCG-3’
Anti-sense 5’-AATTCGGATGTTAGGCACCACCAGGAACTGGTCCCTTCTTAGCTTCAGCCTCTCTT 
TTC-3’
Figure 11. DNA sequences of the ordered oligonucleotides.
Expression vector pET15b
All genes were transferred to the expression vector pET15b (Novagen). The genes were doubly 
digested with XhoI/BamHI and ligated into the XhoI/BamHI linearized pET15b. Colonies were 
screened by restriction analysis with XhoI/BamHI.
ELP expression
PET15b vectors were transformed into the expression strain BLR(DE3) (Novagen). For a typical 
expression 25 mL Luria Broth cultures, supplemented with 100 μg/mL ampicillin and 12.5 μg/mL 
tetracycline, were inoculated and incubated at 37 °C with shaking overnight. These cultures were 
diluted to an OD600 of 0.1 in a 500 mL LB culture supplemented with 100 μg/mL ampicillin and 12.5 
μg/mL tetracycline, and incubated at 37 °C with shaking. At an OD600 of 0.6 the expression was 
induced by the addition of IPTG to a final concentration of 1 mM. After incubation at 25 °C overnight 
the cultures were harvested by centrifugation (18,000 x g, 4 °C). The cell pellet was resuspended in 
PBS, and incubated with lysozyme (1 mg/mL PBS) at 4 °C for 30 min. The cells were then lysed by 
ultrasonic disruption at 4 °C (10 min, 30%  duty cycle, 5 units power). The lysate was centrifuged (15 
min, 3768 x g, 4 °C Minifuge RF, Heraeus Sepatech, Germany) to remove insoluble matter. 
ELP purification
The ELP proteins were purified by inverse transition cycling. 29 In short, ELPs were aggregated by 
adding NaCl to a concentration of 1 M and increasing the temperature of the cell lysate to 65 °C. The 
aggregated protein was separated from solution by centrifugation at 40 °C (10 min, 4566 x g, 
Multifuge, Heraeus Sepatech, Germany). The supernatant was decanted and discarded, and the pellet 
containing the protein was resuspended in cold PBS. The resolubilized pellet was then centrifuged at 
4 °C (10 min, 4566 x g) to remove any remaining  insoluble matter. After an extra round of inverse 
transition cycling, the efficiency of purification was analyzed by SDS-PAGE. If needed, another round 
of inverse transition cycling  was performed, yielding typically around 10 mg purified protein/L of 
culture.
  The SDS−PAGE analysis was performed on 10−15% gels on a Mini-PROTEAN III system (Bio-
Rad, Hercules, CA) with a discontinuous buffer system, stained with Coomassie brilliant blue silver. 
Protein concentrations were determined by bicinchoninic acid assay (Pierce Chemical Co., Rockford, 
IL). 
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Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass 
spectrometry
MALDI-TOF mass spectrometry measurements were performed on a Bruker Biflex III with 2,5-
dihydroxyacetophenone (DHAP) as matrix. 104 The samples were mixed in a 1:1 ratio on a MALDI 
plate with a solution of 7.6 mg  DHAP in 375 μL EtOH and 125 μL diammonium hydrogen citrate 
(stock solution of 27 mg in 1.5 mL MilliQ water) containing 2% trifluoroacetic acid. 
Turbidity measurements and circular dichroism (CD) spectroscopy
The optical absorbance of ELPs, derived from the high tension voltage, was measured at 350 nm in 
the 5 – 75 °C range on a Jasco J-810 spectropolarimeter (band width: 1 nm, response: 1 sec., 
sensitivity: standard, heating  rate: 1 °C min-1) equipped with a PFD-425s Peltier temperature 
controller (Jasco). The transition temperature was determined from the midpoint of the transition-
induced change at a heating or cooling rate of 1 °C min-1. 
  CD spectra were measured on the same instrument and in the same buffer. The samples were 
measured in the 5 – 75 °C range with 10 °C intervals. 
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Surface Modification of Silicon and Glass
N-Hydroxysuccinimide (NHS)-ester-terminated monolayers were covalently attached in one step onto silicon 
using visible light. This mild photochemical attachment, starting from ω-NHS-functionalized 1-alkenes, 
yields a clean and flat monolayer-modified silicon surface and allows a mild and rapid functionalization of 
the surface by substitution of the NHS-ester moieties with amines at room temperature. Using  a combination 
of analytical techniques, it was shown that the NHS-ester groups were attached fully intact onto the surface, 
and reacted readily with biotin hydrazide, as an example of a biofunctional molecule. As a second method 
of covalent attachment, glass was functionalized with a protein using  glutaraldehyde followed by reductive 
amination. Immobilization on glass is especially promising in the field of diagnostics, when fluorescence is 
used for detection.
Parts of this chapter were published as 
One-Step  Photochemical Attachment of NHS-Terminated Monolayers  onto Silicon Surfaces and Subsequent 
Functionalization
Menglong  Yang, Rosalie L.M. Teeuwen, Marcel Giesbers, Jacob Baggerman, Ahmed Arafat, Frits A. de Wolf, Jan 
C.M. van Hest, and Han Zuilhof
Langmuir, 2008, 24, 7931 –7938
And
Temperature-controlled positioning of fusion proteins in microreactors 
Rosalie L.M. Teeuwen, Han Zuilhof, Frits A. de Wolf, and Jan C.M. van Hest 
Soft Matter, 2009, 5, 2261 –2268
Introduction
The functionalization of inorganic surfaces via molecular self-assembly is of growing  importance, e.g. 
in the respect of the development of molecular electronics, biosensors, and biochips. 1, 2 The basic 
idea for this thesis, reversible immobilization of enzymes for cascade reactions in a microchannel 
using temperature-responsive elastin-like polypeptides (ELPs), requires a layer of covalently attached 
ELPs. To this aim immobilization of bio-molecules to silicon was investigated. However, as optical 
quenching  effects by the silicon bulk were shown to be limiting, glass was looked at as an alternative 
substrate of protein immobilization. 
  In the first half of this chapter the surface modification of silicon with a well-defined amino-
reactive monolayer is reported, combined with the immobilization of the bio-functional molecule 
biotin. Next the functionalization of glass is described, which resulted in immobilized elastin-like 
polypeptides (ELPs).
Surface Modification of Silicon
Given the ubiquitous use of silicon in microfluidic devices, and given the increasing  importance of 
biomolecule arrays and biosensors, it is of significant interest to study the functionalization of silicon 
suitable for immobilization of biomolecules. A major route to the immobilization of amine-
containing biomolecules, such as proteins or amine-end-capped DNA oligomers, involves the use of 
activated esters derived from N-hydroxysuccinimide (NHS). 3 In the most stable manner, this can be 
accomplished via the use of Si−C bound organic monolayers (without involvement of an interfacial 
silicon oxide layer), which allows the formation of NHS-activated surfaces. To obtain such silicon-
bound NHS-functionalized monolayers, four approaches have been reported (Figure 1):
(1) A multistep procedure in which an ω-ester-terminated 1-alkene is attached onto a hydrogen-
terminated silicon surface with subsequent hydrolysis of the ester to a carboxylic acid 4 and surface-
bound conversion of that carboxylic acid to an NHS-ester. 5- 7 While the attachment reaction 
proceeds without any problems with, for example, methyl ester-derived alkenes, 4 the hydrolysis at 
the surface has only been proven to be complete under basic conditions that also diminish the 
quality of the organic monolayer. 8 A second disadvantage of any indirect method is that, in the 
process of modifying  the intermediate carbodiimide-activated acid group with NHS, NHS will stick 
rather persistently to the surface. As a result, such monolayers display a significantly increased 
roughness as can, for example, be seen by AFM. 
(2) A two-step procedure in which direct attachment of an ω-acid-terminated 1-alkene to a H-
terminated silicon surface is performed, followed by a surface-bound conversion of that carboxylic 
acid to an NHS-ester. 9, 10 While the direct attachment of acids eliminates the hydrolysis step, such 
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monolayers typically display water contact angles > 50°, whereas fully acid-terminated monolayers 
on Au display water contact angles < 10°. 11 This may reflect a small fraction of upside-down addition 
and/or effects of low grafting  density. 9, 10 In addition, contamination of the surface by adsorbed NHS 
remains nonideal.
(3) Direct thermal attachment of an ω-NHS-functionalized 1-alkene onto a H-terminated silicon 
surface. While this directly yields NHS-ester-terminated monolayers on silicon, 12, 13 it does not allow 
photoinduced patterning of the surface. In addition, ω-NHS-functionalized 1-alkenes may suffer from 
partial decomposition upon prolonged heating.
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Figure 1. Overview of different methods to obtain NHS-functionalized silicon surfaces: 1) 
photochemical attachment of ω-ester-terminated 1-alkene, followed by hydrolysis and NHS 
functionalization, 2) photochemical attachment of ω-acid-terminated 1-alkene, followed by 
NHS functionalization, 3) direct thermal attachment of ω-NHS-functionalized 1-alkene, 4) 
direct photochemical attachment of ω-NHS-functionalized 1-alkene.
(4) Direct photochemical attachment of an ω-NHS-functionalized 1-alkene using  254 nm light. Such 
photochemical attachment is, unquestionably, of interest for the possible formation of patterned 
activated surfaces. 14 While this leads to the attachment of NHS-terminated monolayers at room 
temperature, XPS analysis of the resulting  monolayers reveals up to 30% decomposition of the NHS-
ester-terminated monolayer and photoinduced oxide formation in the interface between the 
monolayer and the silicon substrate. 12 Given the optical absorption spectrum of NHS-ester moieties, 
photochemical reactions could play a role under these conditions.
  Consequently, in this chapter, we propose a mild one-step attachment of NHS-ester-
terminated monolayers onto silicon surfaces via irradiation with visible light. As has been recently 
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Figure 2. Schematic representation of the formation of a mixed monolayer terminated with 
NHS-ester moieties and of the subsequent substitution of the NHS-ester moiety by biotin 
hydrazide.
shown, 15- 20 this provides a mild, room-temperature alternative for the binding  of covalently attached, 
Si−C linked monolayers onto silicon. The resulting NHS-ester-terminated monolayers were further 
modified by biotin hydrazide (Figure 2). All monolayers were characterized in detail by water contact 
angles, infrared reflection absorption spectroscopy (IRRAS), atomic force microscopy (AFM), and X-
ray photoelectron spectroscopy (XPS) analyses.
Results and Discussion
Formation and characterization of mixed monolayers
Mixed monolayers were obtained from the photochemical reaction (λ = 447 nm) of a hydrogen-
terminated silicon Si(111) surface with a mixture of N-succinimidyl undecylenate (NHS-ester-alkene) 
and 1-decene in different ratios. The mole fraction of the terminal NHS-ester groups on the resulting 
mixed monolayers was expected to approximate the mole fraction of NHS-ester-alkene in the 
reaction mixture. 8 As expected, depending on the composition of reaction solutions, the water 
contact angle of the resulting  mixed monolayers varied from 110° (0% NHS-ester-alkene) to 52° 
(100% NHS-ester-alkene). In comparison with the pure 1-decene-derived monolayer (i.e., 0% NHS), 
infrared reflection absorption spectroscopy (IRRAS) clearly revealed the NHS-ester functionalities in 
the pure NHS-ester alkene monolayer (i.e., 100% NHS) by the appearance of the characteristic CO 
stretching vibrations at 1817, 1788, and 1745 cm−1 (Figure 3) belonging to the ester carbonyl stretch 
and the symmetric and anti-symmetric carbonyl stretches in the succinimidyl end groups, 
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Figure 3. IRRA spectra of the pure NHS-ester alkene monolayer (100% NHS, with the 
characteristic triple-peak carbonyl pattern of NHS-esters) and the pure 1-decene monolayer 
(i.e., 0% NHS) attached on Si(111) (a). AC mode AFM topographic image of 100%  NHS-ester-
terminated surface (1 × 1 µm; color scale from 0 to 0.60 nm) (b). Average area roughness (A 
Ra) and average line roughness (L Ra) (along the arrow) are marked in the image.
respectively. 21, 22 This technique also revealed that the NHS-ester-terminated monolayers were not 
well-ordered, as the antisymmetric and symmetric CH2 stretching  vibrations showed up at ~2926 and 
~2854 cm−1, respectively. 12, 13, 23, 24 AFM analysis showed that the resulting  surfaces were clean and 
flat with, for example, easily recognizable Si(111) edge steps, and with an average line roughness of 
0.06 nm on the terrace surfaces and an average area roughness of 0.09 nm over the whole measured 
surface of a 100% NHS-ester-terminated monolayer.
  A schematic depiction of the types of carbon atoms that are distinguishable by XPS is shown 
in Figure 4. 25-27 Figure 4 shows the XPS narrow scans of C1s, N1s, O1s, and F1s of a 100% and a 50% 
NHS-ester-terminated monolayer on Si(111). The C1s signal of the NHS-ester-terminated monolayers 
can be deconvoluted into three peaks (Figure 5), from low to high binding energy (BE), as (i) a peak at 
285.1 eV (with a full width at half-maximum (fwhm) of 1.4 eV) for carbons in the aliphatic 
hydrocarbon chain; (ii) a peak at 286.4 eV for α-carbons adjacent to the carbonyl carbon atoms; and 
(iii) a peak at 289.7 eV for the carbonyl carbon atoms. The three α-carbons shifted much more than 
an ordinary α-CH2 (general shift of 0.4~0.7 eV) 28 in an alkyl chain, because of the strong electron-
withdrawing effect from the imide group in the NHS moiety. The ratio between these three peaks for a 
100% NHS-ester-terminated monolayer was 9.4: 2.7: 2.4, which was within the experimental error 
equal to the theoretical ratio of 9:3:3 (Table 1). As presented in Figure 5 (narrow scan N1s region), the 
nitrogen of the NHS-ester-terminated monolayer (a) has a binding energy of 402.3 eV. Approximately 
the same BEs and chemical shifts were observed in C1s, N1s, O1s, and F1s narrow XPS spectra for the 
50% NHS-ester-terminated monolayer. These XPS data proved the attachment of mixed monolayers in 
addition to the water contact angle and IRRAS data.
Modification with biotin hydrazide 
As an example for bioapplications (Figure 2), the functionalization of NHS-ester-terminated 
monolayers on Si(111) was demonstrated by modification of these monolayers with biotin hydrazide 
to obtain a biotinylated semiconductor surface. After incubation overnight in a ~5 mM solution of 
biotin hydrazide in 100 mM sodium acetate buffer pH 5.5, the static water contact angle of the 
monolayers was measured. In comparison to 100% NHS-ester-terminated monolayers, the water 
contact angle decreased by 10±3° after modification with biotin hydrazide, as the biotin moiety is 
more hydrophilic than the NHS-ester. However, no trend in this decrease was discernible in relation 
to the fraction of NHS-ester moieties in the monolayers, which can be rationalized by two opposing 
effects: with increasing  NHS-ester content more polar biotin hydrazide moieties will be attached, but 
on the other hand the monolayer itself is already more polar at higher NHS-ester content (water 
contact angle 52−60°), resulting in a smaller additional wetting effect of the transformation of NHS-
ester into biotin moieties. In this regard, it needs to be stated that the stability of properly made alkyl 
monolayers on Si (contact angle after preparation >110°) decreased by <1° under these conditions, 
which allows attribution of this effect solely to the conversion of the NHS-ester moieties. Extended 
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wetting  experiments under these conditions showed that the formed monolayers were significantly 
more stable than those of thiols on gold 29 or siloxanes on glass, 30 and approached that of organic 
monolayers on more chemically inert surfaces like silicon nitride 31, 32 and silicon carbide. 33
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Figure 5. XPS narrow scans of 100% and 50% NHS-ester-terminated monolayers on Si(111). 
Upper row of pictures for carbon 1s regions. Lower row of pictures for N1s , O1s and  F1s 
regions. 
Table 1. Atomic ratios of 100% and 50%  NHS-ester-terminated monolayer by XPS analysis 
Ci:Cii:Ciii
theoretical experimental
100% NHS 9:3:3 9.4:2.7:2.4
50% NHS 19:3:3 19.3:3.3:2.4
Figure 4. Types of C atoms that can be distinguished by XPS in the NHS-ester-terminated 
monolayers (a), and after the functionalization with biotin hydrazide (b).
  More detailed information about the replacement of the NHS-ester moieties was obtained 
from IRRA spectroscopy (Figure 6). For the biotin-modified 100%  NHS-ester-terminated monolayer 
the complete disappearance of the CO stretching vibrations of the NHS-ester, ranging  from 1745 to 
1817 cm−1, revealed the release of the NHS-ester moieties after an overnight incubation in an 
AcONa/AcOH buffer solution containing biotin hydrazide. In line with this, the covalent coupling  of 
biotin hydrazide moieties was evidenced by the appearance of two characteristic amide bonds at 
1647 and 1543 cm−1 assigned to the CO stretch (amide I) and the N—H in-plane bend coupled to the 
C—N stretch (amide II), respectively. 34 The attachment of biotin hydrazide was also indicated by the 
emerging of the N—H stretch vibration at 3225 cm−1. Another new peak at 1718  cm−1 could be 
assigned to the carboxyl CO stretch, since part of the NHS-ester moieties hydrolyzed into carboxylic 
acids during the overnight incubation in acidic buffer solution, in line with XPS data (see below). In 
contrast, the absence of these peaks in the spectrum for the pure decene monolayer (0% NHS-ester) 
corroborated the specific reactivity of biotin hydrazide toward the NHS-ester functionality. Small 
peaks at 1719 and 3271 cm−1 on the pure decene monolayer are likely due to traces of nonspecific 
adsorption of carboxyl contaminations after an overnight incubation in the AcONa/AcOH buffer with 
biotin hydrazide. In addition, AFM measurements (Figure 6) displayed that the resulting surface was 
really clean and flat, as after sonication of the sample in sodium acetate buffer and water (to remove 
any physically adsorbed hydrazide) the AFM image clearly displayed the terrace structure of the 
Si(111) substrate and both the average area roughness over the whole measured surface and the 
average line roughness on the terrace surface were again <0.1 nm. Only such a flat and bioactive 
surface indeed matches the requirements of biochip fabrication.
  The substitution of the NHS-ester moiety by biotin hydrazide was also confirmed by XPS. 
Figure 7 shows the XPS narrow scans of C1s, N1s, and O1s of a 100% NHS-ester-terminated monolayer 
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Figure 6. IRRA spectra of 100% NHS-ester and 0% NHS-ester monolayers after modification 
with biotin hydrazide (a). AC mode AFM topographic image of biotin-modified 100%  NHS-
ester monolayer (1 × 1 µm; color scale from 0 to 0.60 nm) (b). Both the average area 
roughness (A Ra) and the average line roughness (L Ra) are marked in the image.
on Si(111) before and after binding  biotin hydrazide. The C1s signal of the biotin hydrazide-modified 
monolayer could also be deconvoluted into three peaks: one carbonyl peak at 288.9 eV (iii) and two 
noncarbonyl subpeaks at 286.3 eV (ii) and 285.0 eV (i), with a Ciii:Cii:Ci ratio of 3:4.3:15.8 
(theoretical ratio of 3:4:14, as illustrated in Figure 4). Comparing the biotin hydrazide-modified 
monolayer with the original NHS-ester-terminated monolayer, the shift of the N1s peak from 402.3 to 
400.3 eV and the loss of the O1s peak at 535.5 eV confirmed the removal of NHS moieties, while the 
attachment of biotin hydrazide was indicated by the increase of the N/C atomic ratio from 1/16.4 to 
4/28.8  (theoretically: from 1/15 to 4/21) and the ratio of noncarbonyl carbons to carbonyl carbons 
((Ci + Cii)/Ciii) from 15.1/3 to 20.1/3 (theoretically: from 12/3 to 18/3) as well as the appearance of a 
small but detectable S2p peak at 164 eV. The fact that the N/C ratio was smaller while the (Ci + Cii)/Ciii 
ratio was larger than the theoretically expected ratios for an ideal biotin hydrazide-modified 
monolayer suggests that biotin hydrazide did not replace the NHS-ester moieties completely.
  The fraction of NHS-ester moieties that were converted to biotin can be calculated by 
comparing the N/C and (Ci + Cii)/Ciii ratios from the XPS data with the theoretically expected ratios. 
The theoretical ratios for a 100% NHS-ester-terminated monolayer are N/C = 1/15 and (Ci + Cii)/Ciii = 
12/3. These ratios should become N/C = 4/21 and (Ci + Cii)/Ciii = 18/3 for a 100% efficient formation 
of the biotin-terminated monolayer, while for the hydrolyzed NHS-ester monolayer (giving an acid-
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Figure 7. XPS narrow scans of a biotin-modified 100% NHS-ester monolayer for C1s (top), N1s 
(bottom left), and O1s (bottom middle). [For ease of comparison, data for the 100% NHS 
monolayer were added to the N1s and O1s graphs.] (Bottom right) S2p region for the biotin-
modified monolayer, deconvoluted into peaks for Si plasmon and S2p.
terminated monolayer) these ratios should be 0/11 and 10/1, respectively. Based on the XPS-
measured N/C ratio of 4/28.8  and (Ci + Cii)/Ciii of 20.1/3 for the biotin-modified monolayer, the 
fraction of NHS-ester moieties converted into biotin hydrazide moieties (x) or COOH (y) and the 
remaining NHS-ester moieties (1 − x − y) were calculated from the following equations:
and 
  A solution to these equations is found for x = 0.58  and y = 0.40; i.e. the NHS-ester moieties 
were almost fully converted into either biotin (58%) or acid (40%) moieties. The remaining  fraction of 
NHS was indeed low (100% − 58% − 40% = 2%).
  The biotin hydrazide could not replace the NHS-ester moieties completely, which is 
attributed to two reasons: (1) The steric hindrance of the biotin hydrazide moieties in the resulting 
monolayer may hamper full replacement of the NHS-ester moieties. (2) Due to this (slow) reaction, 
part of the terminal NHS-ester groups will have hydrolyzed in the overnight incubation in acidic 
AcONa/AcOH buffer solution. This was substantiated by the emergence of a carboxyl CO peak at 
1718  cm−1 in the IRRA spectra, an obvious additional component at ~534 eV for COOH in the 
oxygen region in XPS spectra, as well as the observation that the (Ci + Cii)/Ciii ratio was larger than the 
theoretical value.
Surface Modification of Glass
Detection systems for commercially available protein microarrays and biosensors are often based on 
fluorescence, mostly by fluorescently labeled antibodies. Although silicon is a perfect substrate to 
obtain well-defined monolayers, it is a difficult material to combine with fluorescence detection. In 
case the emission energy of the fluorescent molecule exceeds the band gap of silicon, the excitation 
energy is efficiently transferred to excite an electron from the valence to the conduction band in the 
silicon, resulting in quenching  of fluoresence. Assuming an emission wavelength for a fluorescent 
molecule between 500 and 700 nm (2.5 – 1.8  eV), the band gap of 1.1 eV for bulk crystalline silicon 
35 can be easily bridged by those energies. Danos et al. showed that for 3,3′-dioctadecyl 
oxacarbocyanine perchlorate (DiO), a dye with spectral properties comparable to fluorescent 
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proteins, fluorescence quenching  depended highly on the distance to the silicon surface. 36 A 
quenching  of 90%  was observed at a distance of 2 nm from the silicon surface, which was in the 
range of the expected thickness of monolayers on silicon. 12, 19 This stimulated us to look also at other 
possibilities as substrate of protein immobilization. A substrate that is spectrally transparent for visible 
light is glass, which is therefore commonly used in combination with a fluorescence detection 
system. Furthermore, glass can be modified using milder methods than for silicon modification, 
which potentially simplifies microreactor production. Therefore, our focus was shifted from 
functionalization of silicon towards immobilization on glass. 
  Proteins easily lose their conformation and activity due to denaturation, dehydration, and 
oxidation. This requires immobilization strategies to attach proteins in their native state. Three 
different approaches are mainly used, namely physical immobilization, affinity attachment and 
covalent linking. Physical adsorption of proteins on surfaces is possible through intermolecular forces 
like hydrophobic or polar interactions. Disadvantages of this method include random orientation of 
the proteins and weak attachment. Affinity attachment offers an approach that can be used to 
immobilize proteins in specific orientation. This method employs e.g. avidin, a His-tag, gluthatione S-
transferase or immunoglobulin G-labeled protein, which can be attached to a surface functionalized 
with its complementary partner. The drawback of affinity attachment is the requirement to tag the 
protein. In some cases this tag is a relatively large molecule. 
  Covalent linking  provides a wide range of different chemistries to be used. For bio-
functionalized glass surfaces, several chemistries that use naturally available functional groups in 
proteins, like −NH2 of lysines or the N-terminus, −COOH of aspartic acid, glutamic acid or the C-
terminus, and −SH of cysteines have been reported. Rozkiewicz et al. used an aldehyde-
functionalized glass slide to immobilize the gelatin-like, hydrophilic protein Col3a1 with its lysine 
residues. 37 These surfaces were used to culture mammalian cells in a specific pattern. Oligopeptides 
were coupled to an amino-surface via the C-terminus using NHS by Soultani-Vigneron et al. 38 
Similar chemistry was used by Arya to immobilize cholesterol oxidase through its −COOH 
functionalities randomly distributed over the protein surface to act as a cholesterol biosensor. 39
  These covalent linking  methods use functional groups that are abundantly present in proteins, 
resulting in random orientation on the surface. A more site-specific functional group is the cysteine, 
which is incidentally present in proteins. A glucose-binding protein equipped with a zinc-finger 
domain was attached via a cysteine to a thiol-modified glass surface with the bifunctional linker bis-
maleimidoethane by Smith et al. 40 N-terminal cysteines can be used to attach proteins or peptides to 
a α-thioester-modified glass slide via native chemical ligation. 41, 42 Camarero et al. opted for the 
inverted approach of immobilization of protein α-thioesters to a glass slide functionalized with a 
linker containing a protected N-terminal cysteine. 43
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  These functional groups are conveniently present in proteins by nature, but other strategies 
use reactive groups introduced by non-natural amino acids or post-expressional modification of the 
protein, enabling site-specific attachment, i.e. high control over protein orientation on the surface. An 
example of the latter approach is the immobilization of a diene-functionalized streptavidin to a 
maleimide-functionalized glass slide using Diels-Alder chemistry. 44 For the Cu(I)-catalyzed 1,3-
dipolar cycloaddition between an azide and an acetylene, commonly referred to as ‘click’ chemistry, 
both approaches are possible. Sun et al. introduced the non-natural amino acid azidohomoalanine 
during  expression to obtain an azide-functionalized thrombomodulin, which was attached to an 
acetylene-modified glass slide. 45 As an alternative approach post-expressional modification of the 
proteins has been used with an azide or acetylene, followed by immobilization to the glass surface 
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Figure 8. Overview of different methods to obtain bio-functionalized glass surfaces: amine 
chemistry (a), carboxyl chemistry (b), thiol chemistry (c), Diels-Alder chemistry (d), 1,3-
dipolar cycloaddition (e), Staudinger ligation (f), and α-oxo semicarbazone ligation (g).
via ‘click’ chemistry. 46, 47 An azide-functionalized fluorescent protein could also be immobilized 
using the Staudinger ligation. 46 The last example is the attachment strategy used by Olivier et al.  48 
They attached a glyoxylyl-functionalized peptide to a semicarbazide surface via α-oxo 
semicarbazone ligation. An excellent review about protein immobilization is written by Rusmini, 49 
giving an extensive overview of covalent and bioaffinity immobilization.
  Covalent linking  of elastin-like polypeptides (ELPs) has been reported by other groups using 
some of the chemistries described above. Nath et al. covalently immobilized ELPs via reaction of the 
primary amine groups located at the N-terminal end of the ELPs to a glass surface covered with the 
reactive NHS ester. 50 Amine chemistry was also used by Na et al., who attached a lysine-tagged ELP 
to an aldehyde-functionalized glass slide. 51 Another approach was applied by Zhang  et al.: 52 using 
auxotrophic expression the photo-reactive non-natural amino acid para-azidophenylalanine was 
introduced in the ELP part of a fusion protein, which formed crosslinks with the silanized glass 
surface upon UV irradiation.
  Since ELPs are structural proteins and do not display orientation-dependent activity, site-
specific immobilization is not required. However, using the N-terminus and amine groups of two 
lysines located near the N-terminus of our ELP, the method described in this chapter did result in ELPs 
site-specifically attached to the surface. Our method was based on amine chemistry described before 
between amines and a aldehyde-modified glass surface 53, 54 followed by reductive amination. 55 In 
the second half of this chapter the modification of glass slides is described using  standard 
immobilization protocols (Figure 9). All intermediate steps were characterized by water contact 
angles, and X-ray photoelectron spectroscopy (XPS) analyses.
Results and Discussion
For reversible immobilization of ELP fusion proteins on a surface a hydrophobic area is essential. 
Since this process is executed even more effectively when the surface itself is functionalized with a 
layer of stimulus-responsive ELP molecules, we followed this strategy. 50, 56 In Figure 9 the used 
immobilization strategy is depicted based on standard immobilization methods. A cleaned glass slide 
was functionalized with an amino-terminated silane, N-2-(amino ethyl)-3-amino propyl trimethoxy 
silane (AEAPTS). 39, 57, 58 Using  glutaraldehyde followed by reductive amination, 59 the glass slide was 
functionalized with KK-ELP2, to create a surface with temperature-controlled hydrophobicity, which 
is capable of interactions with ELP fusion proteins. KK-ELP2 was chosen to prepare the functional 
surface because it exhibited a lower Tt compared to KK-ELP1, guaranteeing a hydrophobic basis at 
the Tt of both fusion proteins (Chapter 2). The intermediate steps of immobilization were analyzed 
with static contact angle measurements and XPS (Table 2).
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  From the carbon composition and relatively high contact angle (31.6°) of the cleaned glass 
slide 57 it could be concluded that some contaminants still remained on the surface. Despite this 
slight contamination the presence of amino functionalities on the surfaces was evidenced by the 
increased N1s signal compared to the cleaned glass substrate, and by increased contact angles. For 
the aldehyde-terminated surfaces a further increased contact angle was observed, while the carbon/
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Table 2. Contact angles, relative surface compositions of functionalized surfaces, and 
deconvoluted C 1s peaks of the functionalized surfaces, both derived from XPS measurements. 
Cleaned 
glass slide
Amino-terminated 
glass slide
Aldehyde-
terminated 
glass slide
KK-ELP2-
functionalized 
glass slide
contact angle 
(°) 31.6±3.3 46.8±0.2 56.4±0.9 63.9±1.2
O 1s % 55.68 50.79 45.78 22.01
N 1s % 0.91 2.92 2.41 9.21
C 1s % 15.11 14.92 27.08 59.14
Si 2p % 28.3 31.37 24.74 9.65
C 1s % 285 eV 81.74 70 64.15 55.24
C 1s % 286 eV 9.8 23.22 21.08 24.51
C 1s % 288 eV 8.46 6.79 14.77 20.25
Figure 9. Schematic representation of functionalization of a glass slide with KK-ELP2. In the 
first step the glass slide is aminosilylated with AEAPS, then modified with glutaraldehyde. KK-
ELP2 is subsequently covalently immobilized using reductive amination.
nitrogen ratio roughly doubled between the amino and aldehyde-terminated surfaces, as theoretically 
expected. KK-ELP2 immobilization was evident from the increase in the nitrogen and carbon signals, 
the significant decrease of the silicon signal from the underlying  glass substrate, and increased 
contact angle. The small variation in the contact angle measured at various positions of the substrate 
for all functionalized surfaces was indicative of a homogeneous functionalization.
  The C1s signal of the functionalized surfaces was deconvoluted into three peaks (Table 2, 
Figure 10, Figure 11), at 285, 286 and 288  eV, for carbon atoms in the aliphatic hydrocarbon chain 
(i), for the carbon atoms adjacent to amino nitrogen atoms (ii), and for carbonyl carbon atoms (iii), 
respectively. 31, 33, 60 The amino-terminated glass slide displayed a clear increase in the 286 eV peak, 
while the aldehyde-terminated glass slide showed the emergence of a peak at 288 eV. Both these 
peaks were further raised after the last step of KK-ELP2 immobilization, indicating the successful 
immobilization of KK-ELP2 on the glass slide.
  For an indication of the layer thickness XPS data for the Si2p signals was used to calculate the 
thickness of the ELP2 layer on glass. The ratio of the intensities of these signals is exponentially 
related to the layer thickness (τ),61 according to the equation:
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Figure 10. Types of C atoms that can be distinguished by XPS in the amino-terminated glass 
slide (a), after functionalization with glutaraldehyde (b), and after the functionalization with 
KK-ELP2 (c).
with I(τ) the intensity of the signal for the KK-ELP2-functionalized glass slide, I0 the intensity of the 
signal for the cleaned glass slide, and λ the attenuation length. The attenuation length (λ = 3 nm) was 
chosen by extrapolation, 61-63 resulting  in a thickness of 4.4 ± 0.5 nm. Because of assumptions in the 
calculation method an experimental uncertainty of 10 – 15% is expected. The calculated layer 
thickness was valid compared to the dimensions of a 30 kDa protein, namely GFP, which is 42 Å long 
and 24 Å in diameter. 64, 65 
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Figure 11. XPS C1s narrow scans of the intermediate steps of KK-ELP2 immobilization, 
deconvoluted into peaks for aliphatic carbon atoms (i), carbon atoms adjacent to amino 
nitrogen atoms (ii), and carbonyl carbon atoms (iii)): cleaned glass slide (a), amino-terminated 
glass slide (b), aldehyde-terminated glass slide (c), and KK-ELP2-functionalized glass slide (d).
Conclusions
As shown with IRRAS, XPS, AFM, and static contact angle measurements, it is possible to 
conveniently prepare well-defined NHS-ester-terminated mixed monolayers covalently attached onto 
silicon surfaces using visible light at room temperature. Under these conditions, no degradation of 
the NHS-ester moieties can be detected, and a highly controllable and mild one-step attachment is 
therefore feasible. These NHS-ester moieties could be substituted by larger amines, such as biotin 
hydrazide, easily providing a clean and flat biotinylated surface. Since the fraction of ω-NHS-
functionalized 1-alkene in the reactive alkene solution determines the fraction of NHS-ester sites on 
the modified surface, this yields direct control over the fraction of NHS-ester moieties in the 
monolayer. As a result, the density of, for example, biotin functionalities can be fine-tuned. Finally, 
this light-induced attachment approach is compatible with, for example, photoinduced patterning 
techniques. 
  Static contact angle measurements and XPS showed that glass surfaces could easily be 
modified and functionalized with elastin-like polypeptides using  standard immobilization protocols. 
Since glass is compatible with fluorescence detection systems, this facilitate reversible 
immobilization of fluorescent ELP fusion proteins in a microchannel using a temperature gradient 
over a surface.
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Experimental Section
Materials
Petroleum ether 40/60, dichloromethane, and ethyl acetate were distilled before use. 1,2,4-
Trichlorobenzene was distilled twice and stored on CaCl2. 1-Decene (Fluka, 97%) and undecylenic 
acid (Acros, 99%) were distilled twice at reduced pressure; acetone (Acros, 99+%), 2-propanol 
(Fisher, p.a . ) , NH4F (S igma, 98+%), N -hydroxysuccinimide (NHS) (S igma) , N,N′-
dicyclohexylcarbodiimide (DCC) (Sigma, 99%), and EZ-Link biotin hydrazide (Pierce) were used as 
obtained. Single polished n-type Si(111) substrates (475−550 µm thick, resistivity 1.0−5.0 Ωcm) were 
obtained from Addison Engineering, San Jose, CA.
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N-Succinimidyl Undecylenate (NHS-ester-alkene)
The preparation procedure was as described before. 66 In brief, 
undecylenic acid (3.64 g, 19.8  mmol) and NHS (2.53 mg, 22.0 
mmol) were dissolved in 100 mL of ethyl acetate. DCC (4.54 g, 
22.0 mmol) was added to the solution on ice, and the mixture was 
stored at 4 °C overnight. The reaction mixture was filtered to remove depositions and evaporated in a 
low-pressure rotavapor to remove solvents. The resulting waxy solid was recrystallized from 20 mL of 
2-propanol, collected by vacuum filtration with a Büchner funnel, and rinsed with a small amount of 
water. After drying  in vacuum overnight, NHS-ester-alkene was obtained (3.37 g, 12.0 mmol, 61%) 
with purity > 99% (GC). 1H NMR (300 MHz, CDCl3): δ 5.80 (m, 1H), 4.97 (m, 2H), 2.85 (s, 4H), 
2.62 (t, 2H), 2.05 (q, 2H), 1.76 (m, 2H), 1.33−1.42 (m, 10H). The 1H NMR spectrum was in 
agreement with literature. 12, 13
Monolayer preparation 
The approach is indicated schematically in Figure 2. The detailed procedure was as described before. 
19 In brief, oxygen plasma-cleaned Si(111) chips were etched to a H-terminated surface by immersion 
in an argon-saturated 40%  aqueous NH4F solution for 15 min under an argon atmosphere. 
Monolayers were prepared by immersing  the freshly prepared H-terminated Si(111) chips into a 
deoxygenated solution of NHS-ester-alkene and/or 1-decene in 1,2,4-trichlorobenzene, followed by 
irradiation with 447 nm light for 16 h. The total concentration of alkenes was 0.5 M, while the alkene 
composition was varied with different NHS-ester-alkene ratios of 0, 50, and 100%.
Attachment of biotin hydrazide
NHS-ester-terminated monolayer samples were placed in a solution of ~5 mM biotin hydrazide in 
100 mM sodium acetate buffer pH 5.5. After incubation overnight, the samples were cleaned by 
sonication in sodium acetate buffer, rinsed copiously with H2O and CH2Cl2, and dried by nitrogen 
flushing.
Glass surface functionalization 
Glass slides were cleaned for 1 h in a piranha solution consisting  of H2SO4 and H2O2 in a ratio of 
7:1. After washing extensively with MilliQ water, the glass slides were immersed in a 0.5% (w/v) 
solution of N-2-(amino ethyl)-3-amino propyl trimethoxy silane (AEAPTS) 57 in MilliQ water 
overnight. The glass slides were washed extensively with MilliQ water, and immersed in a 50% (v/v) 
solution of 50% glutaraldehyde in PBS. KK-ELP2 was immobilized on these aldehyde-functionalized 
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slides by placing drops of a 0.1 mg/mL solution in PBS on the surface in the presence of NaCNBH3 (3 
mM). 55, 67 After 16 h the slides were washed extensively with MilliQ water, dried under nitrogen, and 
stored at 4 °C. 
Contact angle measurements
Static water contact angles were measured in duplo with an automated Krüss Drop Shape Analysis 
System DSA100 (Krüss GmbH, Hamburg). At least six small droplets of 3.0 μL deionized water were 
dispensed and the contact angles were determined using a Tangent 2 fitting model.
Infrared reflection absorption spectroscopy (IRRAS)
IRRAS measurements were performed with a Bruker Tensor 27 instrument with a liquid-nitrogen-
cooled mercury cadmium telluride (MCT) detector (Bruker, Germany), using a commercial variable-
angle reflection unit (Auto Seagull, Harrick Scientific). A Harrick grid polarizer was installed in front 
of the reflection unit and was used for measuring  spectra with p-polarized (parallel) radiation at an 
incident angle of 68° with respect to the normal of the sample surface. Single-channel transmittance 
spectra were collected using a spectral resolution of 4 cm−1, 1024 scans in each measurement, and 
using a oxygen plasma-cleaned Si(111) chip as reference. 
X-ray Photoelectron Spectroscopy (XPS)
The XPS analysis of the surfaces was performed using a JPS-9200 Photoelectron spectrometer (JEOL, 
Japan). The high-resolution spectra were obtained at takeoff angle of 80° under ultrahigh vacuum 
(UHV) conditions using  monochromatic Al Kα X-ray radiation at 12 kV and 25 mA, using  an analyzer 
pass energy of 20 eV (Si surfaces) or 10 eV (glass surfaces). All high-resolution spectra were corrected 
with a linear background before fitting.
Atomic force microscopy (AFM)
AFM images were obtained with a JSPM-5400 microscope (Jeol, Japan) with silicon cantilevers 
operating  in the alternating current (AC) mode in air. The scan size was 1 × 1 µm2 at a scan rate of 
1.0 Hz.
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4
Transition Temperatures of Elastin-like 
Polypeptides in Mixtures
Elastin-like polypeptides (ELPs) with varying degrees of polymerization and composition were produced via 
protein engineering. Lower critical solution temperatures of aqueous solutions containing  two or three of 
these different molecular weight ELPs were investigated. In contrast to elastin-based side-chain polymers 
(EBPs) linear polypeptides preserve their individual transition temperature upon mixing.
Part of this chapter was published as
Elastin-like polypeptides of different molecular weight show independent transition temperatures when mixed
Rosalie L.M. Teeuwen, Frits A. de Wolf, Han Zuilhof, and Jan C.M. van Hest 
Soft Matter, 2009, DOI 10.1039/b909777e
Introduction
Elastin is a structural protein that plays a crucial role in mammalian tissue as it induces elasticity to 
e.g. skin and arteries. 1, 2 Elastin, which is constructed by crosslinking of its precursor polymer, 
tropoelastin, has drawn much attention from the materials science community because of its striking 
stimulus-responsive character. Upon heating, the water-soluble protein, which lacks a secondary 
structure, undergoes a phase transition, forming  a β-spiral structure, which renders the protein 
hydrophobic and causes it to aggregate. This Lower Critical Solution Temperature (LCST) behavior is 
completely reversible. Pioneering work by Urry et al. has shown that tropoelastin can be mimicked 
by elastin-like polypeptides (ELPs), which are composed of the amino acid repeat sequence Val-Pro-
Gly-Xaa-Gly (Val = valine, Pro = proline, Gly = glycine), in which the fourth amino acid residue Xaa 
can be any natural amino acid except proline. 3, 4 It was demonstrated that the LCST could be varied 
over an extensive temperature range by changing the hydrophobicity of the fourth residue, the length 
of the polymer, ionic strength of the medium and the ELP concentration. ELPs can be readily 
produced in high yields by molecular biology techniques using Escherichia coli (Chapter 2) as 
expression system. 5, 6
  The unique properties of elastin expand the possibilities for the use of this material in a 
variety of applications. Block copolymers of elastin and silk, and elastin polymers containing  cell 
adhesion domains have been constructed for the formation of hydrogels for tissue engineering. 7-11 
Block copolymers of two different types of elastin have been made to form block copolymer micelles 
with stimulus responsive behavior. 12 ELPs modified with drugs have been used for tumor tissue 
targeting. 13-16 The LCST character of ELPs has been applied to position proteins, and aggregate and 
purify fusion proteins after fermentative production from a cell lysate. 6, 17 Although research has been 
mainly focused on linear ELPs, well-defined, low PDI synthetic polymers with pendant elastin 
pentapeptides, called elastin-based side-chain polymers (EBPs), have recently been synthesized using 
atom transfer radical polymerization (ATRP) 18, 19 and reversible addition–fragmentation chain transfer 
polymerization (RAFT). 20 Both polymerization techniques resulted in stimuli-responsive materials 
mimicking the linear elastin behavior.
  Recently, Fernández-Trillo et al. showed the temperature-responsive behavior of a blend of 
these EBPs in an aqueous environment. 21 Mixtures of EBPs with different chain lengths displayed a 
single transition temperature, which depended on the ratio of polymers in the binary mixture. This 
behavior seemed to be in conflict with the temperature-responsive behavior of a blend of ELPs, 
briefly mentioned by Meyer et al. 22 In that case an independent transition for each ELP, which had 
the same degree of polymerization and varied in amino acid composition, was observed. 
  The temperature-responsive behavior of a mixture of ELPs is important during  the stepwise 
positioning of ELP fusion proteins in a microchannel. In case the behavior of a mixture of ELPs 
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resembles the investigated EBPs, the positioned ELP fusion protein will dissolve again once the 
transition temperature is raised and the second ELP fusion protein is introduced. This prompted us to 
perform a similar investigation after the temperature-responsive behavior of a blend of linear ELPs 
varying only in length, which, to the best of our knowledge, had never been performed before. 
  This chapter will show that these independent transitions are also observed for mixtures of 
ELPs. These ELPs differing in molecular weight were produced using  protein engineering  and 
expressed in E. coli as expression system. Their characterization was described, and the mixtures of 
the three different ELPs in varying  composition were investigated using turbidity measurements. The 
blends of linear ELPs behaved in a contrary way compared to EBPs, and this behavior was 
independent of the nature of the ELP length or precise amino acid composition. 22
Results and Discussion
ELP gene synthesis
To investigate whether ELPs of the same composition but with variation in length keep their 
independent transitions or show a single transition temperature upon blending, three ELPs were 
produced with 20, 40, and 90 pentapeptide repeats (Figure 1) using protein engineering. In short, 
four synthetic oligonucleotides were annealed and ligated into the cloning vector to form a monomer 
consisting of 10 repeats of the pentapeptide. Multimerization until the desired chain length was 
obtained, was achieved via recursive directional ligation 23 with restriction enzymes BsmFI and FokI 
(Scheme 1). 
  In Figure 2 the three ELP genes with varying  lengths are shown after restriction analysis. For 
expression in Escherichia coli, the ELP genes were transferred to the expression vector pET15b. 
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Figure 1. Used ELP sequences with 20, 40 and 90 pentapeptide repeats. Guest residue Xaa of 
the pentapeptide Val-Pro-Gly-Xaa-Gly was replaced by Val, Leu, and Gly in a 5:2:3 ratio.
ELP expression and purification
The three proteins were expressed in the Escherichia coli expression strain BLR(DE3). The ELPs were 
purified by inverse transition cycling  (ITC), 24 which uses the LCST of the proteins. This method 
alternates between steps of high and low temperatures. In the step with the raised temperature salt 
was added to promote aggregation of the ELPs, and after centrifugation the supernatant containing 
contaminants was discarded. In the next step a cold buffer with low salt concentration was added to 
dissolve the ELP, and after centrifugation denatured proteins were removed. After purification the 
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Scheme 1. Scheme representing the ELP multimerization, resulting  in the genes for ELP-20, 
ELP-40 and ELP-90. BsmFI and FokI were used for multimerization (restriction enzyme 
recognition sites: ).
Figure 2. Agarose DNA gel showing three ELP genes with varying lengths, digestion with 
XhoI/BamHI after multimerization: a) ELP-20 (a), ELP-40 (b), ELP-90 (c). 
yield was between 7 mg and 10 mg purified protein per liter culture. The resulting proteins were 
characterized with SDS-PAGE (Figure 3), which nicely showed the mass differences of the three ELPs.
ELP characterization
MALDI-TOF mass spectrometry (Figure 4, Table 1) was used to exactly determine the molecular 
weight. The measured molecular weight was slightly less than the calculated weight, which was also 
observed and discussed for the ELPs in Chapter 2. No contaminants were detected, indicating  highly 
pure protein samples. For ELP-20 and ELP-40 small peaks, representing  dimers, could be 
distinguished in the spectra. In the spectrum of ELP-90 doubly and triply charged species were clearly 
visible, at 20 kDa and 13 kDa respectively. 
  Turbidity profiles were measured (Figure 5), and the transition temperatures (Table 1) were 
determined at half of the maximal optical density at 350 nm in PBS supplemented with 2 M NaCl in 
anticipation of the relatively high transition temperature for ELP-20. The transition temperatures 
showed clear differences, 25 which allowed the effect of mixing on the LCST to be monitored.
Transition Temperatures of Elastin-like Polypeptides in Mixtures
69
Figure 3. Typical SDS-PAGE Coomassie stained gel of the three produced ELPs after 
purification; a) ELP-20 (a), ELP-40 (b), ELP-90 (c).
Table 1 Molecular weight and transition temperature of ELPs                                                     
Protein Calculated (Da) Measured (Da)a Tt (°C)b
ELP-20 12082 11830 45
ELP-40 20075 19902 25
ELP-90 40059 39711 14
a Molecular weight, measured by MALDI-TOF  b Transition temperature, determined at half of 
the maximal optical density at 350 nm from turbidity measurements in PBS supplemented 
with 2 M NaCl                                                                                                                           
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Figure 4. MALDI-TOF measurement of ELP-20 (a), ELP-40 (b), ELP-90 (c).
Figure 5. Normalized turbidity profile of ELP-20 (a, 0.03 mg/mL), ELP-40 (b, 0.05 mg/mL), 
and ELP-90 (c, 0.05 mg/mL) in PBS supplemented with 2 M NaCl measured at 350 nm.
Mixtures of ELPs varying in molecular weight
Three different binary blends were made of the ELPs, and their turbidity profile at 350 nm was 
measured as function of temperature (Figure 6). For the blend of ELP-20 and ELP-90, which display 
the largest difference in transition temperature, distinct separate transitions for each ELP in the blend 
were visible. Also the blends with a smaller difference in transition temperature, ELP-20 with ELP-40 
and ELP-40 with ELP-90, exhibited separate transitions for the different ELPs present in the blend. The 
observed transition temperatures were similar to the measured transition temperatures of the pure 
ELPs.
  In the next step, the turbidity profile of a mixture of all three ELPs was measured (Figure 7). 
As with the blends consisting of two ELPs, separate, independent transitions were clearly visible at 
three transition temperatures for each of the ELPs present in the blend. Again, these transition 
temperatures resembled the transition temperatures for the pure ELPs.
  The behavior of the ELP blends is strikingly in contrast with the earlier mentioned EBPs. The 
observed single transition temperature for these polymers upon blending  can be explained by the 
Flory-Huggins theory for polymer solutions, 21, 26, 27 which uses the interaction parameter χ to 
describe the intermolecular interactions. Assembly is mainly driven by an increase in hydrophobicity, 
and cooperativity between the different side-chain peptides is not easily achievable. A plausible 
explanation for the different behavior of ELPs is that intermolecular interactions during  folding 
prevail. Upon heating  ELPs undergo conformational changes from random coil into type II β–turn, 
exposing  hydrophobic amino acid side chains to the solvent, leading to triple-helical filaments and 
aggregates based on hydrophobic interactions. 3, 28, 29
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Figure 6. Normalized turbidity profile of binary blends of ELP-20 (0.07 mg/mL), ELP-40 (0.05 
mg/mL), and ELP-90 (0.05 mg/mL) in PBS supplemented with 2 M NaCl measured at 350 nm: 
ELP20/ELP-40 (a), ELP-20/ELP-90 (b), ELP-40/ELP-90 (c).
  These aggregates can only be formed by ELP molecules interacting with other ELP molecules 
that also have undergone a conformational change, i.e. ELPs with the same transition temperature, in 
our case ELPs with the same length, which results in the separate independent transition temperatures 
for each ELP in the blend. In the case of the EBPs, although different EBPs have separate transition 
temperatures, the side-chain peptides are the same. Upon heating  the side-chain peptides take on a 
β–turn conformation, which happens for all EBPs in the blend. This leads to intermolecular 
hydrophobic interactions between alle EBPs, resulting in a single transition temperature for the EBP 
blend.
  The experiments with EBPs by Fernández-Trillo et al. and the ones with ELPs reported in this 
chapter were performed in a similar solvent with the same heating  rate of 1 °C/min. The concentration 
of polymer in the EBPs differed from the ELP concentration, 0.65 mg/mL to 0.17 mg/mL. The used 
concentration for the ELP mixtures is in the range of the experiments performed by Meyer et al. 22 It is 
not likely that the concentration difference explains the conflicting behavior of EBP and ELP mixtures. 
  In order to obtain more insight into the rate of the transition process a kinetics study was 
performed. Turbidity profiles were generated at varying heating rates for an ELP-40/ELP-90 mixture 
(Figure 8), of which the two transition temperatures were in close proximity. For all rates the 
independent transitions were visible. For the 0.1 and 1 °C/min rates the transition temperatures were 
the same, proving  that 1 °C/min is a representative rate for turbidity measurements. However, in case 
of the 0.1 °C/min heating a plateau was reached, indicating that the first transition was completed 
before the second phase transition occurred, whereas with the 1 °C/min experiment a slight overlap 
of both transitions was visible. This effect was even more pronounced for the transition measured at 
10 °C/min, indicating  that the ELP aggregation process was not able to follow this steep heating 
profile. This also caused a shift of the transition temperatures to higher values. The decrease of the 
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Figure 7. Turbidity profile of a blend (black line) of ELP-20 (0.2 mg/mL), ELP-40 (0.05 mg/mL), 
and ELP-90 (0.05 mg/mL), and the separate ELPs in PBS supplemented with 2 M NaCl 
measured at 350 nm.
signal for the 0.1 °C/min experiment above 32 °C was due to precipitation of the formed aggregates, 
which was more pronounced in this experiment because of its prolonged duration. This kinetics study 
demonstrates that although the ELP transition at the LCST is a relatively slow process, independent 
transitions of the different ELPs are obtained, indicating that they fold separately. For an efficient 
application of the LCST behavior heating profiles around 1 °C/min should be used in order to allow 
the system enough time to adjust to the changing temperature.
  Using  circular dichroism (CD) spectroscopy we investigated the secondary structure change 
of ELPs. It has been extensively documented by Urry that ELPs undergo a conformational change from 
random coil to β-spiral using techniques including circular dichroism, 30 nuclear magnetic resonance, 
5, 31 dynamic light scattering, 28 and X-ray crystal structure analysis. 32 Similar results were obtained 
by Tamburro, 33-35 although both used the data to support two different models that explain ELP 
elasticity. 36, 37 With this experiment we wanted to investigate if the observed transitions in the ELP 
mixtures were directly related to conformational changes of the polypeptides. The measurements were 
carried out in PBS supplemented with 2 M NaCl at different temperatures between 5 °C and 65 °C 
(Figure 9). Measurements were taken at 5 °C intervals for ELP-40, ELP-90, and their mixture. Due to 
an elevated chloride concentration the data below 210 nm was not interpretable. The spectra showed 
a shift from random coil to a different secondary structure, most probably a β-spiral conformation, for 
ELP-40 around 25 °C, which is the transition temperature for this protein as observed with turbidity 
measurements. For ELP-90 two distinct structures were observed as well, one below and one above 
the transition temperature. Below the transition temperature a minimum was visible at 222 nm. 
Above the transition temperature the minimum decreased for both ELP-40 and ELP-90, which is in 
accordance with literature. 30, 35 For the ELP mixture similar observations were made. Around 20 °C 
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Figure 8. Normalized turbidity profile of the blend of ELP-40 (0.05 mg/mL), and ELP-90 (0.05 
mg/mL) in PBS supplemented with 2 M NaCl measured at 350 nm, measured at different 
heating rates: 0.1 °C/min (a), 1 °C/min (b), and 10 °C/min (c).
the minimum at 222 nm started decreasing, which corresponded with the transition temperature of 
ELP-90. The secondary structure changed until 30 °C, which is characteristic for ELP-40. When the 
two sets of CD data of the single ELP transitions were added together a graph similar to the measured 
data for the ELP-40/ELP-90 mixture was obtained. These observations confirm the conclusion derived 
from the turbidity profiles that upon mixing different molecular weight ELPs retain their independent 
transitions and show that they are directly related to the conformational changes of the polypeptides.
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Figure 9. Temperature/wavelength CD spectra of ELP-40 (a, 0.05 mg/mL), ELP-90 (b, 0.05 mg/
mL), and ELP-40/ELP-90 (c, each 0.05 mg/mL). All spectra were measured in PBS 
supplemented with 2 M NaCl. Sum of the spectra of ELP-40 (a) and ELP-90 (b) is depicted in 
(d).
Mixtures of ELPs varying in composition
As stated before, Meyer et al. 22 briefly mentioned independent transitions for ELPs which had the 
same degree of polymerization and varied in amino acid composition. To observe whether this was 
also true for our ELPs, a mixture of KK-ELP1 and KK-ELP2 was investigated. The production, 
purification and characterization of these ELPs were described in Chapter 2. KK-ELP2 was the same 
protein as ELP-90, in which guest residue Xaa of the pentapeptide ValProGlyXaaGly was replaced by 
Val, Leu, and Gly in a 5:2:3 ratio. For the more hydrophilic protein KK-ELP1 guest residue Xaa was 
replaced by Val, Ala, and Gly in a 5:2:3 ratio. Both proteins consisted of 90 pentapeptides, assuring 
they were of the same grade of polymerization. The separate transition temperatures of KK-ELP1 and 
KK-ELP2 were determined (Chapter 2) at 54 °C and 38 °C, respectively. In Figure 10a the turbidity 
profile of the mixture of KK-ELP1 and KK-ELP2 in PBS is depicted, which shows that for ELPs of the 
same polymerization grade also the independent transition temperatures in the mixture were 
preserved. These independent transitions remained at the temperatures, determined for the pure ELPs.
  As well as the amino acid composition of ELPs, the concentration of solutes in the solvent 
also has an effect on the transition temperature. To see whether this effect was also present in ELP 
mixtures, the mixture of KK-ELP1 and KK-ELP2 was investigated by turbidity measurements in PBS 
supplemented with varying  concentrations of NaCl (Figure 10). For KK-ELP1, the transition 
temperature dropped from 54 °C to 24 °C with 2 M NaCl. A slightly smaller decrease was observed 
for KK-ELP2, from 38 °C to 12 °C, which is close to the value determined for ELP-90. For all salt 
concentrations the independent transitions were easily detected.
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Figure 10. Normalized turbidity profile measured at 350 nm of a mixture of KK-ELP1 and KK-
ELP2 (each 0.1 mg/mL) in PBS supplemented with NaCl: 0 M (a), 0.5 M (b), 1 M (c), 1.5 M (d) 
and 2 M (e).
Conclusions
The ability to independently control the LCST of a mixture of ELPs has interesting  potential 
applications. It allows the step-by-step separation of a multicomponent homogeneous mixture in its 
individual components. This concept will be applied in the stepwise positional assembly of ELP 
fusion proteins in a microchannel using temperature gradients. In Chapter 3 the immobilization of 
ELPs on a glass surface was proven. Together with the preserved LCST of the separate ELPs in a 
mixture, this opens up the way to patterning of ELP fusion proteins (Chapter 5), which can 
conveniently be produced via protein engineering to the N or C terminal part of proteins.
  In conclusion, we have shown that blends of ELPs of varying length display independent 
transitions for each ELP. This behavior was also visible for ELPs of varying  amino acid composition. 
Furthermore, these independent transitions were preserved for varying salt concentrations. These 
blends of linear ELPs behave in a contrary way compared to EBPs, and this behavior is independent 
of the nature of the ELP length or precise amino acid composition. 22
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Experimental Section
Nomenclature
The ELP gene can be described using  the notation ELP[V5L2G3], 38 where the capitals between the 
brackets represent the single letter amino acid code replacing guest residue Xaa in the pentapeptide 
Val-Pro-Gly-Xaa-Gly, and the subscript stands for the number of guest residues in the monomer gene. 
For convenience the genes and proteins are abbreviated to ELP-n, where n designates the number of 
pentapeptide repeats. 
Cloning
Standard molecular biology protocols were used for gene synthesis and oligomerization. Digested 
inserts and linearized vectors were purified by agarose gel electrophoresis (QIAquick Gel Extraction 
Kit , Qiagen, Valencia, CA). All clones were maintained in E. coli XL1-Blue. Colonies were screened 
by PCR, and the DNA sequence of all putative inserts was verified by DNA sequencing.
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ELP gene synthesis
The vector pMTL23-δ-BsaI-aIII was constructed from two synthetic aIII oligonucleotides (Figure 11), 
that were annealed to form double-stranded DNA with XhoI- and EcoRI-compatible ends, and ligated 
into XhoI/EcoRI linearized pMTL23-δ-BsaI (BsaI site removed from Amp gene). 39 A synthetic gene 
encoding 10 repeats of a pentapeptide ELP was constructed from four V5L2G3 synthetic 
oligonucleotides (Figure 11). These oligonucleotides were annealed to form double-stranded DNA 
with BsmBI- and EcoRI-compatible ends, subsequently phosphorylated, and ligated into BsmBI/EcoRI 
linearized and dephosphorylated pMTL23-δ-BsaI-aIII, resulting in pMTL23-δ-BsaI-aIII-ELP-10. 
  For a typical oligomerization, pMTL23-δ-BsaI-aIII-ELP-10 was linearized with BsmFI, and 
enzymatically dephosphorylated. The insert was doubly digested from pMTL23-δ-BsaI-aIII-ELP-10 
with BsmFI and FokI, and ligated into the linearized vector. This was repeated until three ELP genes 
were constructed consisting  of 20, 40, and 90 repeats of the pentapeptide, resulting in vectors 
pMTL23-δ-BsaI-aIII-ELP-20, pMTL23-δ-BsaI-aIII-ELP-40 and pMTL23-δ-BsaI-aIII-ELP-90. 
  The genes for aII were constructed from synthetic aII oligonucleotides (Figure 11). The 
oligonucleotides were annealed to form double-stranded DNA with XhoI- and EcoRI-compatible 
ends, and ligated into XhoI/EcoRI linearized pMTL23-δ-BsaI, resulting  in pMTL23-δ-BsaI-aII. 
Colonies were screened by restriction analysis with SmaI. The ELP genes were doubly digested from 
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aIII
Sense    5’-TCGAGAAAAGAGAGGCTGAAGCGGGACGTCTCGGTGCCTAACATCCG-3’
Anti-sense  5’-AATTCGGATGTTAGGCACCGAGACGTCCCGCTTCAGCCTCTCTTTTC-3’
aII
Sense   5’-TCGAGAAAAGAGAGGCTGAAGCTAAGAAGGGACCAGTTCCTGGTGGTGCCTAAC 
ATCCG-3’
Anti-sense 5’-AATTCGGATGTTAGGCACCACCAGGAACTGGTCCCTTCTTAGCTTCAGCCTCTC 
TTTTC-3’
V5L2G3
Sense I   5’-GTGCTGGTGGTGTTCCGGGCGTCGGTGTTCCTGGAGTCGGTGTTCCAGGTGGAGGT 
GTTCCAGGATTGGGTGTTCCTGGTGTAGGTG-3’
Anti-sense I  5’-GGAACACCTACACCAGGAACACCCAATCCTGGAACACCTCCACCTGGAACACCGAC 
TCCAGGAACACCGACGCCCGGAACACCACCA-3’
Sense II   5’-TTCCTGGTGTTGGTGTTCCAGGTGTTGGTGTTCCAGGTGGAGGTGTTCCTGGTTT 
GGGAGTTCCTGGTGGTGGTGCCTAACATCCG-3’
Anti-sense II  5’-AATTCGGATGTTAGGCACCACCACCAGGAACTCCCAAACCAGGAACACCTCCACC 
TGGAACACCAACACCTGGAACACCAACACCA-3’
Figure 11. DNA sequences of the used oligonucleotides (Eurogentec, Seraing, Belgium).
pMTL23-δ-BsaI-aIII-ELP with BsmFI and EcoRI, and ligated into BsmFI/EcoRI linearized and 
dephosphorylated pMTL23-δ-BsaI-aII, resulting in pMTL23-δ-BsaI-aII-ELP. 
  The ELP genes were doubly digested with XhoI/BamHI and ligated into XhoI/BamHI 
linearized expression vector pET15b (Novagen), resulting  in vectors pET15b-ELP-20, pET15b-ELP-40 
and pET15b-ELP-90. Colonies were screened by restriction analysis with XhoI/BamHI.
ELP expression and purification
PET15b-ELP vectors were transformed into the expression strain BLR(DE3) (Novagen). For a typical 
expression a 100 mL Luria Broth culture, supplemented with 100 μg/mL ampicillin and 12.5 μg/mL 
tetracycline, was inoculated with a single colony and incubated at 37 °C overnight. The overnight 
culture was diluted to an OD600 of 0.1 in a 0.5 L LB culture supplemented with 100 μg/mL ampicillin 
and 12.5 μg/mL tetracycline, and incubated at 37 °C. At an OD600 of 0.6 the expression was induced 
by the addition of IPTG to a final concentration of 1 mM. After incubation at 25 °C overnight the 
cultures were harvested by centrifugation (18,000 × g, 4 °C). The cell pellet was resuspended in PBS, 
and incubated with lysozyme (1 mg/mL PBS) at 4 °C for 30 min. The cells were then lysed by 
ultrasonic disruption at 4 °C. The lysate was centrifuged (15 min, 3768  x g, 4 °C Minifuge RF, 
Heraeus Sepatech, Germany) to remove insoluble matter. 
  The ELPs were purified by inverse transition cycling. 40 In short, ELPs were aggregated by 
adding NaCl to a concentration of 2 M and increasing the temperature of the cell lysate to 65 °C. The 
aggregated protein was separated from solution by centrifugation at 40 °C (10 min, 4566 x g, 
Multifuge, Heraeus Sepatech, Germany). The supernatant was decanted and discarded, and the pellet 
containing the fusion protein was resuspended in cold PBS. The resolubilized pellet was then 
centrifuged at 4 °C (10 min, 4566 x g) to remove any remaining insoluble matter. 
  SDS-PAGE analysis was performed on a Mini-PROTEAN system (Bio-Rad, Hercules, CA) with 
a 7.5%  gel, stained with Coomassie brilliant blue. Protein concentrations were determined by 
bicinchoninic acid assay (Pierce Chemical Co., Rockford, IL).
Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass 
spectrometry
MALDI-TOF measurements were performed on a Bruker Biflex III with 2,5-dihydroxyacetophenone 
(DHAP) as matrix. 41 The samples were mixed in a 1:1 ratio on a MALDI plate with a solution of 7.6 
mg DHAP in 375 μL EtOH and 125 μL diammonium hydrogen citrate (stock solution of 27 mg in 1.5 
mL MilliQ water) containing 2% trifluoroacetic acid. 
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Turbidity measurements and circular dichroism (CD) spectroscopy
The optical absorbance of ELPs, derived from the high tension voltage, was measured in phosphate 
buffered saline (pH 7.4) supplemented with 2 M NaCl at 350 nm in the 5 – 65 °C range on a Jasco 
J-810 spectropolarimeter (spectral width: 1 nm, response: 1 sec., sensitivity: standard) equipped with 
a PFD-425s Peltier temperature controller (Jasco). Experiments were conducted with different heating 
rates: 0.1, 1 and 10 °C/min.
  CD spectra were measured on the same instrument, and in the same buffer. The samples were 
measured in the 5 – 65 °C range with 5 °C intervals. The raw data was converted to mean residue 
ellipticity.
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5
Temperature-controlled Positioning of Fusion 
Proteins in Microreactors
We present a non-covalent immobilization system based on stimulus-responsive elastin-like polypeptides 
(ELPs) to facilitate the positioning of proteins in microchannels. Two ELP variants were constructed and 
connected to fluorescent proteins EGFP and DsRed2. These fusion proteins showed an inverse transition 
behavior which could be simply controlled by varying  concentrations of NaCl. With these ELP fusion proteins 
we were able to demonstrate the formation of two patches of fluorescent proteins on the bottom of a 
microreactor using only the temperature-responsive property of ELPs.
Part of this chapter was published as
Temperature-controlled positioning of fusion proteins in microreactors 
Rosalie L.M. Teeuwen, Han Zuilhof, Frits A. de Wolf, and Jan C.M. van Hest 
Soft Matter, 2009, 5, 2261 –2268
Introduction
In nature, cascade reactions are often performed by enzymes assembled in complexes, such as the 
pyruvate dehydrogenase complex, which is composed of multiple copies of three different enzymes 
catalyzing the oxidative decarboxylation of pyruvate. 1, 2 Due to the close proximity of the active sites 
side reactions are reduced and reaction rates are increased. One approach to mimic the efficiency of 
natural cascade reactions is to apply microreactor technology: if the different enzymes involved in 
the cascade process are positioned in the correct order and within the appropriate distance of each 
other, the continuous liquid flow within a microreactor will ascertain directed transport of the 
reagents from one active site to the next. To allow this approach to be useful a versatile 
immobilization methodology has to be established that enables the controlled positioning  of multiple 
proteins within a microchannel environment. Methods for covalent immobilization of enzymes on 
surfaces are abundant, 3-8 but have as a drawback that multiple chemical procedures have to be 
combined to positionally assemble the different enzyme patches of the cascade. For example, Clark 
and Fréchet used three rounds of successive local photografting and immobilization for the 
immobilization of a three-enzyme cascade in a microchannel, 9 and Nishizawa and coworkers 
applied a similar procedure to immobilize different enzymes by electrical pulses. 10 To significantly 
simplify the local deposition of proteins we present here a non-covalent immobilization system with 
stimulus-responsive elastin-like polypeptides (ELPs), which only needs a temperature gradient over 
the microchannel.
  ELPs are based on the repetitive pentapeptide motif Val-Pro-Gly-Xaa-Gly with guest residue 
Xaa, and exhibit a tunable inverse phase transition behavior (precipitation at increased temperature). 
11-13 This has for example been used to immobilize ELP fusion proteins by thermodynamically 
reversible addressing  of proteins, 14, 15 and for the reversible adsorption of organophosphorus 
hydrolase fused to ELP onto hydrophobic polystyrene microtiter plates, while retaining  its 
functionality. 16 In these examples immobilization of one ELP fusion protein was achieved, mainly 
triggered by ionic strength in combination with a surface with patterned hydrophobicity. 
  The current work presents a strategy for a thermally triggered positional assembly of two ELP 
fusion proteins on one surface. In our strategy, the ELP tails of both fusion proteins differ in their 
amino acid composition, resulting in different transition temperatures.
Results and discussion
ELP and ELP fusion protein gene synthesis
The genes for two different ELPs, as well as their corresponding fluorescent fusion proteins were 
constructed using recursive directional ligation, as described in Chapter 2. 17, 18 For ELP1 the guest 
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residue in the pentapeptide motif was occupied by Val, Ala, and Gly in a ratio of 5:2:3, 18 and for the 
more hydrophobic ELP2 Val, Leu, and Gly were incorporated at the guest residue position in the same 
ratio. Of both ELPs, consisting  of 90 repeats of the pentapeptide, variants were prepared, and were 
equipped with two lysines near the N-terminus for convenient attachment to a surface, resulting in 
the genes for KK-ELP1 and KK-ELP2. The thermostable fluorescent proteins EGFP and DsRed2 were 
cloned to the C-terminus of both ELPs, 18 resulting in the genes for ELP1-EGFP and ELP2-DsRed2.
  In Figure 1 the genes for ELP1 (1450 bp) and ELP1-EGFP (2188  bp) are shown after digestion 
with restriction enzymes XhoI and BamHI. The upper band (2428  bp) in both lanes represents the 
other half of the digested vector. All genes were transferred to the Escherichia coli expression vector 
pET15b with XhoI and BamHI, which added a leader sequence containing a 6xHis-tag and a 
thrombin cleavage site.
ELP and ELP fusion protein expression and purification
All ELP proteins were expressed in the Escherichia coli expression strain BLR(DE3) 18 in 500 mL shake 
flask cultures. After breaking the cells, the ELPs were purified by inverse transition cycling  (ITC) 19, 
which uses the LCST of the proteins. This method alternates between steps of high and low 
temperatures. In the step with the raised temperature salt was added to promote aggregation of the 
ELPs, and after centrifugation the supernatant containing  contaminants was discarded. In the next 
step a cold buffer with low salt concentration was added to dissolve the ELP, and after centrifugation 
denatured proteins were removed. After purification the yield was between 8  mg  and 13 mg  purified 
protein per liter culture. This is comparable with yields described in Chapter 2 and 5, but somewhat 
lower compared to reported yields for GFP cloned to the N-terminus of ELPs. 20,21 In Figure 2 a 
typical SDS-PAGE gel is depicted showing the purified proteins. The expected weight difference 
between KK-ELP1 (lane c) and KK-ELP2 (lane d) of about 0.8 kDa is clearly visible.
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Figure 1. Agarose DNA gel showing the fragments of ELP1 and ELP1-EGFP fusion genes, after 
digestion with XhoI/BamHI: pMTL23-δ-BsaI-aIII-ELP1 (a) and pMTL23-δ-BsaI-ELP1-EGFP (b).
ELP and ELP fusion protein characterization
The ELP fusion proteins were further characterized by MALDI-TOF mass spectrometry (Table 1). The 
molecular weights were close to the calculated values. The mass differences were similar to the mass 
difference observed and discussed in Chapter 2. 
  The aggregation of the ELP fusion proteins was monitored by turbidity spectrophotometry as a 
function of temperature (Figure 3, Table 1). The transition temperature was determined at half the 
maximal turbidity change in PBS, which for the fusion protein ELP2-DsRed2 was 39 °C. The transition 
temperature of ELP1-EGFP could not be determined in PBS since, due to the high transition 
temperature, the temperature had to be increased above 70 °C partly resulting in denatured 
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Figure 3. Turbidity profile of KK-ELP2 (a), KK-ELP1 (b), ELP2-DsRed2 (c) and ELP1-EGFP (d); 
(0.1 mg/mL) in PBS measured at 350 nm.
Figure 2. Typical SDS-PAGE coomassie stained gel after purification of ELP2-DsRed2 (a), 
ELP1-EGFP (b), KK-ELP1 (c), KK-ELP2 (d).
fluorescent protein. 20 The measurements showed the expected influence of the amino acid 
composition of the ELPs 21 on the transition temperature of the ELP fusion proteins.
  The characterization of KK-ELP1 and KK-ELP2 is extensively described in Chapter 2, and a 
summary is given in Figure 3 and Table 1. The influence on the transition temperature of the fusion 
partner for ELP2-DsRed2 is minimal, and corresponded to the difference usually observed for ELP 
fusion proteins. 16, 18, 22-25 However, EGFP seemed to have a significant effect on the transition 
temperature of ELP1-EGFP, which differed from the 4 °C increase in transition temperature observed 
in literature. 25 In this case the fusion partner was attached to the N-terminus of the ELP, and a linker 
was used between the GFP and the ELP, which might decrease the influence of GFP on ELP behavior. 
We seamlessly fused EGFP to the C-terminus of ELP protein, which means no linker was present, 
explaining the relatively large influence of EGFP on the transition temperature for our fusion protein. 
  To lower the transition temperature to values that were suitable for biologically active 
proteins, turbidity profiles for the fusion proteins ELP1-EGFP and ELP2-DsRed2 were generated with 
varying NaCl concentrations (Figure 4). 18 Going  up to 1 M NaCl the transition temperature of ELP1-
EGFP and ELP2-DsRed2 decreased from 54 °C and 38  °C, respectively, to 44 °C and 21 °C. The salt 
concentration was increased even further to 2 M, which resulted in a reduced transition temperature 
of 26 °C and 11 °C for ELP1-EGFP and ELP2-DsRed2, respectively.
  To investigate whether these transition temperatures at varying  salt concentrations were also 
retained in a mixture of the ELP fusion proteins, the turbidity profile for such a mixture was measured 
(Figure 5). In Chapter 4 a similar experiment was described for a mixture of KK-ELP1 and KK-ELP2, 
which confirmed the retained transition temperatures at varying salt concentrations. For a salt 
concentration of 1M the transitions lay at 40 °C and 24 °C. Going  up to 2 M NaCl the transition 
temperature of ELP1-EGFP and ELP2-DsRed2 was lowered to 27 °C and 14 °C, respectively. 
Especially for ELP1-EGFP these values were close to the measured transition temperatures for the pure 
ELP fusion proteins. Furthermore, the difference in transition temperature for both ELPs was large 
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Table 1. Calculated and measured molecular weight of used proteins, determined by MALDI-
TOF ms, and the transition temperature derived from the turbidity profiles (Figure 3).                
Protein Calculated (Da) Measured (Da)
Transition temperature 
(°C)a
KK-ELP1 39244 38965 54
KK-ELP2 40059 39711 38
ELP1-EGFP 66393 65971 b
ELP2-DsRed2 66029 65680 39
a The transition temperature determined at half the maximal turbidity change in PBS; b not 
determined, since the transition temperature was > 70 °C.                                                         
enough to distinguish two separate precipitation events in a mixture of both fusion proteins, as was 
observed with these turbidity measurements.
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Figure 4. Normalized turbidity profile of ELP1-EGFP (A) and ELP2-DsRed2 (B); measured at 
350 nm (0.1 mg/mL) in PBS supplemented with NaCl: 0 M (a), 0.5 M (b), 1 M (c), 1.5 M (d) 
and 2 M (e).
Figure 5. Normalized turbidity profile measured at 350 nm of a mixture of ELP1-EGFP and 
ELP2-DsRed2 (each 0.1 mg/mL) in PBS supplemented with NaCl: 0 M (a), 0.5 M (b), 1 M (c), 
1.5 M (d) and 2 M (e).
  This preserved transition temperature was also observed with fluorescence microscopy 
(Figure 6). A mixture of ELP1-EGFP and ELP2-DsRed2 in PBS supplemented with 1 M NaCl was 
maintained at different temperatures. ELP2-DsRed2 precipitated selectively on the bottom of the cell 
after being  kept at 30 °C for 14 h, and ELP1-EGFP was deposited during heating at 50 °C. 
Reversibility was shown by cooling at 4 °C.
Temperature-controlled positioning of ELP fusion proteins
In order to create a temperature gradient over the surface of a microchannel, a reactor was designed 
which contained two separately controlled heaters combined with two pairs of sensors (Figure 7). 
This reactor could be manually assembled to include an ELP functionalized glass slide to act as 
hydrophobic base for temperature-controlled positioning of the ELP fusion proteins. Furthermore, 
after disassembly of the reactor the protein deposited on the glass slide could be analyzed with 
fluorescence spectroscopy.
  Based on the turbidity measurements of ELP1-EGFP and ELP2-DsRed2, PBS was chosen as 
optimal medium for experiments of positional assembly of ELP2-DsRed2 fusion proteins (transition 
temperature = 39 °C), while PBS supplemented with 0.5 M NaCl (PBS/NaCl) was chosen for ELP1-
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Figure 6. Selective aggregation of a mixture of ELP1-EGFP and ELP2-DsRed2 (each 0.1 mg/
mL) in PBS supplemented with 1 M NaCl, incubated at 30 °C (1), 50 °C (2), and 4 °C (3). 
GFP1 filter (a), DsRed filter (b), overlap of both filters (c) (For full-color picture see Appendix).
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Figure 8. Scheme of positional assembly in a reactor with an arrow indicating  the flow 
direction. a) Assembled reactor with functionalized glass. b) Positioning of ELP2-DsRed2 
using  heater 1. c) Positioning of ELP1-EGFP using heater 1 and 2, resulting  in positional 
assembly of both ELP fusion proteins in two patches.
Figure 7. a) Side view of reactor holder with two Nanoports, and a spacer with O-ring 
between the functionalized bottom slide and cover slide. b) Top view chip with two 
independently controlled heaters, each surrounded by two sensors to monitor the 
temperature. c) Photo of reactor holder with two Nanoports and six small screws. d) Photo of 
chip with two heaters and four sensors, controlled via a 12-pin connector to PC (For full-color 
picture see Appendix).
EGFP (yielding transition temperature = 52 °C). In Figure 8  the positional assembly process is 
schematically depicted. Application of a temperature gradient over an ELP-functionalized glass slide 
leads to local precipitation and thus positional assembly of both ELP fusion proteins at different spots 
on the surface. The use of fluorescent proteins allowed for convenient demonstration of the efficacy 
of the positional assembly concept.
  The reactor was assembled with a glass slide functionalized with KK-ELP2. The 
immobilization method of KK-ELP2 on glass, and the characterization of the intermediate steps of 
immobilization with contact angle measurements and X-ray photoelectron spectroscopy were 
described in Chapter 3. ELP2-DsRed2 was positioned with heater 1 set to 40 °C, while heater 2 was 
maintained at 20 °C in PBS. Subsequently, ELP1-EGFP was positioned next to ELP2-DsRed2 with 
heater 1 maintained at 40 °C, and heater 2 set to 55 °C in PBS/NaCl. After a washing  step with PBS/
NaCl, the reactor was dried with air, and disassembled. The glass slide was analyzed with a 
fluorescence scanner equipped with 473 and 532 nm lasers and suitable filters (Figure 9). The 532 
nm scan showed a fluorescent spot for ELP2-DsRed2 on the glass surface at the expected position at 
the left side, decreasing  in intensity with decreasing  temperature. Analogously, a spot at the right side 
of the slide was visible for ELP1-EGFP with the 473 nm laser. The overlap of both scans (Figure 9c) 
displays that both spots formed distinct areas on the surface.
  Two different control experiments were executed (Figure 10). The first control experiment 
employed a non-functionalized glass slide under the same conditions as the immobilization 
experiment. In this case no hydrophobic surface was present. No adsorption of the ELP fusion 
proteins was detected, which showed the necessity of the presence of this hydrophobic surface for 
immobilization of ELP fusion proteins. In the second control experiment again an ELP-functionalized 
glass slide was used, only this time the temperature of the heaters was not increased but kept at 20 
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Figure 9. Fluorescence scans of the glass slide after positional assembly of ELP1-EGFP and 
ELP2-DsRed2. a) 532nm laser/570DF20 filter, b) 473 nm laser/ 508FS10-25, c) overlap of 
scan a and b (For full-color picture see Appendix).
°C. No fluorescence of the ELP fusion proteins was detected, indicating that without heating 
adsorption to the glass was not possible. 
  Bearing  in mind the two negative control experiments, positional assembly of fusion proteins 
on a surface in a reactor succeeded without the use of a patterned surface, based only on the 
temperature-responsive behavior of ELPs.
CalB-ELP Fusion Protein
The next step towards a working  cascade in a microchannel was the immobilization of ELPs fused to 
enzymes instead of fluorescent proteins. Candida antarctica Lipase B (CalB) was chosen as first fusion 
partner, because it is a well-known enzyme and can be used in combination with glucose oxidase 
(GOx) 26 and horseradish peroxidase (HRP) to form a cascade (Figure 11). 9, 27 In the first step of such 
a cascade 1,2,3,4-tetra-O-acetyl-β-glucopyranose is hydrolyzed by CalB to β-D-glucopyranose. This 
product will then act as substrate for GOx, which oxidizes it to D-gluonolactone and peroxide. The 
produced peroxide is used in the last step for the oxidation of 2,2’-azino-bis(3-ethyl-
benzothiazoline-6-sulfonic acid) (ABTS) by HRP into the radical cation detectable at 405 nm. 
Results and discussion
Construction of CalB-ELP2 gene, production and purification of CalB-ELP2
ELP2 was connected to the C terminus of CalB to create an ELP fusion protein. The gene for CalB-
ELP2 was constructed by ligation of the ELP2 gene into vector pET22b-CalB 28 using  restriction 
enzymes BlpI and XhoI, resulting in pET22b-CalB-ELP2.
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Figure 10. Fluorescence scans of the glass slide of the negative control experiments. a) 532 
nm laser/570DF20 filter, b) 473 nm laser/ 508FS10-25. Negative control 1 was performed on 
a non-functionalized glass slide. Negative control 2 was executed on an ELP functionalized 
glass slide with heaters set at at 20 °C (For full-color picture see Appendix).
  The vector pET22b-CalB-ELP2 was transformed into the Escherichia coli strain 
BL21(DE3)pLysS. The protein was typically expressed in a 500 mL shake flask culture, and purified by 
inverse transition cycling (ITC), 19 which uses the LCST of the ELP. After purification the yield was 5 
mg purified CalB-ELP2 per liter culture. During purification CalB-ELP2 could be easily tracked in the 
intermediate purification steps on an agar plate containing Tween 80 and CaCl2 (Figure 12a). CalB 
converts Tween 80, a sorbitol fatty acid ester, into the hydrolyzed oleic acid, which forms a white 
waxy substance around the applied sample. Almost no activity remained in the pellets after 
centrifugation at 4 °C. However, after centrifugation at 40 °C a reasonable amount of CalB was left in 
the supernatants, indicating the possibility of a yield that can be further optimized. The separation 
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Figure 11. Envisioned immobilization of cascade reaction in microchannel with CalB, GOx 
and HRP fused to ELPs.
Figure 12. a) Activity of CalB-ELP2 on Tween 80 agar plate in intermediate steps of 
purification: cell pellet (cp), supernatant after centrifugation at 40 °C in different cycles (s1, 
s2, s3), pellet after centrifugation at 4 °C in different cycles (p1, p2, p3). b) Typical SDS-PAGE 
coomassie stained gel after purification of CalB-ELP2.
step at 40 °C can be optimized by increased salt concentrations or longer incubation times. 
Incubation at a higher temperature is not preferable, since temperatures of >60 °C induce 
denaturation of CalB. 29 In Figure 12b a typical SDS-PAGE gel is depicted showing the purified CalB-
ELP2. The band just below 75 kDa represents the protein with the expected weight of 71 kDa.
Characterization of CalB-ELP2
CalB-ELP2 was further characterized by reversed phase liquid chromatography-mass spectrometry 
(RPLC-MS). After deconvolution the protein yielded a peak at 70800 Da, which was 100 Da more 
than expected molecular weight of 70700 Da. The most likely explanation for this mass difference is 
an extra amino acid, e.g. valine, which has a mass of 99 Da. This additional amino acid could not be 
observed in the DNA sequencing results.
  The aggregation of CalB-ELP2 was monitored by turbidity spectrophotometry as a function of 
temperature (Figure 13). The transition temperature determined at 50%  of the maximal turbidity 
change in PBS supplemented with 0.5 M NaCl was 37 °C. In Chapter 2 the transition temperature in 
PBS/0.5 M NaCl for KK-ELP2 was determined at 30 °C. This difference was usually seen for ELP fusion 
proteins 16, 18, 22-25 and fell within the observed range. 
  The activity of CalB-ELP2 was determined by monitoring  the hydrolysis of para-nitrophenol 
butyrate into para-nitrophenol. Its absorbance can be measured at 405 nm (Figure 14). Although the 
activity of CalB-ELP2 is lower than CalB-N3, compared to ELP and PBS CalB-ELP2 is clearly active. 
The slope of the curve in the first 30 min was taken as a measure of the hydrolytic activity. For CalB-
ELP2 the activity was retained for 16% compared to the CalB-N3 reference. 28 ELP and PBS showed 
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Figure 13. Normalized turbidity profile measured at 350 nm of CalB-ELP2 in PBS 
supplemented with 0.5 M NaCl.
an activity of 1% compared to the reference sample. A quantitative comparison is difficult due to 
aging effects that cause differences with freshly expressed CalB-N3. Furthermore, ITC purification 
could have an effect on the CalB activity.
Temperature-controlled positioning of CalB-ELP2 
As a prelimimary experiment CalB-ELP2 was immobilized on a glass surface inside the reactor. The 
reactor was assembled with a glass slide functionalized with KK-ELP2. Both heaters were set at 30 °C, 
CalB-ELP2 was incubated, and after a washing  step with PBS/0.5 M NaCl, the reactor was dried with 
air, and disassembled. The glass slide was analyzed by placing it on a Tween 80 agar plate to 
determine the position of the CalB activity (Figure 15). The contours of the reactor could be vaguely 
discerned, indicating positioning over the whole reactor surface. For this experiment the conditions 
can be greatly optimized. The temperature of the heaters in combination with the salt concentration 
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Figure 15. Photograph of CalB-ELP2 immobilized on a glass slide. The CalB activity was 
detected on a Tween 80 agar plate. Contours of reactor are indicated by the dotted line.
Figure 14. CalB activity assay of CalB-ELP2. The production of para-nitrophenol was 
monitored by measuring  absorbance at 405 nm: CalB-ELP2 (◼), CalB-N3 (▲), ELP (◦), and 
PBS (●).
is an aspect that should be looked into more thoroughly. Instead of the combination of 0.5 M NaCl 
with 30 °C, no supplemented salt and a higher temperature of the heaters seem more favorable. 
Furthermore, positioning of CalB-ELP2 on one side of the surface is an important step in the direction 
of a cascade reaction in a microreactor.
Conclusions
The construction of two elastin variants with fluorescent proteins EGFP and DsRed2 generated 
proteins with an inverse transition behavior that could be simply controlled by varying concentrations 
of NaCl. With these stimulus-responsive proteins we were able to demonstrate the formation of two 
patches of fluorescent proteins within a microreactor using only the temperature-responsive property 
of ELPs. The transition temperature of the ELPs was easily manipulated by amino acid composition 
and NaCl concentration. This research was extended towards the immobilization of a CalB-ELP fusion 
protein as the first step of a cascade reaction.
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Experimental section
Nomenclature
The ELP constructs are described using the notation ELP[XiYjZk-n], 30 where the capitals between the 
brackets represent the single letter amino acid code replacing  Xaa in the pentapeptide Val-Pro-Gly-
Xaa-Gly. The subscript stands for the number of guest residues in the monomer gene, and the n 
designates the number of pentapeptide repeats. ELP[V5A2G3-90] is abbreviated by ELP1, while ELP2 is 
short for ELP[V5L2G3-90]. Two additional lysines to be used in surface immobilization were 
incorporated into the ELP constructs by modifying the cloning  vector with adapterKK, containing  two 
additional lysines.
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Cloning
Standard molecular biology protocols were used for gene synthesis and oligomerization. Digested 
inserts and linearized vectors were purified by agarose gel electrophoresis (QIAquick Gel Extraction 
Kit , Qiagen, Valencia, CA). All clones were maintained in E. coli XL1-Blue. Colonies were screened 
by PCR, and the DNA sequence of all putative inserts was verified by DNA sequencing.
Fluorescent protein gene synthesis
The vector pMTL23-δ-BsaI-FP was constructed from two synthetic Adapter FP oligonucleotides 
(Figure 16) which were annealed to form double-stranded DNA with XhoI- and EcoRI-compatible 
ends, and ligated into XhoI/EcoRI linearized pMTL23-δ-BsaI-aIII. The genes for the two fluorescent 
proteins EGFP and DsRed2 were doubly digested from pEGFP-N1 and pDsRed2-N1 (Clontech) with 
AgeI and NotI, and ligated into AgeI/NotI linearized pMTL23-δ-BsaI-FP to yield pMTL23-δ-BsaI-EGFP 
and pMTL23-δ-BsaI-DsRed2.
ELP1-EGFP fusion gene construction
The vector pMTL23-δ-BsaI-EGFP was linearized with BsmBI, and enzymatically dephosphorylated. 
The ELP1 gene was doubly digested from pMTL23-δ-BsaI-aIII-ELP1 with BsmBI and BanI, and ligated 
into the linearized vector. The ELP fusion gene was doubly digested from pMTL23-δ-BsaI-ELP1-EGFP 
with BsmFI and EcoRI, and ligated into BsmFI/EcoRI linearized and dephosphorylated pMTL23-δ-
BsaI-XX, resulting in pMTL23-δ-BsaI-XX-ELP1-EGFP.
ELP2-DsRed2 fusion gene construction
The vector pMTL23-δ-BsaI-DsRed2 was linearized with BsmBI and XhoI, and enzymatically 
dephosphorylated. The ELP2 gene was digested from pMLT23-δ-BsaI-XX-ELP2 with XhoI/BanI and 
ligated into the linearized pMTL23-δ-BsaI-DsRed2 to yield pMTL23-δ-BsaI-XX-ELP2-DsRed2.
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Adapter FP
Sense   5’-GTGCTGGTGGACCGGTGTAACATCCGAGCGGCCGCCATCCG-3’
Anti-sense  5’-AATTCGGATGGCGGCCGCTCGGATGTTACACCGGTCCACCA-3’
Figure 16. DNA sequence of the used oligonucleotide (Eurogentec, Seraing, Belgium)
Expression vector pET15b
The ELP and ELP fusion genes were doubly digested with XhoI/BamHI and ligated into XhoI/BamHI 
linearized expression vector pET15b (Novagen), resulting in vectors pET15b-KK-ELP1, pET15b-KK-
ELP2 and pET15b-ELP1-EGFP, and pET15b-ELP2-DsRed2. Colonies were screened by restriction 
analysis with XhoI/BamHI.
Fusion of ELP2 with CalB
Vector pET22b-CalB 28 was linearized with BlpI and XhoI, and enzymatically dephosphorylated. The 
ELP2 gene was digested from pET15b-ELP2 (Chapter 2) with BlpI/XhoI, and ligated into the linearized 
pET22b-CalB. This resulted in the vector pET22b-CalB-ELP2. Colonies were screened by PCR and by 
restriction analysis, and the DNA sequence of inserts was verified by DNA sequencing.
Protein expression
The pET15b vectors were transformed into the expression strain BLR(DE3) (Novagen). For a typical 
expression 25 mL Luria Broth cultures, supplemented with 100 μg/mL ampicillin and 12.5 μg/mL 
tetracycline, were inoculated and incubated at 37 °C with shaking overnight. These cultures were 
diluted to an OD600 of 0.1 in a 500 mL LB culture supplemented with 100 μg/mL ampicillin and 12.5 
μg/mL tetracycline, and incubated at 37 °C with shaking. At an OD600 of 0.6 the expression was 
induced by the addition of IPTG to a final concentration of 1 mM. After incubation at 25 °C overnight 
the cultures were harvested by centrifugation (18,000 × g, 4 °C). The cell pellet was resuspended in 
PBS, and incubated with lysozyme (1 mg/mL PBS) at 4 °C for 30 min. The cells were then lysed by 
ultrasonic disruption at 4 °C. The lysate was centrifuged (15 min, 3768  x g, 4 °C Minifuge RF, 
Heraeus Sepatech, Germany) to remove insoluble matter.
Protein expression of pET22b-CalB-ELP2
PET22b-CalB-ELP2 vector was transformed into the expression strain B21(DE3)pLysS (Novagen). For a 
typical expression 25 mL Luria Broth cultures, supplemented with 100 μg/mL ampicillin and 34 μg/
mL chloramphenicol, were inoculated and incubated at 37 °C with shaking overnight. These cultures 
were diluted to an OD600 of 0.1 in a 500 mL LB culture supplemented with 100 μg/mL ampicillin and 
34 μg/mL chloramphenicol, and incubated at 37 °C with shaking. At an OD600 of 0.8  the expression 
was induced by the addition of IPTG to a final concentration of 1 mM. After incubation at 25 °C 
overnight the cultures were harvested by centrifugation (18,000 × g, 4 °C). The cell pellet was 
resuspended in PBS, and incubated with lysozyme (1 mg/mL PBS), PMSF (1 mM) and Triton-X100 
(0.1%) at 4 °C for 30 min. The cells were then lysed by ultrasonic disruption at 4 °C. The lysate was 
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centrifuged (15 min, 3768 x g, 4 °C Minifuge RF, Heraeus Sepatech, Germany) to remove insoluble 
matter. 
Protein purification
The ELP and ELP fusion proteins were purified by inverse transition cycling. 18 The fluorescent 
proteins are thermostable < 70 °C. 20 In short, ELPs were aggregated by adding NaCl to a 
concentration of 1 M and increasing the temperature of the cell lysate to 65 °C. The aggregated 
protein was separated from solution by centrifugation at 40 °C (10 min, 4566 x g, Multifuge, Heraeus 
Sepatech, Germany). The supernatant was decanted and discarded, and the pellet containing  the 
fusion protein was resuspended in cold PBS. The resolubilized pellet was then centrifuged at 4 °C (10 
min, 4566 x g) to remove any remaining insoluble matter. The inverse transition cycling was repeated, 
yielding  between 8  and 13 mg purified protein/L culture. 25, 31 For CalB-ELP2 the yield was 5 mg 
purified protein/L culture.
  SDS-PAGE analysis was performed on a Mini-PROTEAN system (Bio-Rad, Hercules, CA) with 
10% gels, for staining Coomassie brilliant blue and silver were used. Protein concentrations were 
determined by bicinchoninic acid assay (Pierce Chemical Co., Rockford, IL). Tween 80 agar plates to 
monitor CalB activity were prepared according  to Blank et al. 32 The petri dishes contained 50 mM 
Tris pH 7.2, 20 mM CaCl2, 2% (v/v) Tween 80 and 1.8% (w/v) agar.
Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass 
spectrometry
MALDI-TOF measurements were performed on a Bruker Biflex III with 2,5-dihydroxyacetophenone 
(DHAP) as matrix. 33 The samples were mixed in a 1:1 ratio on a MALDI plate with a solution of 7.6 
mg DHAP in 375 μL EtOH and 125 μL diammonium hydrogen citrate (stock solution of 27 mg in 1.5 
mL MilliQ water) containing 2% trifluoroacetic acid. 
Reversed phase liquid chromatography-mass spectrometry (RPLC-MS)
RPLC-MS measurement was performed on a system consisting  of the following components: 
Shimadzu SCL-10A VP system controller with Shimadzu LC-10AD VP liquid chromatography pumps 
with a Phenomenex Jupiter C4 5u (100 mm x 2.1 mm) reversed phase column and gradients of water-
acetonitrile supplemented with 0.1%  formic acid (or 0.1% trifluoro acetic acid)), a Shimadzu 
DGU-14A degasser, a Thermo Finnigan surveyor autosampler, a Thermo Finnigan surveyor PDA 
detector and a Finnigan LCQ Deca XP Max.
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Turbidity measurements
The optical absorbance of ELPs, derived from the high tension voltage, was measured at 350 nm in 
the 5-65 °C range on a Jasco J-810 spectropolarimeter (band width: 1 nm, response: 1 sec., 
sensitivity: standard, heating rate: 1 °C/min) equipped with a PFD-425s Peltier temperature controller 
(Jasco).
CalB activity assay
Lipase activity of CalB-ELP2 was analyzed by the hydrolysis of para-nitrophenol butyrate (p-NPB, 
Sigma). The reaction mixture (50 µL, pH 7) was composed of 50 mM NaH2PO4, 150 mM NaCl, 
enzyme (100 nM), isopropanol (5%), Triton (0.1%) and p-NPB (1 mM). The production of para-
nitrophenol was monitored at 25 °C for 2 h with 2 minute intervals by measuring absorbance at 405 
nm in a Multicounter Wallac Victor2 (PerkinElmer Life Science). This experiment was carried out in 
triplo. The slope of the curve in the first 30 min was taken as a measure of hydrolytic activity.
Fluorescence microscopy
A mixture of ELP1-EGFP and ELP2-DsRed2 (each 0.1 mg/mL) in PBS supplemented with 1 M NaCl 
was incubated overnight in a 1 mm quartz cell (Hellma, Müllheim, Germany) at 30 °C, 50 °C, and, 
after shaking, 4 °C, respectively. The cell content was visualized with a Leica MZFLIII 
stereomicroscope (Leica Microsystems, Germany) equipped with a cooled CCD camera (CoolSNAP, 
Princeton Instruments, Trenton, NJ) in fluorescence mode using GFP1 and DsRed filters. MetaVue 
software (Molecular Devices, Downingtown, PA) was used for image processing.
Reactor experiments
The reactor holder was designed and produced by LioniX BV (Enschede, The Netherlands), with 
Nanoports as in- and outlet. After assembly with a 0.8  mm spacer with Kalrez O-ring  (17 × 1 mm) 
between the functionalized bottom slide and the fused silica cover slide, the internal dimensions of 
the reactor were about 5 × 22 mm.
  The reactor was assembled including  an ELP-functionalized glass slide. PBS was pumped (rate 
100 μL/min.; NE-1000, ProSense, The Netherlands) into the reactor. Heaters 1 and 2 were set at 40 
°C and 20 °C, respectively, and equilibrated for about 15 min. ELP2-DsRed2 (0.1 mg/mL in PBS) was 
incubated in the reactor for 15 min, and subsequently washed with PBS for 6 min, and with PBS 
supplemented with 0.5 M NaCl (PBS/NaCl) for 3 min. Then heater 2 was raised to 55 °C. After 
equilibration for 15 min ELP1-EGFP (0.1 mg/mL in PBS/NaCl) was incubated in the reactor for 15 
min. After a PBS/NaCl wash for 6 min, the solution was removed from the reactor with air. The 
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reactor was disassembled while the heaters were still active, and the fusion proteins immobilized on 
glass slides were visualized with the fluorescent image analyzer FLA-5100 in combination with 
processing software Multi Gauge (Fuji Photo Film Co., Ltd., Tokyo, Japan) using  473 and 532 nm laser 
excitation combined with the filters 508FS10-25 and 570DF20, respectively. 
  A negative control experiment was conducted on a cleaned glass slide. The slide was first 
wiped with acetone p.a., then sonicated in acetone p.a. After 5 min. the glass slide was dried with air 
and assembled in the reactor. The sequence of steps was as described above.
  A second negative control experiment was executed as follows: the reactor was assembled 
including an ELP-functionalized glass slide. PBS was pumped (rate 100 μL/min.) into the reactor. 
Heaters 1 and 2 were set at 20 °C, and equilibrated for about 15 min. ELP2-DsRed2 (0.1 mg/mL in 
PBS) was incubated in the reactor for 15 min., and subsequently washed with PBS for 6 min. Then 
ELP1-EGFP (0.1 mg/mL in PBS/NaCl) was incubated in the reactor for 15 min. After a PBS/NaCl wash 
for 6 min, the solutions were removed from the reactor with air. The glass slides were visualized with 
the fluorescent image analyzer.
  CalB-ELP2 was immobilized as follows: the reactor was assembled including  an ELP-
functionalized glass slide. PBS supplemented with 0.5 M NaCl was pumped (rate 100 μL/min.) into 
the reactor. Heaters 1 and 2 were set at 30 °C, and equilibrated for about 15 min. CalB-ELP2 (0.1 mg/
mL in PBS) was incubated in the reactor for 15 min, and subsequently washed with PBS/NaCl for 6 
min. The solutions were removed from the reactor with air, and the CalB activity on the glass slide 
was visualized by placement on a Tween 80 agar plate.
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‘Clickable’ Elastins
Elastin-like polypeptides (ELPs) functionalized with azide or alkyne groups were produced 
biosynthetically and coupled via the Cu-catalyzed azide-alkyne cycloaddition to fluorescent probes, 
a polymer and two proteins, i.e. the enzyme Candida Antarctica lipase B and the fluorescent protein 
DsRed2. The formed protein-ELP hybrids adapted the characteristic ELP LCST behavior, and also 
retained the specific property of the ‘clicking’ partner.
Part of this chapter was published as 
Single-Step Azide Introduction in Proteins via an Aqueous Diazo Transfer 
Stijn F. M. van Dongen, Rosalie L. M. Teeuwen, Madhavan Nallani,  Sander S. van Berkel,  Jeroen J. L. M. 
Cornelissen, Roeland J. M. Nolte and Jan C. M. van Hest
Bioconjugate Chem., 2009, 20, 20–23
And 
“Clickable” elastins: elastin-like polypeptides functionalized with azide or alkyne groups
Rosalie L.M. Teeuwen, Sander S. van Berkel, Tim H.H. van Dulmen, Sanne  Schoffelen, Silvie A. Meeuwissen, 
Han Zuilhof, Frits A. de Wolf, and Jan C.M. van Hest
Chem. Comm., 2009, 27, 4022–4024
Introduction
Bioconjugation offers the possibility to introduce biological functionality into hybrid materials by 
connecting biomolecules and synthetic molecules with each other. This methodology has become 
increasingly important for the development of new materials for applications in the fields of 
diagnostics, medicine and tissue engineering. 1- 3 The structural protein elastin 4, 5 has in this respect 
drawn significant attention from the materials science community, because of its striking  stimulus-
responsive character. Upon heating, the water-soluble and unorganized protein undergoes a phase 
transition, forming a hydrophobic β-spiral structure, which results in the formation of aggregates. This 
Lower Critical Solution Temperature (LCST) behavior is completely reversible and can be mimicked 
by elastin-like polypeptides (ELPs), which are composed of the amino acid repeat sequence Val-Pro-
Gly-Xaa-Gly (Val = valine, Pro = proline, Gly = glycine), in which the fourth amino acid residue Xaa 
can be any natural amino acid except proline. 6, 7 ELPs can be readily produced in high yields by 
molecular biology techniques using E. coli as expression system. 8, 9 The LCST can be varied over an 
extensive temperature range by changing  the hydrophobicity of the fourth residue, the length of the 
polypeptide, ionic strength of the medium or the ELP concentration. 6, 10- 12
  The unique properties of elastin expand the possibilities for the use of this material in a 
variety of applications. The LCST character of ELPs has been applied to position proteins fused to 
ELPs in a controlled fashion for diagnostics, 13, 14 and to aggregate and purify fusion proteins after 
fermentative production from a cell lysate. 10 Block copolymers of elastin and silk, and elastin 
polymers containing cell adhesion domains have been constructed for the formation of hydrogels for 
tissue engineering. 15- 18 Block copolymers of different types of elastin have been prepared to form 
micelles with stimulus-responsive behavior. 19 Although recombinant DNA technology has facilitated 
the production of these fusion proteins, it is still laborious to design each fusion protein starting  from 
the genetic level.
  Conjugation of ELPs to (bio)molecules is a more versatile approach, not only giving  rise to 
ELP-protein conjugates, but also to a variety of biohybrid materials. For example, block copolymers of 
elastin and PEI or PAA have been constructed for the modification of surfaces applied in tissue 
engineering. 20, 21 Furthermore, ELPs modified with drugs 22- 26 or fluorescent probes 27, 28 have been 
used in tumor tissue targeting. In all these examples ELPs were reacted at the C-terminus, or at lysine 
or cysteine residues using the more traditional N-hydroxysuccinimide ester or maleimide-thiol 
coupling chemistry, respectively. These conjugation methods use functional groups that are 
abundantly present in proteins, which results in multiple point attachment.
  Site-specific coupling to proteins can be improved by using orthogonal functionalities. A 
well-known example is the Cu-catalyzed azide-alkyne cycloaddition (CuAAC). 29 This method has 
been thoroughly investigated and applied in bioconjugation. 30- 32 The non-natural reactive groups 
(azide or alkyne) can be introduced into a protein using single site replacement strategies 33 or 
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auxotrophic expression 34- 37 by replacing methionine 1 with azidohomoalanine 2 (AHA) or 
homopropargylglycine 3 (HPG). 
  In this chapter we present the biosynthesis of ‘clickable’ elastins and their use as versatile 
modular building blocks by conjugation of the ELPs via the CuAAC reaction. This is demonstrated by 
the conjugation to three different moieties, namely fluorescent probes, a polymer, and proteins, 
resulting in different hybrid materials, which display the characteristics of each of the ‘clicking’ 
partners. This approach offers a more versatile method to obtain ELP-enzyme conjugates compared to 
traditional molecular biology techniques for fusion proteins. Commercially available enzymes used in 
known cascade reactions can easily be functionalized with an ELP for application in microreactors as 
described in Chapter 5.
Results and Discussion
ELP production and purification
The ELPs were produced using protein engineering. After cloning ELP2 gene with recursive 
directional ligation, 12 the finished pET15b-ELP2 vector (Chapter 2) was transformed into the 
auxotrophic Escherichia coli expression strain B834(DE3)pLysS. The pET15b vector attached a leader 
sequence to the ELP2 gene, which has one methionine in addition to the translational start 
methionine. AHA and HPG were both incorporated into ELP2 according  to literature procedures, 38 
resulting in AHA-ELP and HPG-ELP, respectively. The ELPs were purified by inverse transition cycling 
(ITC), 11 which uses the LCST of the proteins (Figure 2). This purification method alternates between 
steps of high and low temperatures, removing contaminations after each centrifugation step. After 
purification the yield was approximately 10 mg purified protein per liter culture.
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Figure 1 Structure of methionine 1 and its analogues azidohomoalanine 2, 
homopropargylglycine 3, and CuAAC ligand 4.
ELP characterization
MALDI-TOF mass spectrometry (Figure 3, Table 1) was used to determine the molecular weight. The 
mass of AHA-ELP and HPG-ELP was compared to the ELP without methionine analogues in the leader 
sequence, called Met-ELP. This ELP was described and characterized in Chapter 2 as ELP2.
  The measured molecular weight of all ELPs was significantly less than the calculated weight, 
which was also observed and discussed for the ELPs in Chapter 2. The spectra showed highly pure 
protein samples, indicating the absence of proteolysis or the production of truncated proteins. The 
only additional signals in the spectra were small peaks originating from ELP dimers, as indicated by 
the double mass values.
  In order to obtain more insight in the proteins tryptic digests were performed on the ELPs, 
and the masses were determined by MALDI-TOF mass spectrometry in the linear mode (Figure 3, 
Table 1). This should theoretically lead to the same values for all ELPs, since incorporation of non-
natural amino acids occurs only within the leader sequence, which was removed during the digest. 
The mass difference of the ELPs was in a 35 Da range, which was in agreement with the resolution of 
100 Da. For Met-ELP the difference with the calculated mass was roughly similar to the difference for 
the complete protein with the addition of the N-terminal methionine.  Further, the mass difference for 
AHA-ELP and HPG-ELP before and after tryptic digest was in the same range. The above-mentioned 
findings indicated that the cause for the observed difference between calculated and measured mass 
should be search for in the ELP sequence.
  Incorporation of AHA or HPG was hard to detect in the full proteins. The tryptic digests were 
therefore also analyzed by MALDI-TOF mass spectrometry in the reflective mode (Figure 4). 
Incorporation of the methionine analogues was expected in two fragments, namely the peptide 
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Figure 2. Typical SDS-PAGE coomassie stained gel after purification: AHA-ELP (a), and HPG-
ELP (b).
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Figure 3. MALDI-TOF spectra of Met-ELP (a), AHA-ELP (b), HPG-ELP (c). The spectra after 
tryptic digest are indicated with ‘tryp’.
Table 1. Calculated and measured molecular weights of proteins, determined by MALDI-TOF.  
After tryptic digest
Protein Calculated (Da) Measured (Da) Calculated (Da) Measured (Da)
Met-ELP 39802 39462 36982 36756
AHA-ELP 39792 39599 36982 36721
HPG-ELP 39758 39541 36982 36740
fragment with residue 1-16 and the fragment with residue 18-24. These peaks were observed for the 
reference protein Met-ELP at 1769 Da and 801 Da, respectively. A sodium adduct of the latter was 
detected at 823 Da. The peptide fragment 1-16 was expected to appear at 1900 Da, but the 
decreased molecular mass fitted the removal of the N-terminal methionine by methionine amino 
peptidase. 39, 40 For AHA-ELP the expected peaks for AHA incorporation in peptide fragment 1-16 and 
fragment 18-24 appeared at 1895 Da and 796 Da, respectively. The fragments of Met-ELP were also 
present, which indicated that incorporation of AHA was not 100%. The expected peaks for HPG-ELP 
were observed at 1878  Da and 779 Da. The peptide fragment 2-16 of Met-ELP at 1768  Da was also 
present, which was a sign of partial incorporation of HPG. The sodium adducts of fragment 18-24 at 
779 Da overlapped with the peak of the methionine fragment, which made it difficult to qualify the 
amount of incorporation. Although analysis of the tryptic digests showed that incorporation of the 
methionine analogues was not complete, the presence of the methionine analogues in the ELPs was 
confirmed.
  The transition temperature for AHA-ELP and HPG-ELP was derived from the turbidity profile 
measured at half of the maximal optical density at 350 nm (Figure 5). The transition temperature of 
both AHA-ELP (38  °C) and HPG-ELP (37 °C) was comparable to Met-ELP (37 °C), which proved that 
incorporation of the non-natural amino acids had no influence on the characteristic ELP behavior.
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Figure 4. MALDI-TOF spectra of the two peptide fragments containing  methionine or its 
analogues obtained from tryptic digest of Met-ELP (a), AHA-ELP (b), HPG-ELP (c). 
‘Clicking’ ELPs to fluorescent probes
As a first example to demonstrate the coupling capacity of the ‘clickable’ ELPs fluorescent probes 
were employed, 41- 44 in particular the strongly emitting TokyoGreen based fluorophores. 45- 47 Since 
derivatives of TokyoGreen suitable for CuAAC chemistry were not readily available, the azide-
containing and alkyne-containing green fluorescent probes 6 and 8 (Scheme 1) were developed. 
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Figure 5. Normalized turbidity profile of Met-ELP (a), AHA-ELP (b), and HPG-ELP (c), each 
0.1 mg/mL in PBS measured at 350 nm.
Scheme 1 Synthesis of alkyne and azido fluorophores. Reagents and conditions: i) Ethylene 
carbonate, K2CO3, toluene, Ar-atm., 115 °C, 24 h (98%); ii) TBDMS-Cl, DMF, imidazole, r.t. 2 
h (95%); iii) a) Mg, EtBr2, Et2O, r.t., 2 h, b) TBDMS-xanthone (at 0 °C), THF, r.t., 1.5 h, c) 
MeOH, TFA, r.t., 30 min; (5 (89%), 7 (33%)) iv) Ms-Cl, CH2Cl2, DMAP, 0 °C to r.t., 4 h (25%); 
v) NaN3, DMF, 60 °C, 36 h (27%); vi) DiAD, PPh3, CH2Cl2, 0 °C to r.t. 48  h (72%); vii) 
K2CO3, MeOH, r.t., 18 h (99%).
  AHA-ELP and HPG-ELP were both successfully labeled with ClickGreen derivatives 8 and 6, 
respectively, in the presence of Cu(I)Br and tristriazole ligand 4 48, 49 (Figure 6). As expected, 
fluorescence was absent in the negative controls using fluorophore 5.
‘Clicking’ ELP to a polymer
As an example of a polymer-protein hybrid material coumarin-functionalized PEG2000 50 (13, Figure 
7a) was reacted with HPG-ELP. After dialysis the reaction was analyzed with SDS-PAGE (Figure 7b). 
The Coomassie stained gel showed two bands of comparable intensity, indicating a yield of 
approximately 50% for the formation of the polymer-protein hybrid. The upper band showed 
fluorescence upon irradiation with UV light, which confirmed the reaction of HPG-ELP with the 
coumarin-functionalized PEG2000. The reason that functionalization did not go to completion can be 
partly explained by the fact that a fraction of the ELP produced still contained methionine instead of 
HPG. Furthermore, coupling of macromolecules remains an inherently difficult process. 
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Figure 6. SDS-PAGE gel of labeling AHA-ELP (A) and HPG-ELP (H) with fluorescent probes 8 
and 6, respectively. Final concentrations: Cu(I)Br (4.8 mM), 4 (9.6 mM), 5, 6 and 8 (90 μM).
‘Clicking’ ELP to proteins
The previous examples showed that the ‘click’ strategy is effective for relatively small molecules. For 
the envisioned application of preparing fusion proteins in order to enable cascade reactions in 
microchannels, the approach needed to be successful for large biomolecules as well, including 
preservation of their functionality. 
  For the first illustration of ‘clicking’ a protein to HPG-ELP, the red fluorescent protein DsRed2 
51, 52 was expressed in BLR(DE3). The protein was purified using the His-tag present in the leader 
sequence (Figure 8). The small band below the DsRed2 band was hydrolyzed DsRed2, which was the 
protein without the leader sequence.
  DsRed2 has no functional groups available to take part in the ‘click’ reaction, but 22 lysines 
are present to be modified into an azido group using  an aqueous diazo transfer agent. 53, 54 Analysis 
by ESI-TOF showed that an average of 4 amines was converted to the corresponding  azides, as 
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Figure 7. a) Structure of coumarin-functionalized PEG2000, b) SDS-PAGE gel of HPG-ELP 
labeled with 13.
Figure 8. SDS-PAGE gel of DsRed2 purified using His-tag.
presented in Figure 9. The broad signal for the azido-functionalized DsRed2 included approximate 
masses for mono-, di-, tri- and tetra-azido-DsRed2, together with a small peak for the 
unfunctionalized protein. The symmetry of the signal suggested that penta- and higher degrees of 
DsRed2-N3 were also present. 
  HPG-ELP was reacted with the fluorescent azido-DsRed2, and analyzed by SDS-PAGE (Figure 
10). The band of the product appeared on the Coomassie stained gel just below 75 kDa, and its 
intensity was comparable to the unreacted HPG-ELP at 40 kDa, indicating a yield similar to the 
formation of the polymer-protein hybrid. The upper band and the unreacted DsRed2-N3 showed 
fluorescence upon analysis with a fluorescence scanner equipped with a 473 nm laser and suitable 
filter, which confirmed the reaction of HPG-ELP with DsRed2-N3.
  The transition temperature of the DsRed2-ELP conjugate was derived from its turbidity profile 
(Figure 11). The transition temperature shifted to 35 °C, and the inverse transition was slightly 
broader, when compared to HPG-ELP. Both these observations were in accordance with literature, 10, 
55 in which the LCST characteristics of proteins genetically fused to ELP are described. The DsRed2-
ELP conjugate was also compared to the ELP2-DsRed2 fusion protein described in Chapter 5. The 
transition temperature of the latter was 38  °C, similar to the ELP transition, and close to the transition 
temperature of the conjugate. This experiment showed that conjugation had no significant influence 
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Figure 9. ESI-TOF spectra of DsRed2 (a), and azido functionalized DsRed2 (b).
on the transition temperature, while the conjugate still exhibited the fluorescent characteristic of the 
DsRed2 part.
  As a final example an azido-functionalized enzyme, Candida Antarctica lipase B (CalB),56 
was ‘clicked’ to HPG-ELP, and analyzed by SDS-PAGE (Figure 12, lane a). The product CalB-ELP 
appeared as a band around 74 kDa. This reaction proceeded with a yield comparable to the polymer-
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Figure 10. SDS-PAGE gel of HPG-ELP labeled with azido functionalized DsRed2: HPG-ELP 
(a), DsRed2-N3 (b), and reaction mixture (c). The fluorescence scan was carried out with a 
473 nm laser and a 508FS10-25 filter.
Figure 11. Normalized turbidity profile of the DsRed2-ELP conjugate (a, 0.07 mg/mL), HPG-
ELP (b, 0.1 mg/mL) and genetically fused ELP2-DsRed2 (c, 0.07 mg/mL) in PBS measured at 
350 nm. In the insert the turbidity profile of the DsRed2-ELP conjugate (a) and DsRed2 (d) is 
shown.
protein hybrid. Unreacted AHA-CalB (34 kDa) was removed using  the LCST characteristics of the 
CalB-ELP conjugate (Figure 12, lane b). FPLC was used to further purify CalB-ELP (F24) from 
unreacted HPG-ELP (F29-F33), as shown in Figure 13.
  Subsequently, the hydrolytic activity of the CalB part of the CalB-ELP conjugate was 
determined by measuring the hydrolysis of para-nitrophenol butyrate into para-nitrophenol at 405 nm 
(Figure 14). Its activity was compared to HPG-ELP and AHA-CalB, which had been subjected to 
‘click’ conditions. The slope of the curve in the first 30 min was taken as a measure of the hydrolytic 
activity. The activity of the conjugate was 50%  of AHA-CalB. In Chapter 5 the activity of the CalB-
ELP2 fusion protein was investigated, which was 35%  lower in comparison with the CalB-ELP 
conjugate, although it was difficult to make a quantitative comparison due to aging effects. HPG-ELP 
and PBS showed an activity of 1% compared to the reference sample.
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Figure 12. SDS-PAGE gel of HPG-ELP labeled with azido functionalized CalB. Reaction 
mixture (a), CalB-ELP conjugate after removal of unreacted AHA-CalB using LCST (b). 
Figure 13. FPLC trace of removal of HPG-ELP (fraction 29-33, F29-F33) from CalB-ELP 
conjugate (fraction 24, F24), measured at 280 (a) and 254 nm (b).
  The transition temperature of the ELP part of CalB-ELP was also determined (Figure 15). The 
transition temperature shifted to 46 °C, and the inverse transition was slightly broader. Both these 
observations were again in accordance with literature. 10, 55 The transition temperature of 37 °C for 
the genetically fused CalB-ELP2 protein described in Chapter 5 was measured in PBS supplemented 
with 0.5 M NaCl, which decreased the transition temperature. The temperature difference for this 
CalB-ELP2 and ELP2 in PBS/0.5 M NaCl is similar to the temperature difference for the ‘clicked’ CalB-
ELP conjugate and HPG-ELP in PBS without additional salts.
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Figure 14. Comparison of the hydrolytic activity of AHA-CalB (●a), CalB-ELP conjugate (●b), 
CalB-ELP2 fusion protein (●c), PBS (◦), and HPG-ELP (▲).
Figure 15. Normalized turbidity profile of CalB-ELP conjugate (a, 0.07 mg/mL), HPG-ELP (b, 
0.1 mg/mL) and CalB-ELP fusion protein (c, 0.07 mg/mL) in PBS measured at 350 nm. The 
CalB-ELP fusion protein was measured in PBS supplemented with 0.5 M NaCl.
Conclusions
The ability to selectively conjugate ELPs to a variety of materials using orthogonal functionalities 
enables one to introduce the characteristic LCST behavior of ELPs in hybrid structures in a convenient 
and efficient way. With the three examples described above it has been demonstrated that this 
strategy is successful for small molecular probes as well as for large biomolecules such as enzymes. 
The two illustrations of protein-ELP conjugates clearly demonstrate that the use of ‘clickable’ elastins 
is a successful approach to obtain conjugates which exhibit LCST behavior after functionalization. 
The functionality of the ‘clicking’ partners was also preserved, i.e. fluorescence for DsRed2 and 
catalytic activity of CalB, which could lead to application of these conjugates for cascade reactions in 
microchannels.
  For application of enzyme-ELP conjugates in microchannels a more flexible method to obtain 
these conjugates is desirable, since incorporation of non-natural amino acids into enzymes is 
laborious, especially when multiple enzymes are needed in a cascade. The diazo transfer reaction, as 
performed on DsRed2, could prove to be a convenient solution, because lysines are abundantly 
present on the surface of enzymes, which makes this reaction suitable for commercially available 
enzymes, resulting in a simple technique to obtain multiple enzyme-ELP conjugates for application in 
microreactors.
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Experimental Section
Nomenclature
The ELP construct is described using the notation ELP[V5L2G3-90], 57 where the capitals between the 
brackets represent the single letter amino acid code replacing guest residue Xaa in the pentapeptide 
Val-Pro-Gly-Xaa-Gly. The subscript stands for the number of guest residues in the monomer gene, and 
the ELP consists of 90 pentapeptide repeats. 
Chapter 6
114
Auxotrophic expression
PET15b-ELP or pET22b-CalB 56 was transformed into the methionine auxotrophic expression strain 
B834(DE3)pLysS (Novagen). For a typical expression a 100 mL Luria Broth culture, supplemented 
with 100 μg/mL ampicillin and 50 μg/mL chloramphenicol, was inoculated with a single colony and 
incubated at 37 °C overnight. The overnight culture was diluted to an OD600 of 0.1 into 0.5 L M9 
minimal medium supplemented with all 20 natural amino acids (40 mg/L each), thiamine (0.0005%), 
ampicillin (100 μg/mL) and chloramphenicol (50 μg/mL), and incubated at 37 °C to OD600 of 0.8. To 
induce synthesis of T7 polymerase in the presence of methionine, isopropyl-D-thiogalactopyranoside 
(IPTG) was added to a final concentration of 1 mM, and the culture was incubated for 15 min at 37 
°C. Cells were spun down (10 min, 3768  x g, 4 °C Minifuge RF, Heraeus Sepatech, Germany), 
washed twice in cold NaCl (0.9%), and resuspended in 0.5  L M9 minimal medium supplemented 
with 19 natural amino acids (40 mg/L each, no methionine), thiamine (0.0005%), ampicillin (100 μg/
mL) and chloramphenicol (50  μg/mL). After incubation for 10 min at 37 °C, the culture was 
supplemented with azidohomoalanine (AHA)56 or homopropargylglycine (HPG; Chiralix, Nijmegen, 
The Netherlands) (40 mg/L) and IPTG (1 mM), followed by incubation overnight at 25 °C. Cells were 
harvested by centrifugation (18,000 x g, 4 °C). ELP purification is described below, and AHA-CalB 
was purified according to literature procedure. 56
ELP purification
The ELPs were purified by inverse transition cycling. 58 In short, ELPs were aggregated by adding 
NaCl to a concentration of 2 M and increasing the temperature of the cell lysate to 65 °C. The 
aggregated protein was separated from solution by centrifugation at 40 °C (10 min, 4566 x g, 
Multifuge, Heraeus Sepatech, Germany). The supernatant was decanted and discarded, and the pellet 
containing the fusion protein was resuspended in cold PBS. The resolubilized pellet was then 
centrifuged at 4 °C (10 min, 4566 x g) to remove any remaining insoluble matter. The inverse 
transition cycling was repeated, yielding typically 10 mg purified protein/L of culture. 
  SDS-PAGE analysis was performed on a Mini-PROTEAN system (Bio-Rad, Hercules, CA) with 
a 7.5%  or 10% gel, stained with Coomassie brilliant blue. Protein concentrations were determined by 
bicinchoninic acid assay (Pierce Chemical Co., Rockford, IL).
DsRed2 cloning, expression, and purification
The gene for the fluorescent protein DsRed2 was transferred from the vector pMTL23-δ-BsaI-DsRed2 
(Chapter 5) to the expression vector pET15b (Novagen) with XhoI and BamHI. Colonies were 
screened by restriction analysis with XhoI/BamHI.
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  DsRed2 was expressed the same way as ELPs in Chapter 2. In short, the vector was 
transformed into the expression strain BLR(DE3) (Novagen). A 25 mL Luria Broth culture, 
supplemented with 100 μg/mL ampicillin and 12.5 μg/mL tetracycline, was inoculated and incubated 
at 37 °C with shaking overnight. This culture was diluted to an OD600 of 0.1 in a 500 mL LB culture 
supplemented with the appropriate antibiotics, and incubated at 37 °C with shaking. At an OD600 of 
0.6 the expression was induced by the addition of IPTG to a final concentration of 1 mM. After 
incubation at 25 °C overnight the cultures were harvested by centrifugation (18,000 x g, 4 °C), and 
were further purified using the His-tag  following  the protocol for batch purification under native 
conditions (The QIAexpressionist, June 2003, Qiagen). The purified DsRed2 was concentrated and 
dialyzed against PBS with a centrifugal filter unit (Amicon Ultra-15 10 kDa, Millipore), yielding ± 80 
mg purified protein/L of culture.
Preparation of DsRed2-N3
Azide groups were introduced in the DsRed2 protein with the diazotransfer agent imidazole-1-
sulfonyl azide hydrochloride. 53, 54 To 0.5 mL DsRed2 (2.6 mg/mL, 87 µM) was added 70 μL K2CO3 
(0.1 M in MilliQ water), 1 μL CuSO4 (40 mM in MilliQ water), ending with 20 μL diazotransfer agent 
(24 mM in MilliQ water, 0.5 equiv. relative to amines in DsRed2). The solution was incubated at 
room temperature overnight, and purified over a 5 mL Sephadex-G50 (Amersham Biosciences) 
column equilibrated with MilliQ water. The solution was partly lyophilized to yield 2.5 mg/mL.
Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF)/electrospray 
ionization time-of-flight (ESI-TOF) mass spectrometry
MALDI-TOF measurements were performed on a Bruker Biflex III with 2,5-dihydroxyacetophenone 
(DHAP) as matrix. 59 The samples were mixed in a 1:1 ratio on a MALDI plate with a solution of 7.6 
mg DHAP in 375 μL EtOH and 125 μL diammonium hydrogen citrate (stock solution of 27 mg in 1.5 
mL MilliQ water) containing 2% trifluoroacetic acid. 
  Tryptic digests were performed and analyzed by MALDI-TOF mass spectrometry. Sequencing-
grade modified trypsin (0.5 µg, Promega) was added to the ELPs in PBS. After incubation for 3h at RT 
the tryptic digests were analyzed with α-cyanohydroxycinnamic acid (Sigma) or DHAP as matrix. 
  ESI-TOF measurements were performed using  an AccuTOF-CS (JEOL) with samples dialyzed 
towards MQ containing 0.5% formic acid.
Turbidity measurements
The optical absorbance of ELPs, derived from the high tension voltage, was measured at 350 nm in 
the 5-65°C range on a Jasco J-810 spectropolarimeter (band width: 1 nm, response: 1 sec., sensitivity: 
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standard, heating  rate: 1°C min-1) equipped with a PFD-425s Peltier temperature controller (Jasco) in 
phosphate buffered saline (pH 7.4).
Enzyme activity assay 
Lipase activity was analyzed by the hydrolysis of para-nitrophenol butyrate (p-NPB, Sigma). The 
reaction mixture (50 µL, pH 7) was composed of 50 mM NaH2PO4, 150 mM NaCl, enzyme (100 
nM), isopropanol (5%), Triton (0.1%) and p-NPB (1 mM). The production of para-nitrophenol was 
monitored at 25 °C for 2 h with 2 minute intervals by measuring absorbance at 405 nm in a 
Multicounter Wallac Victor2 (PerkinElmer Life Science). This experiment was carried out in triplo. The 
slope of the curve was taken as a measure of hydrolytic activity.
‘Click’ conditions for AHA-ELP and acetylene-ClickGreen
To a mixture of AHA-ELP (10 μL, 0.37 mg/mL in PBS, pH = 7.4) and acetylene-ClickGreen 8 (1.8  μL, 
1 mM in PBS, pH = 7.4) was added 2 μL of Cu(I)Br/4 mixture. The Cu(I)Br/4 mixture contained CuBr 
in MeCN (40 mM) and 4 in MeCN (80 mM) in a 1:1 v/v ratio. MilliQ (6.2 μL) was added to obtain a 
total reaction volume of 20 μL. The reaction mixture was gently shaken at r.t. for 16 hours. The 
reaction mixture was analyzed by SDS-PAGE analysis in combination with fluorescence imaging. 
‘Click’ conditions for HPG-ELP and azido-ClickGreen
To a mixture of HPG-ELP (10 μL, 0.58  mg/mL in PBS, pH = 7.4) and azido-ClickGreen 6 (1.8 μL, 1 
mM in PBS, pH = 7.4) was added 2 μL of Cu(I)Br/4 mixture. The Cu(I)Br/4 mixture contained CuBr in 
MeCN (40 mM) and 4 in MeCN (80 mM) in a 1:1 v/v ratio. MilliQ (6.2 μL) was added to obtain a 
total reaction volume of 20 μL. The reaction mixture was gently shaken at r.t. for 16 hours. The 
reaction mixture was analyzed by SDS-PAGE analysis in combination with fluorescence imaging. 
‘Click’ conditions HPG-ELP and N3-Coumarin-PEG2000
To a mixture of HPG-ELP (20 μL, 0.58  mg/mL in PBS, pH = 7.4) and azido-coumarin-PEG2000 (20 
μL, 2.1 mg/mL in PBS, pH = 7.4) was added 3 × 2 μL of Cu(I)Br/4 mixture over a period of 15 
minutes. The Cu(I)Br/4 mixture contained CuBr in MeCN (40 mM) and 4 in MeCN (80 mM) in a 1:1 v/
v ratio. MilliQ (4.0 μL) was added to obtain a total reaction volume of 50 μL. The reaction mixture 
was gently shaken at r.t. for 16 hours. The excess copper and 4 were removed by spin-filtration using 
a Millipore 10 kDa NMWL membrane. The reaction mixture was analyzed by SDS-PAGE analysis in 
combination with fluorescence imaging.
‘Clickable’ Elastins
117
‘Click’ conditions HPG-ELP and DsRed2-N3
To a mixture of ELP (16 μL, 0.587 mg/mL in PBS, pH = 7.4) and DsRed2-N3 (2 μL, 3.3 mg/mL in MQ) 
was added 2 μL of CuBr/4 mixture. The Cu(I)Br/4 mixture contained Cu(I)Br in MeCN (40 mM) and 
ligand 4 in MeCN (80 mM) in a 1:1 v/v ratio. The reaction mixture was gently shaken at r.t. for 18 
hours and used for gel electrophoresis without further purification. The gel was analyzed with the 
fluorescent image analyzer FLA-5100 in combination with processing software Multi Gauge (Fuji 
Photo Film Co., Ltd., Tokyo, Japan) using 473 nm laser excitation combined with the filter 
508FS10-25.
‘Click’ conditions HPG-ELP and AHA-CalB
To a mixture of HPG-ELP (20 μL, 0.587 mg/mL in PBS, pH = 7.4) and AHA-CalB (20 μL, 2.61 mg/mL 
in PBS, pH = 7.4) was added 3 × 2 μL of Cu(I)Br/4 mixture over a period of 15 minutes. The Cu(I)Br/4 
mixture contained CuBr in MeCN (40 mM) and 4 in MeCN (80 mM) in a 1:1 v/v ratio. MilliQ (4 μL) 
was added to obtain a total reaction volume of 50 μL. The reaction mixture was gently shaken at r.t. 
for 16 hours. The excess copper and 4 were removed by spin-filtration using a Millipore 10 kDa 
NMWL membrane. Next, the mixture was subjected to aqueous NaCl (66 μL, 5M) whereupon the 
CalB-ELP conjugate precipitated from solution. Removal of remaining HPG-ELP in the precipitate was 
achieved by FPLC (Pharmacia SMART system, Superdex 75 PC 3.2/30 column, eluent: PBS, pH = 
7.4).
Syntheses of fluorescent probes
The synthesis of ClickGreen derivatives 6  and 8 commenced with the functionalization of 4-bromo-3-
methylphenol (Scheme 2). As a result compound 9  was obtained in excellent yield (95%) by reacting 
4-bromo-3-methylphenol with ethylene carbonate. The alcohol moiety was subsequently protected 
with a silyl protecting group yielding 10 (95%). Next, a Grignard reaction between 10 and TBDMS 
protected xanthone A was performed followed by the in situ  deprotection resulting  in desired product 
5 in excellent yield (89%). Transformation of primary alcohol into a good leaving  group was 
envisioned to proceed smoothly using a small excess mesyl chloride. Surprisingly, the phenolic 
hydroxyl group turned out to be more reactive than the primary alcohol resulting in a mixture of 
mono and di-mesylated compounds 11a and 11b (both in 25%). Subjecting compound 11a to NaN3 
at a temperature of 60 °C resulted in mesyl substitution and in situ deprotection generating azido-
ClickGreen 6 (27%). 
  Introduction of the TMS-protected propynol onto 4-bromo-3-methylphenol was achieved via 
a Mitsunobu reaction yielding 12 in a good yield (72%). Performing  the Grignard reaction with 12 
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and xanthone A and subsequent hydrolysis of the TBDMS group gave TMS-protected compound 7. In 
the final step the TMS group was removed resulting in acetylene-ClickGreen 8 in quantitative yield.
Materials
All chemicals were obtained from commercial sources and used without further purification, unless 
stated otherwise. Analytical thin layer chromatography (TLC) was performed on Merck precoated 
silica gel 60 F-254 plates (layer thickness 0.25 mm) with the indicated eluent and visualization by 
ultraviolet (UV) irradiation at λ = 254 nm and/or λ = 366 nm. Preparative thin layer chromatography 
(Prep-TLC) was performed on Merck precoated silica gel 60 F-254 plates (layer thickness 1.00 mm) 
with concentration zone and visualization by UV irradiation at λ = 254 nm and/or λ = 366 nm. 
Purification by silica gel chromatography was carried out using  Acros (0.035 – 0.070 mm, pore 
diameter ca. 6 nm) silica gel. THF was distilled under nitrogen from sodium/benzophenone. CH2Cl2 
was distilled under nitrogen from CaH2.
General analytical techniques
NMR spectra were recorded on Bruker DMX300 (300 MHz and 75 MHz for 1H and 13C, respectively) 
and Varian Inova 400 (400 MHz for 1H) spectrometers. 1H-NMR chemical shifts (δ) are reported in 
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Scheme 2. Synthesis of alkyne and azido fluorophores. Reagent and conditions: i) K2CO3, 
toluene, Ar-atm., 115 °C, 24 h; ii) TBDMS-Cl, DMF, imidazole, r.t. 2 h; iii) a) Mg, EtBr2, Et2O, 
r.t., 2 h, b) A (at 0 °C), THF, r.t., 1.5 h, c) MeOH, TFA, r.t., 30 min; iv) Ms-Cl, CH2Cl2, DMAP, 
0 °C to r.t., 4 h; v) NaN3, DMF, 60 °C, 36 h; vi) DiAD, PPh3, CH2Cl2, 0 °C to r.t. 48 h; vii) 
K2CO3, MeOH, r.t., 18 h.
parts per million (ppm) relative to a residual proton peak of the solvent; δ = 7.26 for CDCl3 or δ = 
3.31 for CD3OD. Multiplicities are reported as: s  (singlet), d (doublet), t (triplet), q (quartet), dd 
(doublet of doublets), or m (multiplet). Broad peaks are indicated by the addition of br. Infrared (IR) 
spectra were recorded on an ATI Matson Genesis Series FTIR  spectrometer fitted with an ATR cell. The 
vibrations (ν) are given in cm-1. Samples for MALDI-TOF measurements were prepared from MeOH 
solutions using indoleacrylic acid (IAA) (20 mg/mL) as a matrix. LCQ/MS analysis was performed 
using Thermo scientific Advantage LCQ Lineair-Iontrap Electrospray (ESI-MS).
3,6-bis(tert-butyldimethylsilyloxy)-9H-xanthen-9-one (A)
3,6-Dihydroxy-9H-xanthen-9-one (0.500 g, 2.20 mmol) was 
dissolved in dry DMF (45 mL) after which TBDMS chloride (1.99 g, 
13.2 mmol) and imidazole (1.50 g, 22.0 mmol) were added. After 
stirring  at room temperature for 2h, the reaction mixture was 
diluted with toluene, washed extensively three times with water and dried over Na2SO4. Evaporation 
in vacuo left a light brown solid, which was recrystallized from ethanol to give A as off-white needle 
crystals (0.841 g, 84%  yield). RF = 0.90 (nheptane/EtOAc, 1:2); 1H NMR (CDCl3, 400 MHz) δ: 8.20 
(td, J = 9.1, 1.2, 1.2 Hz, 2H), 6.85 (dd, J = 9.2, 2.2 Hz, 2H), 6.84 (s, 2H), 1.01 (s, 18H), 0.29 (s, 12H) 
ppm. 13C NMR (CDCl3, 50 MHz) δ: 161.3, 159.1, 157.7, 128.2, 117.6, 116.4, 107.3, 25.5, 18.3, 4.4 
ppm. FT-IR vmax: 2924, 16.15, 1279,1270, 850, 840 cm-1. HRMS (CI+) m/z calcd for C25H37O4Si2 
457.2234, found 457.2230 [M+H]+.
2-(4-Bromo-3-methoxyphenoxy)ethanol (9)
Modified literature procedure60: under an Ar-atmosphere, K2CO3 (207 mg, 1.50 mmol) 
was added to a solution of 3-methyl-4-bromophenol (134 mg, 0.75 mmol) and ethylene 
carbonate (264 mg, 3.00 mmol) in dry toluene (5 mL). The mixture was heated to 115 
°C and stirred for 24 hours. After completion, water (20 mL) was added and the 
emulsion was extracted with EtOAc (2 × 25 mL). The organic layers were combined, 
dried over anhydrous Na2SO4 and evaporated in vacuo. Further purification was accomplished by 
column chromatography (nheptane/EtOAc, 2:1) to afford 9 as an off-white semisolid (169 mg, 98%). 
RF = 0.48 (n-heptane/EtOAc, 1:1); 1H NMR (400 MHz, CDCl3) δ: 7.40 (d, J = 8.7 Hz, 1H), 6.81 (d, J = 
3.0 Hz, 1H), 6.63 (dd, J = 8.7, 3.0 Hz, 1H), 4.05 (m, 2H), 3.95 (m, 2H), 2.36 (s, 3H) ppm. 13C NMR 
(75 MHz, CDCl3) δ: 157.7, 138.9, 132.8, 117.1, 115.8, 113.5, 69.3, 61.3, 23.1 ppm. FT-IR vmax film: 
3382 (br), 2911, 2358, 2336, 1476 (s), 1238, 1027 cm-1. HRMS (EI+) m/z calcd for C9H11O2Br [M]+● 
229.9942, found 229.9945.
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(2-(4-Bromo-3-methylphenoxy)ethoxy)(tert-butyl)dimethylsilane (10)
To a stirred solution of 2-(4-bromo-3-methylphenoxy)ethanol (9, 1,00  g, 4.35 
mmol) in DMF (30 mL) were added TBDMS-Cl (978  mg, 6.52  mmol) and 
imidazole (888  mg, 13.0 mmol). The reaction was finished after 1.5 hours stirring 
at room temperature. DMF was evaporated in vacuo and column chromatography 
(n-heptane/EtOAc, 2:1) afforded 10 as a colorless oil (1.48  g, 99%). RF = 0.86 (n-
heptane/EtOAc, 1:1); 1H NMR (400 MHz, CDCl3) δ: 7.38  (d, J = 8.7 Hz, 1H), 6.80 (d, J = 3.0, 1H), 
6.62 (dd, J = 8.7, 3.0 Hz, 1H), 4.00 (m, 2H), 3.95 (m, 2H), 2.36 (s, 3H), 0.91 (s, 9H), 0.10 (s, 6H) 
ppm. 13C NMR (75 MHz, CDCl3) δ : 158.2, 138.7, 132.7, 117.2, 115.4, 113.6, 69.5, 62.0, 25.9, 23.1, 
18.4, 5.2 ppm. FT-IR vmax film: 2923, 1473 (s), 1241, 1128, 828, 776 cm-1. HRMS (ESI+) m/z calcd 
for C15H26O2BrSi [M+H]+ 345.0885, found 345.0907.
6-Hydroxy-9-(4-(2-hydroxyethoxy)-2-methylphenyl)-3H-xanthen-3-one (5)
Modified literature procedure46: In a flame-dried Schlenk tube under an Ar-
atmosphere, dried magnesium powder (36.5 mg, 1.50 mmol) was suspended in 
a minute quantity of dry Et2O. After activation of the Mg  with a drop of 1,2-
dibromoethane, compound 10 (329 mg, 0.96 mmol) dissolved in dry Et2O (1.5 
mL) was slowly added to the mixture while gas formation was maintained by 
interval warming with a heat gun. When no more gas formation was observed, 
the mixture was stirred for 30 min at room temperature and was then cooled to 0 °C. Compound A 
(325 mg, 0.71 mmol) dissolved in dry THF (4 mL) was added dropwise to the reaction mixture. Upon 
warming  to room temperature, the color changed from yellow to brownish to deep purple in 1.5 
hours. The mixture was quenched with CH3OH and the remaining Mg  was filtered off. Deprotection 
of the TBDMS groups with aqueous HCl (2 M, 8 mL) took 10 min and was followed by TLC. After 
complete deprotection, H2O (20 mL) was added and the mixture extracted with EtOAc (3 × 40 mL). 
The organic layers were combined and dried over anhydrous Na2SO4. The solvent was removed in 
vacuo and further purification was performed by column chromatography over silica gel (CH3OH/
CH2Cl2, 1:19). The resulting orange sticky oil was lyophilized to obtain compound 5 as a red-orange 
fluffy solid (211 mg, 82%). RF = 0.30 (CH3OH/CH2Cl2, 1:9); 1H NMR (400 MHz, CD3OD) δ: 7.24 (d, 
J = 9.2 Hz, 1H), 7.17 (d, J = 8.4 Hz, 1H), 7.09 (d, J = 2.3 Hz, 1H), 7.05 (dd, J = 8.4, 2.5 Hz, 1H), 
6.86 (d, J = 2.2 Hz, 1H), 6.84 (dd, J = 9.2, 2.2 Hz, 1H), 4.17-4.15 (m, 2H), 3.94-3.92 (m, 2H), 2.04 
(s, 3H) ppm; 13C NMR (75 MHz, CD3OD) δ: 161.8, 159.7 (2C), 158.6, 158.5, 139.1, 132.9 (2C), 
131.6, 125.6, 122.5, 122.5, 117.8, 117.2 (2C), 113.5, 104.2 (2C), 70.8, 61.7, 20.1 ppm. FT-IR vmax 
film: 3377 (br), 2915, 1592 (s), 1461, 1382, 1244, 1207, 1109, 621, 609 cm-1. HRMS (ESI+) m/z 
calcd for C22H18NaO5 [M+Na]+ 385.1052, found 385.1024.
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9-(4-(2-Hydroxyethoxy)-2-methylphenyl)-6-(mesylate)-3H-xanthen-3-one (11a) and 9(4-(2-hydroxyethyl 
mesylate)-2-methylphenyl)-6-(mesylate)-3H-xanthen-3-one (11b)
Compound 5 (100 mg, 0.28  mmol) was suspended in 
dry CH2Cl2 (12 mL) in a flame-dried Schlenk tube 
under an N2-atmosphere. The suspension was cooled 
to 0 °C and DMAP (135 mg, 1.10 mmol) was added. 
After 5 min methanesulfonyl chloride (MsCl, 85.4 
μL, 1.10 mmol) was added. The suspension was 
stirred for 30 min at 0 °C, warmed to room temperature and then stirred for an additional 16 hours to 
obtain a clear solution. Additional CH2Cl2 (15 mL) was added and the solution was washed with H2O 
(15 mL). The aqueous layer was extracted with EtOAc (3 × 20 mL) and the organic layers were 
combined, dried over anhydrous Na2SO4 and evaporated in vacuo. The crude mixture was purified by 
gradient column chromatography over silica gel (CH3OH/CH2Cl2, 1:40 to 1:15) and afforded 11a and 
11b separately as orange sticky oils (30 mg (25%) and 35 mg (25%), respectively). 
Analytical data for compound 11a: RF = 0.55 (CH3OH:CH2Cl2, 1:9); 1H NMR (200 MHz, CDCl3) δ: 
7.40 (dd, J = 1.9, 0.8 Hz, 1H), 7.16-7.12 (m, 2H), 7.08  (d, J = 8.2 Hz, 1H), 7.01 (d, J = 9.8  Hz, 1H), 
6.97-6.96 (m, 1H), 6.94 (dd, J = 8.0, 2.6 Hz, 1H), 6.59 (dd, J = 9.8, 1.9 Hz, 1H), 6.43 (d, J = 1.9 Hz, 
1H), 4.20-4.16 (m, 2H), 4.06-4.02 (m, 2H), 3.25 (s, 3H), 2.06 (s, 3H) ppm. LRMS (ESI+) m/z calcd for 
C23H21O7S [M+H]+ 441.1, found 441.2.
Analytical data for compound 11b: RF = 0.60 (CH3OH:CH2Cl2, 1:9); 1H NMR (200 MHz, CDCl3) δ: 
7.41-7.40 (m, 1H), 7.18-7.13 (m, 1H), 7.13-7.12 (m, 1H), 7.09 (d, J = 8.2 Hz, 1H), 7.01-6.96 (m, 
2H), 6.93 (dd, J = 8.1, 2.5 Hz, 1H), 6.59 (dd, J = 9.5, 1.9 Hz), 6.44 (d, J = 1.9 Hz, 1H), 4.66-4.62 (m, 
2H), 4.36-4.34 (m, 2H), 3.26 (s, 3H), 3.15 (s, 3H), 2.07 (s, 3H) ppm. LRMS (ESI+) m/z calcd for 
C24H23O9S2 [M+H]+ 519.1, found 519.1.
9-(4-(2-Azidoethoxy)-2-methylphenyl)-6-hydroxy-3H-xanthen-3-one (6)
Compound 11a (30 mg, 0.068  mmol) and sodium azide (22 mg, 0.338 mmol) 
were dissolved in DMF (8  mL). The reaction mixture was warmed to 60 °C and 
stirred for 36 hours. A similar workup procedure utilized for the previous 
methods afforded azido-ClickGreen 6 as an orange-red solid after 
lyophilization from dioxane and H2O (7 mg, 27%). RF = 0.35 (CH3OH/CH2Cl2, 
1:9); 1H NMR (400 MHz, CD3OD) δ: 7.18  (d, J = 8.4 Hz, 1H), 7.11 (d, J = 9.8 
Hz, 2H), 7.08 (d, J = 2.5 Hz, 1H), 7.03 (dd, J = 8.4, 2.6 Hz, 1H), 6.71 (d, J = 2.0 Hz, 2H), 6.70 (ddd, 
J = 9.7, 2.2, 0.4 Hz, 2H), 4.29 (t, J = 4.8 Hz, 2H), 3.66 (t, J = 4.8 Hz, 2H), 2.04 (s, 3H) ppm; 13C 
NMR (75 MHz, CD3OD) δ: 184.5, 161.0, 159.5 (2C), 156.1 (2C), 139.2, 132.3 (2C) 131.6, 126.5, 
123.11 (2C), 117.7, 116.2 (2C), 104.5 (2C), 68.6, 51.4, 20.0 ppm. FT-IR vmax film: 3317 (br), 2915, 
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2107, 1593 (s), 1502, 1462 (s), 1282, 1242, 1204, 1104, 845, 616 cm-1. HRMS (ESI+) m/z calcd for 
C22H18N3O4 [M+H]+ 388.1295, found 388.1297.
(3-(4-bromo-3-methylphenoxy)prop-1-ynyl)trimethylsilane (12)
Under an N2-atmosphere, 3-methyl-4-bromophenol (93 mg, 0.50 mmol), propargyl 
alcohol (64 mg, 73.1 μL, 0.50 mmol) and PPh3 (137.6 mg, 0.525  mmol) were 
dissolved in dry CH2Cl2 (5 mL). The mixture was cooled to 0  °C and diisopropyl 
azodicarboxylate (DiAD, 107 μL, 0.55 mmol) was added drop wise. The reaction was 
allowed to warm to r.t. and was subsequently stirred for 48 h. After completion, HCl (1M, 5 mL) was 
added. The water layer was washed once with CH2Cl2 (5 mL) and the combined organic layers were 
subsequently washed with aq. NaHCO3 (sat. 10 mL). The organic layer was dried over anhydrous 
Na2SO4 and evaporated in vacuo. Further purification was accomplished by column chromatography 
(n-heptane/EtOAc, 3:1) to afford 12 as colorless oil (106 mg, 72%). RF = 0.78  (n-heptane/EtOAc, 3:1); 
1H NMR (400 MHz, CDCl3) δ: 7.41 (d, J = 8.8 Hz, 1H), 6.87 (d, J = 2.7 Hz, 1H), 6.69 (dd, J = 8.8, 
3.0 Hz, 1H), 4.63 (s, 2H), 2.37 (s, 3H), 0.17 (s, 9H) ppm. 13C NMR (50 MHz, CDCl3) δ: 156.9, 138.8, 
117.6, 116.2, 113.9, 99.7, 93.0, 56.8, 23.1, -0.3 (3C) ppm. Both HRMS and LRMS techniques were 
employed to acquire the mass of the described compound. Unfortunately, none of the techniques 
used gave a comprehensible mass spectrum.
9-(4-(3-(TMS)-prop-2-ynyloxy)-2-methylphenyl)-6-hydroxy-3H-xanthen-3-one (7)
In a flame-dried Schlenk tube under an Ar-atmosphere, dried magnesium 
powder (8.6 mg, 0.36 mmol) was suspended in a minute quantity of dry 
Et2O. After activation of the Mg with a drop of 1,2-dibromoethane, 
compound 12 (106 mg, 0.36 mmol) dissolved in dry Et2O (2 mL) was slowly 
added to the mixture while gas formation was maintained by interval 
warming  with a heat gun. When no more gas formation was observed, the 
mixture was stirred for 30 min at r.t. and then cooled to 0 °C. Compound A (114 mg, 0.25 mmol) 
dissolved in dry THF (2 mL) was added drop wise to the reaction mixture. Upon warming to room 
temperature, the color changed from yellow to brownish to deep purple in 1.5 hours. The mixture 
was quenched with CH3OH and the remaining Mg was filtered off. Deprotection of the TBDMS 
groups with aqueous HCl (2 M, 5 mL) took approximately 10 min and was followed by TLC. After 
complete deprotection, H2O (20 mL) was added and the mixture extracted with EtOAc (3 × 20 mL). 
The organic layers were combined and dried over anhydrous Na2SO4. The solvent was removed in 
vacuo and further purification was performed by gradient column chromatography over silica gel 
(CH2Cl2/CH3OH, 95:5 / 9:1). The resulting orange sticky oil (i.e. compound G, (35 mg, 33%)) was 
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taken through to the next step without extensive characterization. RF = 0.46 (CH3OH/CH2Cl2, 1:9). 
LRMS (ESI+) m/z calcd for C26H25O4Si [M+H]+ 429.6, found 429.3.
6-Hydroxy-9-(2-methyl-4-(prop-2-ynyloxy)phenyl)-3H-xanthen-3-one (8)
Compound 7 (35 mg, 0.08  mmol) was dissolved in CH3OH (5 mL) followed by 
the addition of K2CO3 (40 mg, 0.29 mmol). The reaction mixture was stirred for 
18  hours at r.t. Since no RF difference was observed for the product and the 
starting material, the reaction was followed by MS-analysis. The crude reaction 
mixture was purified by preparative TLC (CH2Cl2/CH3OH, 9:1) resulting in the 
acetylene-ClickGreen 8 as an orange fluffy solid after lyophilization from H2O/
dioxane (10 mL, 1:0.5 v/v) (28 mg, 99%). RF = 0.46 (CH3OH:CH2Cl2, 1:9). 1H NMR (400 MHz, 
CDCl3) δ: 7.11-7.09 (m, 3H), 7.00-6.97 (m, 2H), 6.87 (d, J = 2.1 Hz, 2H), 6.83 (dd, J = 9.2, 2.1 Hz, 
2H), 4.78 (d, J = 2.4 Hz, 2H), 2.60 (t, J = 2.4 Hz, 1H), 2.03 (s, 3H) ppm. 13C NMR (50 MHz, CDCl3) 
δ: 178.4, 160.2, 159.6 (2C), 156.1, 139.1, 132.3 (2C), 131.5, 126.7, 123.2 (2C), 118.0 (2C), 115.9, 
113.7 (2C), 104.5, 79.5, 77.2, 56.8, 14.5. HRMS (ESI+) m/z calcd for C23H17O4 [M+H]+ 357.1127, 
found 357.1118.
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Summary
In nature, cascade reactions are often performed by enzymes assembled in complexes. One approach 
to mimic the efficiency of natural cascade reactions is to apply microreactor technology: if the 
different enzymes involved in the cascade process are positioned in the correct order and within the 
appropriate distance of each other, the continuous liquid flow within a microreactor will ascertain 
directed transport of the reagents from one active site to the next. To allow this approach to be useful, 
a versatile immobilization methodology has to be established which enables the controlled 
positioning of multiple proteins within a microchannel environment. The main goal of the research 
described in this thesis was the development of such an immobilization system for enzymes 
connected to temperature-responsive elastin-like polypeptides, which can be controlled using  a 
temperature gradient over the microchannel. 
  Recently, an increased interest in catalytic reactions performed in microfluidic devices by 
enzymes has emerged. Originally, the use of enzymes in microreactors was restricted to the area of 
diagnostics. Lately, biocatalysis in microreactors has started to expand in the direction of synthesis. 
The efficiency and selectivity of enzymes is outstanding and in many cases easier to achieve 
compared to traditional organic synthesis. This makes the integration of biocatalysts with 
microreactors a promising  development for the application in organic chemistry. An extensive 
overview of the use of enzymes in microreactor technology is given in Chapter 1.
  The temperature-responsive elastin-like polypeptides (ELPs), envisioned for temperature-
controlled positioning  of enzymes in a microchannel, represent a special class of structural proteins. 
They display Lower Critical Solution Temperature (LCST) behavior, which is dependent on molecular 
weight, salt concentration, protein composition and concentration. A series of these polypeptides 
with varying amino acid composition were designed by using  techniques from protein engineering 
and molecular biology, which is described in Chapter 2. These ELPs were produced in Escherichia 
coli, and purified using  their LCST. The LCST behavior of the purified proteins was more accurately 
characterized by turbidity measurements, and depended greatly on the amino acid composition and 
the concentration of solutes in the solvent. 
  Reversible immobilization of enzymes using temperature-responsive ELPs requires a layer of 
covalently attached ELPs inside the microchannel. To this aim immobilization of bio-molecules to 
silicon was investigated in Chapter 3. As shown with IRRAS, XPS, AFM, and static contact angle 
measurements, it was possible to conveniently prepare well-defined N-hydroxysuccinimide-ester-
terminated mixed monolayers covalently attached onto silicon surfaces using visible light at room 
temperature. Using this mild photochemical attachment, no degradation of the NHS-ester moieties 
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was detected, and these moieties could be substituted by larger amines. Additionally, the density of 
functionalities could be fine-tuned. As a second method of covalent attachment, glutaraldehyde 
functionalized glass was conjugated with amine moieties present in proteins followed by reductive 
amination. Static contact angle measurements and XPS showed that glass surfaces could easily be 
modified and functionalized with ELP. The compatibility of glass with fluorescence detection systems 
offered a promising  outlook for the reversible immobilization of fluorescent ELP fusion proteins in a 
microchannel using a temperature gradient over a surface.
  The ability to independently control the LCST of a mixture of ELPs is important for the 
stepwise positioning of ELP fusion proteins in a microchannel. This application requires a step-by-step 
separation of a multicomponent homogeneous mixture in its individual components. In Chapter 4 the 
production of ELPs with varying  degrees of polymerization and composition via protein engineering 
is described. The LCST of aqueous mixtures containing two or three of these different molecular 
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Figure 1. Scheme of positional assembly in a reactor with an arrow indicating the flow 
direction. a) Assembled reactor with functionalized surface. b) Positioning of enzyme fused to 
ELP using heater 1. c) Positioning of second enzyme fused to ELP using heater 1 and 2, resulting 
in positional assembly of both ELP fusion proteins in two patches.
weight ELPs was investigated. The turbidiy measurements showed that blends of ELPs displayed 
independent transitions for each ELP. This behavior was observed for ELPs varying in length, as well 
as differing in amino acid composition. Furthermore, these independent transitions were preserved 
for varying salt concentrations. 
  The work in this thesis describes the development of a non-covalent immobilization system 
based on stimulus-responsive ELPs to facilitate the positioning of proteins in microchannels. In 
Chapter 5 the work presented in the previous chapters was combined for the thermally triggered 
positional assembly of two ELP fusion proteins on one surface. Two ELP variants differing  in their 
amino acid composition, which resulted in different transition temperatures, were constructed and 
connected to fluorescent proteins EGFP and DsRed2. These fusion proteins showed the expected 
LCST behavior, which could be simply controlled by varying concentrations of NaCl. Furthermore, 
their independent LCSTs were preserved in mixtures of the fusion proteins. Using only the 
temperature-responsive property of the ELP fusion partner, the formation of two patches of fluorescent 
proteins on the bottom of a microreactor was demonstrated. This research was extended towards the 
immobilization of ELPs fused to enzymes instead of fluorescent proteins. Candida antarctica Lipase B 
was chosen as initial fusion partner for the first step of a cascade reaction.
  The use of traditional molecular biology techniques can be a laborious process to obtain 
multiple ELP-enzyme fusions needed for cascade reactions in microreactors. A more versatile 
approach to obtain ELP-enzyme conjugates is presented in Chapter 6. Non-natural amino acids were 
incorporated yielding  ‘clickable’ elastins, which were conjugated to different moieties via Cu-
catalyzed azide-alkyne cycloadditions. The functionality of the ‘clicking’ partners, namely fluorescent 
probes, a polymer, and proteins, was preserved in the resulting hybrid materials. The two illustrations 
of protein-ELP conjugates demonstrated that the use of ‘clickable’ elastins is a successful approach to 
obtain conjugates which exhibit LCST behavior after functionalization. The ability to selectively 
conjugate ELPs to a variety of materials using  orthogonal functionalities introduces a new method to 
incorporate the characteristic LCST behavior of ELPs into hybrid structures in a convenient and 
efficient way. 
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Samenvatting
In de natuur worden cascadereacties vaak efficiënt uitgevoerd door enzymen die verenigd zijn in 
complexen. Deze efficiëntie kan geïmiteerd worden met behulp van microreactor-technologie: als de 
verschillende enzymen uit de cascade in de juiste volgorde zijn gepositioneerd en op de juiste 
afstand van elkaar, dan zorgt de continue vloeistofstroom in de microreactor voor transport van de 
reactanten van de ene actieve site naar de volgende. Om dit te bereiken is een veelzijdige 
immobilisatiemethode nodig, waarmee verschillende enzymen heel precies geplaatst kunnen worden 
binnen een microkanaaltje. Het belangrijkste doel van het onderzoek in dit proefschrift is de 
ontwikkeling van een dergelijke immobilisatiemethode voor enzymen die gebonden zijn aan 
elastine-achtige polypeptides. Deze polypeptides zijn temperatuurgevoelig en door deze eigenschap 
kunnen ze, met behulp van een temperatuurgradiënt, gecontroleerd geïmmobiliseerd worden in een 
microkanaaltje.
  De laatste jaren is er een toenemende belangstelling voor enzym-gekatalyseerde reacties in 
microreactoren. Aanvankelijk was het gebruik van enzymen in microreactoren beperkt tot de 
diagnostiek. De laatste tijd ontwikkelt de biokatalyse in microreactoren zich in de richting van 
synthese. De uitstekende efficiëntie en selectiviteit zijn in veel gevallen gemakkelijker te bereiken 
met enzymen dan met traditionele organisch-chemische procedures. Hierdoor is de integratie van 
biokatalyse met microreactoren een veelbelovende ontwikkeling  voor toepassing in organische 
chemie. Een uitgebreid overzicht van het gebruik van enzymen in microreactortechnologie wordt 
gegeven in Hoofdstuk 1.
  Elastine-achtige polypeptides (ELP’s), die in dit onderzoek gebruikt worden om enzymen in 
een microkanaaltje te plaatsen, vertegenwoordigen een speciaal type structurele eiwitten die 
reageren op temperatuur. Ze aggregeren reversibel bij verwarming boven een specifieke 
overgangstemperatuur, wat bekend staat als het zogenaamde Lower Critical Solution Temperature 
(LCST)-gedrag, en wat afhankelijk is van molecuulgewicht, aminozuursamenstelling  en zout- en 
eiwitconcentratie. In Hoofdstuk 2 staat beschreven hoe een serie van deze polypeptides, verschillend 
in aminozuursamenstelling, werd ontworpen met technieken uit de protein engineering en de 
moleculaire biologie. De ELP’s werden geproduceerd in de bacterie Escherichia coli en gezuiverd 
door gebruik te maken van hun overgangstemperatuur. Het LCST-gedrag van de gezuiverde eiwitten 
werd nauwkeurig  bepaald met behulp van turbiditeitsmetingen en bleek, zoals verwacht, zeer 
afhankelijk van de aminozuursamenstelling en de concentratie van zouten in de oplossing.
  Voor reversibele immobilisatie van ELP-functionele enzymen in microkanaaltjes, dient de 
wand van deze kanaaltjes te zijn voorzien van een ondergrond van ELP’s. Deze laag ELP’s moet 
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hiervoor covalent aan het oppervlak gebonden zijn. Een nieuwe immobilisatiemethode voor 
biomoleculen op si l icium wordt behandeld in Hoofdstuk 3. IRRAS, XPS AFM en 
contacthoekmetingen werden gebruikt om te bewijzen dat het mogelijk is om goed gedefinieerde 
monolagen op silicium te maken. Deze monolagen werden gemaakt door een N-
hydroxysuccinimide-ester met behulp van zichtbaar licht bij kamertemperatuur chemisch te 
verankeren. De NHS-ester bleef intact tijdens immobilisatie en kon daarom gebruikt worden voor 
koppeling met amine-functionele moleculen.. Verder was het mogelijk om de dichtheid van deze 
actieve esters te controleren. Naast silicium werd glas, gefunctionaliseerd met glutaraldehyde, 
gebruikt als substraat. ELP’s met amine-groepen werden gekoppeld aan het glas, waarna reductieve 
aminering  volgde. Contacthoekmetingen en XPS lieten zien dat het glasoppervlak efficiënt te 
modificeren was. Doordat glas uitstekend gecombineerd kan worden met detectiesystemen die 
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Figuur 1. Schema van plaatsing van enzymen in een reactor. De pijl geeft de richting van de 
vloeistofstroom aan. a) Reactor met een gefunctionaliseerd oppervlak. b) Immobilisatie van een 
enzym gekoppeld aan ELP met behulp van verwarmingselement 1. c) Immobilisatie van het 
tweede enzym gekoppeld aan ELP met behulp van verwarmingselementen 1 and 2. Dit leidt tot 
plaatsing van beide ELP-fusie-eiwitten op verschillende posities.
gebaseerd zijn op fluorescentie, is dit oppervlak zeer geschikt voor de reversibele immobilisatie van 
fluorescente ELP-fusie-eiwitten in een microkanaaltje met behulp van een temperatuurgradiënt.
  De mogelijkheid om het LCST-gedrag van individuele ELP’s in een ELP-mengsel onafhankelijk 
van elkaar te controleren is belangrijk om sequentieel ELP-fusie-eiwitten in een microkanaaltje te 
plaatsen. Hiervoor moeten de verschillende ELP’s één voor één uit een homogeen mengsel te 
scheiden zijn. In Hoofdstuk 4 wordt de productie van ELP’s beschreven die van elkaar verschillen in 
gewicht en aminozuursamenstelling. Het LCST-gedrag van verschillende mengsels van deze ELP’s 
werd onderzocht met behulp van turbiditeitsmetingen. Deze lieten zien dat de ELP’s onafhankelijk 
van elkaar LCST-gedrag vertonen. Dit werd zowel waargenomen voor ELP’s die verschilden in 
aminozuursamenstelling als in gewicht. 
  In Hoofdstuk 5 worden de voorgaande hoofdstukken gecombineerd om twee verschillende 
ELP-fusie-eiwitten op een oppervlak te plaatsen met behulp van een temperatuurgradiënt. Hiervoor 
werden twee verschillende ELP’s geproduceerd die met behulp van moleculair biologische 
technieken gekoppeld waren aan de fluorescente eiwitten EGFP en DsRed2. Het verschil in 
aminozuursamenstelling  van de ELP’s resulteerde in verschillend LCST-gedrag  van deze fusie-
eiwitten. Dit kon nog worden beïnvloed door middel van variërende NaCl-concentraties. Ook 
vertoonden deze fusie-eiwitten individueel LCST-gedrag in een mengsel van fusie-eiwitten. Met 
gebruikmaking van alleen de temperatuurgevoeligheid van de ELP-fusiepartner werden in een ELP-
gefunctionaliseerde glazen microreactor de twee fusie-eiwitten op twee verschillend verwarmde 
posities geïmmobiliseerd, wat kon worden aangetoond met fluorescentie. Dit onderzoek werd 
doorgezet met de immobilisatie van ELP’s gefuseerd met enzymen. Als eerste fusiepartner viel de 
keuze op Candida antartica Lipase B voor de eerste stap in een mogelijke cascadereactie.
  Het gebruik van traditionele moleculaire biologietechnieken bleek een bewerkelijke methode 
te zijn om verschillende ELP-enzym fusies te produceren voor cascadereacties in microreactoren. Een 
veelzijdige manier om ELP-enzym conjugaten te maken wordt beschreven in Hoofdstuk 6. Niet-
natuurlijke aminozuren werden in ELP’s ingebouwd, wat resulteerde in ‘klikbare’ elastines. Deze 
elastines werden ‘geklikt’ aan verschillende moleculen via de koper-gekatalyseerde azide-alkyn 
cycloadditie. De eigenschappen van de ‘geklikte’ partners (fluorescente moleculen, een polymeer en 
functionele eiwitten) bleven behouden in de hybride materialen. De twee voorbeelden van ELP-eiwit 
conjugaten lieten zien dat het gebruik van ‘klikbare’ elastines een succesvolle aanpak is om 
conjugaten te produceren die ook LCST-gedrag vertonen na functionalisering. De mogelijkheid om 
ELP’s selectief aan allerlei soorten materialen te kunnen conjugeren is een nieuwe methode om het 
karakteristieke LCST-gedrag van ELP’s op een gemakkelijke en efficiënte manier in hybride materialen 
in te bouwen.
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Dankwoord
Een promotieonderzoek is een fantastische ervaring, een periode met leuke en af en toe ook 
moeilijkere momenten. Het was doorzetten, incasseren, af en toe een traan laten en uiteindelijk ook 
successen vieren. Door vele mensen werd ik gedurende deze vier jaar geholpen, bijgestaan en 
gemotiveerd, en hen wil ik hiervoor graag bedanken.
  Mijn promotieonderzoek had ik nooit kunnen voltooien zonder de grote belangstelling  en 
steun van mijn begeleiders Jan van Hest, Frits de Wolf en Han Zuilhof.
  Jan, gedurende het hele project was jij de constante factor. Het bijzondere aan mijn project 
was dat ik op drie locaties met drie begeleiders werkzaam ben geweest. Dit was niet altijd makkelijk, 
zeker wel leuk en uitdagend, voor ons allebei. Ik kon altijd bij je terecht als ik advies nodig had, en 
natuurlijk ook om mooie resultaten te delen. Ik ben je zeer erkentelijk voor het blijven geloven in mijn 
capaciteiten en de natuurlijke rust en kalmte waarmee je mij benaderde. Ik zal me onze 
samenwerking met veel plezier blijven herinneren.
  Frits, jouw opmerkingen over mijn werk hebben mij geleerd kritisch naar mijn resultaten te 
kijken. Iets wat me in het verdere verloop van mijn onderzoek erg van pas is gekomen. Het eerste jaar 
heb ik in jouw lab doorgebracht en vanaf het warme welkom dat ik op mijn eerste dag kreeg  heb ik dit 
jaar als erg plezierig ervaren. 
  Han, ik wil je graag bedanken voor je positieve instelling  en voor de mogelijkheden die je me 
hebt geboden om mee te gaan op studiereis naar Californië. Het was een onvergetelijke reis. Verder 
ben ik je erg  erkentelijk dat je me hebt geïntroduceerd bij dr. Arafat, die me heeft ingewijd in de 
geheimen van monolagen op silicium. De periode die ik in jouw groep heb doorgebracht heeft me 
veel kennis, ervaring en nieuwe vrienden opgeleverd.
  Twee keer per jaar kreeg  ik de mogelijkheid om mijn resultaten te presenteren aan de Process 
on a Chip begeleidingscommissie (NWO-ACTS), bestaande uit Raf Reintjens en Friso van Assema 
(DSM), Dirk Verdoes (TNO), Henk Leeuwis (Lionix) en Cees van Rijn (Aquamarijn). Hartelijk dank 
voor jullie interesse in mijn onderzoek. Onmisbaar voor de prachtige plaatjes uit Hoofdstuk 5 was de 
reactor van Lionix; hiervoor wil ik graag Albert Prak bedanken.
  De manuscriptcommissie, bestaande uit Maarten Merkx, Dennis Löwik en Roeland Nolte, wil 
ik hartelijk danken voor de tijd die zij hebben genomen om mijn proefschrift kritisch door te lezen en 
hun hieruit voortvloeiende scherpe commentaar. 
  A special word of thanks to Kristi Kiick. I really appreciate you clearing your busy schedule to 
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attend my defense. I fondly remember the time I spent in your wonderful group at the University of 
Delaware. 
  Een aantal mensen noem ik graag voor hun inspanningen op het gebied van analyses. Liesbeth 
Pierson (Gemeenschappelijk Instrumentarium) voor de hulp met confocal en fluorescentie-
microscopie, Lambert Lambooy (Kindergeneeskunde) voor de beschikking  over de 
fluorescentiescanner, Joost van Dongen (TU Eindhoven) voor de LC-MS analyses van mijn eiwitten en 
Marcel Giesbers (Wageningen UR) voor de XPS metingen.
  Tijdens mijn promotieonderzoek heb ik een aantal studenten mogen begeleiden. Tim, ik ben 
blij dat het werk aan ‘clickable’ elastines waarmee jij bent begonnen een heel mooi artikel heeft 
opgeleverd. Thijs en Rick, de tijd die jullie hebben gewerkt aan structurele eiwitten was niet altijd 
gemakkelijk, maar het was een genoegen om jullie te begeleiden en in het lab te hebben.
  Gedeeld succes is dubbel succes. Veel voldoening heb ik gehaald uit verschillende 
samenwerkingen die resulteerden in geslaagde artikelen. Mijn eerste ervaring had ik met Joost 
Opsteen; ik hoop dat je mijn enthousiasme deelt over fluorescente eiwitten. Later kwamen deze 
eiwitten en mijn favoriete ELPs Stijn van Dongen goed van pas voor zijn selectieve functionalisering 
van eiwitten. Ahmed Arafat,                    , and Menglong  Yang, 谢谢, a heart-felt thank you for the 
work on surface chemistry. Roelof Schipperus, ik ben blij dat je Pichia aan het werk hebt gekregen met 
mijn constructen. Mijn laatste hoofdstuk was echt teamwork; Sanne Schoffelen en Sander van Berkel, 
hartelijk dank voor jullie inzet. Verder wil ik hier nog  een aantal personen noemen die mijn 
onderzoek praktisch vooruit hebben geholpen. Aernout Martens, je inventieve vector heeft het 
kloneringswerk stukken vereenvoudigd. Joris Meijer, in het bijzonder je hulp bij de afronding van mijn 
onderzoek was erg bruikbaar. Ton Dirks, jou wil ik bedanken voor het delen van je polymeren, je 
chemische hulp en ontwerptalent dat tot uiting  komt in de covers van chemcomm en mijn proefschrift. 
Maar bovenal bedankt voor alle steun en goede vriendschap.
  Een woord van dank is hier ook op zijn plaats voor het uitvoeren van mijn onderzoek binnen 
andere afdelingen; aan prof. Ernst Sudhölter (Organische Chemie, Wageningen UR) die altijd warme 
belangstelling toonde voor mijn project, verder aan prof. Henk Stunnenberg  (Moleculaire Biologie) en 
prof. Ger Pruijn (Biomoleculaire Chemie) voor de mogelijkheid om mijn werk gedeeltelijk in het 
NCMLS uit te kunnen voeren. Anita en Josephine, Carla en Siebe, dankjulliewel voor de goede 
organisatie van alle faciliteiten op het lab. 
  Het eerste jaar van mijn project heb ik uitgevoerd bij A&F in Wageningen. Graag wil ik mijn 
collega’s bedanken voor de fijne tijd en met name mijn labgenoten Aernout, Antoine, Emile, Jan, Joost 
en Marc, bij wie ik voor praktische hulp altijd kon aankloppen. 
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  Aan mijn periode bij Organische Chemie in Wageningen denk ik met veel plezier terug. Mijn 
collega’s heb ik op een leuke en ontspannen manier leren kennen tijdens de studiereis naar Californië, 
met name Kishore, Louis, Ioan, Remko, Ruud, en Suzanne. Veel plezier heb ik beleefd met mijn 
kamergenoten Jurjen en Luc. Anouk, ‘girls nights’ with Milena are nights to remember. A few special 
words to Milena, a wonderful friend with so many shared opinions. You made my period in 
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Figure 5.6. Selective aggregation of a mixture of ELP1-EGFP and ELP2-DsRed2 (each 0.1 mg/
mL) in PBS supplemented with 1 M NaCl, incubated at 30 °C (1), 50 °C (2), and 4 °C (3). GFP1 
filter (a), DsRed filter (b), overlap of both filters (c).
Figure 5.7. a) Side view of reactor holder with two Nanoports, and a spacer with O-ring 
between the functionalized bottom slide and cover slide. b) Top view chip with two 
independently controlled heaters, each surrounded by two sensors to monitor the temperature. 
c) Photo of reactor holder with two Nanoports and six small screws. d) Photo of chip with two 
heaters and four sensors, controlled via a 12-pin connector to PC.
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Figure 5.9. Fluorescence scans of the glass slide after positional assembly of ELP1-EGFP and 
ELP2-DsRed2. a) 532nm laser/570DF20 filter, b) 473 nm laser/ 508FS10-25, c) overlap of scan a 
and b.
Figure 5.10. Fluorescence scans of the glass slide of the negative control experiments. a) 
532 nm laser/570DF20 filter, b) 473 nm laser/ 508FS10-25. Negative control 1 was 
performed on a non-functionalized glass slide. Negative control 2 was executed on an ELP 
functionalized glass slide with heaters set at at 20 °C.
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